Scolaris Content Display Scolaris Content Display

Le lavage intra‐cavité et l'irrigation de la plaie pour la prévention de l'infection du site opératoire

Contraer todo Desplegar todo

Referencias

Al‐Shehri 1994 {published data only}

Al‐Shehri MY, Saif S, Ibrahim A, Abu‐Eshy S, Al‐Malki T, Latif AA, et al. Topical ampicillin for prophylaxis against wound infection in acute appendicitis. Annals of Saudi Medicine 1994;14(3):233‐6. CENTRAL

Baker 1994 {published data only}

Baker DM, Jones JA, Nguyen‐Van‐Tam JS, Lloyd JH, Morris DL, Bourke JB, et al. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. British Journal of Surgery 1994;81(7):1054‐6. CENTRAL
Baker DM, Jones JA, Nguyen‐Van‐Tam JS, Morris DL. Taurolidine peritoneal lavage as a prophylaxis against post‐operative infection in colorectal surgery: a randomised double‐blind controlled trial of 300 patients. Irish Journal of Medical Science 1994;163(3):144. CENTRAL

Bourgeois 1985 {published data only}

Bourgeois FJ, Pinkerton JA, Andersen W, Thiagarajah S. Antibiotic irrigation prophylaxis in the high‐risk cesarean section patient. American Journal of Obstetrics and Gynecology 1985;155(2):197‐201. CENTRAL

Brown 2007 {published data only}

Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega G, Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double‐blind, randomized, controlled study. Fertility and Sterility 2007;88(5):1413‐26. CENTRAL

Browne 1978 {published data only}

Browne MK, Mackenzie M, Doyle PJ. A controlled trial of taurolin in established bacterial peritonitis. Surgery, Gynecology and Obstetrics 1978;146:721‐4. CENTRAL

Buanes 1991 {published data only}

Buanes TA, Andersen GP, Jacobsen U, Nygaard K. Perforated appendicitis with generalized peritonitis. Prospective, randomized evaluation of closed postoperative peritoneal lavage. European Journal of Surgery 1991;157(4):277‐9. CENTRAL

Carl 2000 {published data only}

Carl SH, Hampton RS. Normal saline, pelvic and intrauterine irrigation in the high risk cesarean section (CS) patient as a safe and cost‐effective method of infection prophylaxis. American Journal of Obstetrics and Gynecology 2000;182(1):S96. CENTRAL

Case 1987 {published data only}

Case WG, Davenport M, Hardy S, Sagar P, Hutton K, Benson EA. Does lavage of mastectomy wounds with strong tetracycline solution reduce the incidence of postoperative seroma?. Surgical Research Communications 1987;2(2):103‐5. CENTRAL

Cervantes‐Sanchez 2000 {published data only}

Cervantes‐Sanchez CR, Gutiérrez‐Vega R, Vázquez‐Carpizo JA, Clark P, Athie‐Gutierrez C. Syringe pressure irrigation of subdermic tissue after appendectomy to decrease the incidence of postoperative wound infection. World Journal of Surgery 2000;24(1):38‐41. CENTRAL
Cervantes‐Sánchez CR, Gutiérrez‐Vega R, Vázquez‐Carpizo J, Clark P. Pressure irrigation of the surgical wound in complicated appendicitis. Revista Médica del Hospital General de México 1996;59(2):54‐8. CENTRAL

Chang 2006 {published data only}

Chang F‐Y, Chang M‐C, Wang S‐T, Yu W‐K, Liu C‐L, Chen T‐H. Can povidone‐iodine solution be used safely in a spinal surgery?. European Spine Journal 2006;15(6):1005‐14. CENTRAL

Cheng 2005 {published data only}

Cheng MT, Chang MC, Wang ST, Yu WK, Liu CL, Chen TH. Efficacy of dilute Betadine solution irrigation in the prevention of postoperative infection of spinal surgery. Spine 2005;30(15):1689‐93. CENTRAL

Cho 2004 {published data only}

Cho OY, Yoon HS. Effect of the exchange of saline used in surgical procedures on surgical site infection. Taehan Kanho Hakhoe Chi 2004;34(3):467‐76. CENTRAL

Dashow 1986 {published data only}

Dashow EE, Read JA, Coleman FH. Randomized comparison of five irrigation solutions at cesarean section. Obstetrics and Gynecology 1986;68:473‐8. CENTRAL

De Jong 1982 {published data only}

De Jong TE, Vierhout RJ, Van Vroonhoven TJ. Povidone‐iodine irrigation of the subcutaneous tissue to prevent surgical wound infections. Surgery, Gynecology and Obstetrics 1982;155(2):221‐4. CENTRAL

Elliott 1986 {published data only}

Elliott JP, Flaherty JF. Comparison of lavage or intravenous antibiotics at cesarean section. Obstetrics and Gynecology 1986;67(1):29‐32. CENTRAL

Greig 1987 {published data only}

Greig J, Morran C, Gunn R, Mason B, Sleigh D, McArdle C. Wound sepsis after colorectal surgery: the effect of cefotetan lavage. Chemioterapia 1987;6(2 Suppl):595‐6. CENTRAL

Gungorduk 2010 {published data only}

Gungorduk K, Asicioglu O, Celikkol O, Ark C, Tekirdag AI. Does saline irrigation reduce the wound infection in caesarean delivery?. Journal of Obstetrics and Gynaecology 2010;30(7):662‐6. CENTRAL

Halsall 1981 {published data only}

Halsall AK, Montague‐Brown H, Edwards MG, Prasad N, Welsh CL, Mazumder HC, et al. Reduction of wound sepsis after appendicitis: a report of a double‐blind trial of taurolin wound irrigation after appendicectomy. Pharmatherapeutica 1981;2(10):673‐7. CENTRAL

Hargrove 2006 {published data only}

Hargrove R, Ridgeway S, Russell R, Norris M, Packham I, Levy B. Does pulse lavage reduce hip hemiarthroplasty infection rates?. Journal of Hospital Infection 2006;62(4):446‐9. CENTRAL

Harrigill 2003 {published data only}

Harrigill KM, Miller HS, Haynes DE. The effect of intra‐abdominal irrigation at cesarean delivery on maternal morbidity: a randomized trial. Obstetrics and Gynecology 2003;101:80‐5. CENTRAL

Kokavec 2008 {published data only}

Kokavec M, Frištáková M. Efficacy of antiseptics in the prevention of post‐operative infections of the proximal femur, hip and pelvis regions in orthopedic pediatric patients. Analysis of the first results [Prvé výsledky analýzy účinnosti antiseptík v prevencii pooperačných infekcií v oblasti proximálneho femuru, bedrového kĺbu a panvy u detských ortopedických pacientov]. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 2008;75(2):106‐9. CENTRAL

Kubota 1999 {published data only}

Kubota A, Hoki M, Yonekura T, Nose K, Hirooka S, Kosumi T, et al. Effectiveness of acidic oxidative potential water in peritoneal lavage for perforated appendicitis. Asian Journal of Surgery 1999;22(3):282‐4. CENTRAL

Kubota 2015 {published data only}

Kubota A, Goda T, Tsuru T, Yonekura T, Yagi M, Kawahara H, et al. Efficacy and safety of strong acid electrolyzed water for peritoneal lavage to prevent surgical site infection in patients with perforated appendicitis. Surgery Today 2015;45(7):876‐9. CENTRAL

Levin 1983 {published data only}

Levin DK, Gorchels C, Andersen R. Reduction of post‐cesarean section infectious morbidity by means of antibiotic irrigation. American Journal of Obstetrics and Gynecology 1983;147(3):273‐7. CENTRAL

Lord 1983 {published data only}

Lord JW, LaRaja RD, Daliana M, Gordon MT. Prophylactic antibiotic wound irrigation in gastric, biliary, and colonic surgery. American Journal of Surgery 1983;145(2):209‐12. CENTRAL

Magann 1993 {published data only}

Magann EF, Dodson MK, Ray MA, Harris RL, Martin JN, Morrison JC. Preoperative skin preparation and intraoperative pelvic irrigation: impact on post‐cesarean endometritis and wound infection. Obstetrics and Gynecology 1993;81(6):922‐5. CENTRAL

Mahomed 2016 {published data only}

Mahomed K, Ibiebele I, Buchanan J. Povidone‐iodine wound irrigation prior to skin closure at caesarean section to prevent surgical site infection: a randomised controlled trial. BJOG 2016;123(Suppl 2):146‐7. CENTRAL
Mahomed K, Ibiebele I, Buchanan J. The Betadine trial ‐ antiseptic wound irrigation prior to skin closure at caesarean section to prevent surgical site infection: a randomised controlled trial. Australian & New Zealand Journal of Obstetrics & Gynaecology 2016;56(3):301‐6. CENTRAL

Marti 1979 {published data only}

Marti MC, Moser G. Prevention of parietal septic complications by irrigation of the appendectomy wound. Helvetica Chirurgica Acta 1979;45(6):739‐42. CENTRAL

Mirsharifi 2008 {published data only}

Mirsharifi SR, Emami Razavi SH, Jafari S, Bateni H. The effect of antibiotic irrigation of surgical incisions in prevention of surgical site infection. Tehran University Medical Journal 2008;65(11):71‐5. CENTRAL

Mohd 2010 {published data only}

Mohd AR, Ghani MK, Awang RR, Su Min JO, Dimon MZ. Dermacyn irrigation in reducing infection of a median sternotomy wound. Heart Surgery Forum 2010;13(4):E228‐32. CENTRAL

Moylan 1968 {published data only}

Moylan JA, Brockenbrough EC. Antibiotic wound irrigation in the prevention of surgical wound infection. Surgical Forum 1968;19(d):66‐7. CENTRAL

Neeff 2016 {published data only}

Neef HP, Anna MS, Holzner PA, Wolff‐Vorbeck G, Hopt UT, Makowiec F. Effect of polyhexanide on the incidence of surgical site infections after colorectal surgery. Gastroenterology 2016;150(4 (Suppl 1)):S1244. CENTRAL

Nikfarjam 2014 {published data only}

Nikfarjam M, Weinberg L, Fink MA, Muralidharan V, Starkey G, Jones R, et al. Pressurized pulse irrigation with saline reduces surgical‐site infections following major hepatobiliary and pancreatic surgery: randomized controlled trial. World Journal of Surgery 2014;38(2):447‐55. CENTRAL

Oestreicher 1989 {published data only}

Oestreicher M, Tschantz P. Prevention of infection at the operative site: irrigation with iodine derivatives, or NaCl. A prospective and randomized study in general surgery [Prévention de l'infection de la plaie opératoire: lavage par dérivé iodé, ou NaCl. Etude prospective et randomisée en chirurgie générale]. Helvetica Chirurgica Acta 1989;56(1‐2):133‐7. CENTRAL

Oleson 1980 {published data only}

Oleson A, Jorgensen F, Bilde T, Clausen E, Laursen H. Peritoneal lavage of diffuse peritonitis derived from perforated appendix [Peritonealskylning ved diffus peritonitis udgaet fra perforeret appendix]. Ugeskrift for Laeger 1980;142(22):1415‐8. CENTRAL

Oller 2015 {published data only}

Oller I, Ruiz‐Tovar J, Cansado P, Zubiaga L, Calpena R. Effect of lavage with gentamicin vs clindamycin vs physiologic saline on drainage discharge of the axillary surgical bed after lymph node dissection. Surgical Infections 2015;16(6):781‐4. CENTRAL

Ozlem 2015 {published data only}

Ozlem N. May peritoneal aspiration without irrigation decrease postoperative complication rate in perforated appendicitis?. Surgical Endoscopy 2015;29:S52. [Abstract O217]CENTRAL
Ozlem N, Yildirim K, Kesmer S. May peritoneal aspiration without irrigation decrease postoperative complication rate in perforated appendicitis?. European Surgical Research 2013;50(Suppl 1):23‐4. [Abstract OP31]CENTRAL

Peterson 1990 {published data only}

Peterson CM, Medchill M, Gordon DS, Chard HL. Cesarean prophylaxis: a comparison of cefamandole and cefazolin by both intravenous and lavage routes, and risk factors associated with endometritis. Obstetrics and Gynecology 1990;75(2):179‐82. CENTRAL

Platt 2003 {published data only}

Platt AJ, Mohan D, Baguley P. The effect of body mass index and wound irrigation on outcome after bilateral breast reduction. Annals of Plastic Surgery 2003;51(6):552‐5. CENTRAL

Rambo 1972 {published data only}

Rambo WM. Irrigation of the peritoneal cavity with cephalothin. American Journal of Surgery 1972;123(2):192‐5. CENTRAL

Ruiz‐Tovar 2011 {published data only}

Ruiz‐Tovar J, Santos J, Armananzas L, Arroyo A, Lopez A, Alcaide MJ, et al. Evaluation of the effect of intraabdominal irrigation with normal saline and a with a gentamicin‐clindamicin solution on the appearance of postoperative intrabdominal abscess and wound infection after elective surgery for colorectal cancer. 24th European Congress on Surgical Infection; 2011 May 25‐8; León, Spain. 2011:A15. CENTRAL

Ruiz‐Tovar 2012 {published data only}

Ruiz‐Tovar J, Santos J, Arroyo A, Llavero C, Armananzas L, Lopez‐Delgado A, et al. Effect of peritoneal lavage with clindamycin‐gentamicin solution on infections after elective colorectal cancer surgery. Journal of the American College of Surgeons 2012;214(2):202‐7. CENTRAL

Ruiz‐Tovar 2013 {published data only}

Ruiz‐Tovar J, Cansado P, Perez‐Soler M, Gomez MA, Llavero C, Calero P, et al. Effect of gentamicin lavage of the axillary surgical bed after lymph node dissection on drainage discharge volume. Breast 2013;22(5):874‐8. CENTRAL

Ruiz‐Tovar 2016a {published data only}

Ruiz‐Tovar J, Llavero C, Gamallo C, Santos J, Calpena R, Arroyo A, et al. Effect of peritoneal lavage with clindamycin‐gentamicin solution during elective colorectal cancer surgery on the oncologic outcome. Surgical Infections 2016;17(1):65‐70. CENTRAL

Ruiz‐Tovar 2016b {published data only}

Ruiz‐Tovar J, Llavero C, Munoz JL, Zubiaga L, Diez M, Obelche Group. Effect of peritoneal lavage with clindamycin‐gentamicin solution on post‐operative pain and analytic acute‐phase reactants after laparoscopic sleeve gastrectomy. Surgical Infections 17;3:357‐62. CENTRAL

Schein 1990 {published data only}

Schein M, Gecelter G, Freinkel W, Gerding H, Becker PJ. Peritoneal lavage in abdominal sepsis. A controlled clinical study. Archives of Surgery 1990;125(9):1132‐5. CENTRAL

Shimizu 2011 {published data only}

Shimizu H, Inoue T, Fujimura M, Saito A, Tominaga T. Cerebral blood flow after surgery for unruptured cerebral aneurysms: effects of surgical manipulation and irrigation fluid. Neurosurgery 2011;69(3):677‐88. CENTRAL

Silverman 1986 {published data only}

Silverman SH, Ambrose NS, Youngs DJ, Shepherd AF, Roberts AP, Keighley MR. The effect of peritoneal lavage with tetracycline solution on postoperative infection. A prospective, randomized, clinical trial. Diseases of the Colon and Rectum 1986;29(3):165‐9. CENTRAL

Sindelar 1979 {published data only}

Sindelar WF, Mason GR. Efficacy of povidone‐iodine irrigation in prevention of surgical wound infections. Surgical Forum 1977;28:48‐51. CENTRAL
Sindelar WF, Mason GR. Irrigation of subcutaneous tissue with povidone‐iodine solution for prevention of surgical wound infections. Surgery Gynecology and Obstetrics 1979;148(2):227‐31. CENTRAL

Snow 2016 {published data only}

Snow HA, Choi J, Cheng MW, Chan ST. Irrigation versus suction alone during laparoscopic appendectomy: a randomized controlled equivalence trial. International Journal of Surgery 2016;28:91‐6. CENTRAL

St Peter 2012 {published data only}

St Peter SD, Adibe OO, Iqbal CW, Fike FB, Sharp SW, Juang D, et al. Irrigation versus suction alone during laparoscopic appendectomy for perforated appendicitis. Annals of Surgery 2012;4:581‐5. CENTRAL

Takesue 2011 {published data only}

Takesue Y, Takahashi Y, Ichiki K, Nakajima K, Tsuchida T, Uchino M, et al. Application of an electrolyzed strongly acidic aqueous solution before wound closure in colorectal surgery. Diseases of the Colon and Rectum 2011;54(7):826‐32. CENTRAL

Tanaka 2015 {published data only}

Tanaka K, Matsuo K, Kawaguchi D, Murakami T, Hiroshima Y, Hirano A, et al. Randomized clinical trial of peritoneal lavage for preventing surgical site infection in elective liver surgery. Journal of Hepato‐biliary‐pancreatic Sciences 2015;22(6):446‐53. CENTRAL

Tanphiphat 1978 {published data only}

Tanphiphat C, Sangsubhan C, Vongvaravipatr V, La Ongthong B, Chodchoy V, Treesaranuvatana S, et al. Wound infection in emergency appendicectomy: a prospective trial with tropical ampicillin and antiseptic solution irrigation. British Journal of Surgery 1978;65(2):89‐91. CENTRAL

Temizkan 2016 {published data only}

Temizkan O, Asicioglu O, Gungorduk K, Asicioglu B, Yalcin P, Ayhan I. The effect of peritoneal cavity saline irrigation at cesarean delivery on maternal morbidity and gastrointestinal system outcomes. Journal of Maternal‐Fetal & Neonatal Medicine 2016;29(4):651‐5. CENTRAL

Tighe 1982 {published data only}

Tighe B, Anderson M, Dooley C, Egan T, Domhnaill SO, Delaney PV. Betadine irrigation following appendicectomy ‐ a randomized prospective trial. Irish Medical Journal 1982;75(3):96. CENTRAL

Trew 2011 {published data only}

Trew G, Pistofidis G, Pados G, Lower A, Mettler L, Wallwiener D, et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double‐blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction 2011;26(8):2015‐27. CENTRAL

Vallance 1985 {published data only}

Vallance S, Waldron R. Antiseptic vs. saline lavage in purulent and faecal peritonitis. Journal of Hospital Infection 1985;6(Suppl A):87‐91. CENTRAL

Viney 2012 {published data only}

Viney R, Isaacs C, Chelmow D. Intra‐abdominal irrigation at cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology 2012;119:1106‐11. CENTRAL

Akay 2006 {published data only}

Akay AF, Akay H, Aflay U, Sahin H, Bircan K. Prevention of pain and infective complications after transrectal prostate biopsy: a prospective study. International Urology and Nephrology 2006;38(1):45‐8. CENTRAL

Alcantara 2011 {published data only}

Alcantara M, Serra‐Aracil X, Falco J, Mora L, Bombardo J, Navarro S. Prospective, controlled, randomized study of intraoperative colonic lavage versus stent placement in obstructive left‐sided colonic cancer. World Journal of Surgery 2011;35(8):1904‐10. CENTRAL

Al‐Ramahi 2006 {published data only}

Al‐Ramahi M, Bata M, Sumreen I, Amr M. Saline irrigation and wound infection in abdominal gynecologic surgery. International Journal of Gynaecology and Obstetrics 2006;94(1):33‐6. CENTRAL

Anglen 2005 {published data only}

Anglen JO. Comparison of soap and antibiotic solutions for irrigation of lower‐limb open fracture wounds: a prospective, randomized study. Journal of Bone and Joint Surgery 2005;87(7):1415‐22. CENTRAL

Angobaldo 2008 {published data only}

Angobaldo J, Marks M. Prevention of projectile and aerosol contamination during pulsatile lavage irrigation using a wound irrigation bag. Wounds 2008;20(6):167‐70. CENTRAL

Badia 1994 {published data only}

Badia JM, Martinez‐Rodenas F, Oms LM, Valverde J, Franch G, Rosales A, et al. Randomized prospective study on antibiotic prophylaxis compared with lavage of the surgical wound in unperforated appendicitis [Estudio prospectivo aleatorizado de la profilaxis antibiotica comparada con el lavado de la herida quirurgica en apendicitis no perforada]. Medicina Clinica 1994;103(6):201‐4. CENTRAL

Bennett‐Guerrero 2016 {published data only}

Bennett‐Guerrero E, Berry SM, Bergese SD, Fleshner PR, Minkowitz HS, Segura‐Vasi AM. A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA‐02) in patients undergoing abdominal surgery. American Journal of Surgery 2016;10:1‐7. CENTRAL

Bertheussen 1980 {published data only}

Bertheussen KJ, Larsen P. Prophylactic irrigation of wounds with neomycin (Nebacetin). Controlled study of the effect in orthopedic surgical operations [Profylaktisk sarskylning med neomycin (Nebacetin)]. Ugeskrift for Laeger 1980;142(11):685‐6. CENTRAL

Bhargava 2006 {published data only}

Bhargava P, Mehrotra N, Kumar A. Wound infection after metronidazole infiltration. Tropical Doctor 2006;36(1):37‐8. CENTRAL

Boothby 1984 {published data only}

Boothby R, Benrubi G, Ferrell E. Comparison of intravenous cefoxitin prophylaxis with intraoperative cefoxitin irrigation for the prevention of post‐cesarean‐section endometritis. Journal of Reproductive Medicine 1984;29:830‐2. CENTRAL

Cherian 2000 {published data only}

Cherian MN, Korula G, Immanuel A, Zachariah M, Pandey AP. Postoperative analgesia with intramuscular bupivacaine wound irrigation in renal surgery. Acta Anaesthesiologica Scandinavica 2000;44(4):497‐8. CENTRAL

Chisholm 1992 {published data only}

Chisholm CD, Cordell WH, Rogers K, Woods JR. Comparison of a new pressurized saline canister versus syringe irrigation for laceration cleansing in the emergency department. Annals of Emergency Medicine 1992;21(11):1364‐7. CENTRAL

Donnenfeld 1986 {published data only}

Donnenfeld AE, Otis C, Weiner S. Antibiotic prophylaxis in cesarean section. Comparison of intrauterine lavage and intravenous administration. Journal of Reproductive Medicine 1986;31(1):15‐8. CENTRAL

Ducharme 1986 {published data only}

Ducharme JC, Bensoussan A, De Meyer P, Ducharme G. Perforation of acutely inflamed appendix treated intraperitoneal cefazoline [Le traitement de l'appendicite aiguë perforée avec la céfazoline intrapéritonéale]. Chirurgie pédiatrique 1986;27(3):153‐6. CENTRAL

Dwivedi 2009 {published data only}

Dwivedi SK. Pacemaker pocket irrigation with antibiotics has no role in infection prevention. Journal of the American College of Cardiology 2009;53(10):A125. CENTRAL

Everett 1969 {published data only}

Everett MT, Brogan TD, Nettleton J. The place of antibiotics in colonic surgery: a clinical study. British Journal of Surgery 1969;56(9):679‐84. CENTRAL

FLOW 2011 {published data only}

Bhandari M. Fluid lavage of open wounds (FLOW): design and rationale for a large, multicenter collaborative 2 x 3 factorial trial of irrigating pressures and solutions in patients with open fractures. BMC Musculoskeletal Disorders 2010;11:85. CENTRAL
FLOW Investigators, Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels‐Ansdell D, Schemitsch EH, et al. A trial of wound irrigation in the initial management of open fracture wounds. New England Journal of Medicine 2015;373(27):2629‐41. CENTRAL
FLOW Investigators, Petrisor B, Sun X, Bhandari M, Guyatt G, Jeray KJ, Sprague S, et al. Fluid lavage of open wounds (FLOW): a multicenter, blinded, factorial pilot trial comparing alternative irrigating solutions and pressures in patients with open fractures. Journal of Trauma Injury Infection & Critical Care 2011;71(3):596‐606. CENTRAL

Fountas 1999 {published data only}

Fountas KN, Kapsalaki EZ, Johnston KW, Smisson HF, Vogel RL, Robinson JS. Postoperative lumbar microdiscectomy pain. Minimalization by irrigation and cooling. Spine 1999;24(18):1958‐60. CENTRAL

Freischlag 1984 {published data only}

Freischlag J, McGrattan M, Busuttil RW. Topical versus systemic cephalosporin administration in elective biliary operations. Surgery 1984;96(4):686‐93. CENTRAL

Galle 1980 {published data only}

Galle PC, Homesley HD. Ineffectiveness of povidone–iodine irrigation of abdominal incisions. Obstetrics and Gynecology 1980;55:744‐7. CENTRAL

Garg 2013 {published data only}

Garg PK, Kumar A, Sharda VK, Saini A, Garg A, Sandhu A. Evaluation of intraoperative peritoneal lavage with super‐oxidized solution and normal saline in acute peritonitis. Archives of International Surgery 2013;3(1):43‐8. CENTRAL

Georgiadis 2013 {published data only}

Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double‐blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. Journal of Arthroplasty 2013;28(Suppl 8):78‐82. CENTRAL

Geraghty 1984 {published data only}

Geraghty J, Feely M. Antibiotic prophylaxis in neurosurgery. A randomized controlled trial. Journal of Neurosurgery 1984;60(4):724‐6. CENTRAL

Ghafouri 2016a {published data only}

Ghafouri HB, Zare M, Bazrafshan A, Abazarian N, Ramim T. Randomized, controlled trial of povidone‐iodine to reduce simple traumatic wound infections in the emergency department. Injury 2016;47(9):1913‐8. CENTRAL

Ghafouri 2016b {published data only}

Ghafouri HB, Zavareh M, Jalili F, Cheraghi S. Is 1% povidone‐iodine solution superior to normal saline for simple traumatic wound irrigation?. Wound Medicine 2016;15:1‐5. CENTRAL

Givens 2002 {published data only}

Givens VA, Lipscomb GH, Meyer NL. A randomized trial of postoperative wound irrigation with local anesthetic for pain after cesarean delivery. American Journal of Obstetrics and Gynecology 2002;186:1188–91. CENTRAL

Gonen 1986 {published data only}

Gonen R, Samberg I, Levinski R. Effect of irrigation or intravenous antibiotic prophylaxis on infectious morbidity at cesarean section. Obstetrics and Gynecology 1986;67:545–8. CENTRAL

Granick 2007 {published data only}

Granick MS, Tenenhaus M, Knox KR, Ulm JP. Comparison of wound irrigation and tangential hydrodissection in bacterial clearance of contaminated wounds: results of a randomized, controlled clinical study. Ostomy/wound Management 2007;53(4):64‐6, 68. CENTRAL

Hesami 2014 {published data only}

Hesami MA, Alipour H, Nikoupour Daylami H, Alipour B, Bazargan‐Hejazi S, Ahmadi A. Irrigation of abdomen with imipenem solution decreases surgical site infections in patients with perforated appendicitis: a randomized clinical trial. Iranian Red Crescent Medical Journal 2014;16(4):e12732. CENTRAL

Horn 1999 {published data only}

Horn EP, Schroeder F, Wilhelm S, Wappler F, Sessler DI, Uebe B, et al. Wound infiltration and drain lavage with ropivacaine after major shoulder surgery. Anesthesia and Analgesia 1999;89(6):1461‐6. CENTRAL

Hunt 1982 {published data only}

Hunt JL. Generalized peritonitis. To irrigate or not to irrigate the abdominal cavity. Archives of Surgery 1982;117(2):209‐12. CENTRAL

Iqbal 1998 {published data only}

Iqbal J, Shikrani AS, Arain JA. Topical antibiotics for prophylaxis against umbilical wound infection in laparoscopic cholecystectomy. Journal of the College of Physicians and Surgeons ‐ Pakistan 1998;8(4):165‐6. CENTRAL

Iqbal 2015 {published data only}

Iqbal M, Jawaid M, Qureshi A, Iqbal S. Effect of povidone‐iodine irrigation on post appendectomy wound infection: randomized control trial. Journal of Postgraduate Medical Institute 2015;29(3):160‐4. CENTRAL

Keblawi 2006 {published data only}

Keblawi A, Dawley BL. Does saline irrigation in the peritoneal cavity at the time of a non‐scheduled cesarean section reduce maternal morbidity. American Journal of Obstetrics and Gynecology 2006;195(6 (Suppl)):S96. CENTRAL

Kellum 1985 {published data only}

Kellum RB, Roberts WE, Harris JB, Khansur N, Morrison JC. Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. Journal of Reproductive Medicine 1985;30(7):527‐9. CENTRAL

Ko 1992 {published data only}

Ko W, Lazenby WD, Zelano JA, Isom OW, Krieger KH. Effects of shaving methods and intraoperative irrigation on suppurative mediastinitis after bypass operations. Annals of Thoracic Surgery 1992;53(2):301‐5. CENTRAL

Kothuis 1981 {published data only}

Kothuis BJ. The effect of povidone‐iodine on postoperative wound infection in abdominal surgery. The Netherlands Journal of Surgery 1981;33(4):186‐9. CENTRAL

Lau 1986 {published data only}

Lau WY, Fan ST, Chu KW, Yip WC, Chong KK, Wong KK. Combined topical povidone‐iodine and systemic antibiotics in postappendicectomy wound sepsis. British Journal of Surgery 1986;73:958‐60. CENTRAL

Lavery 1986 {published data only}

Lavery JP, Huang KC, Koontz WL, Reinstine J, Marcell C, Rosenberg N. Mezlocillin prophylaxis against infection after cesarean section: a comparison of techniques. Southern Medical Journal 1986;79(10):1248‐51. CENTRAL

Logan 1973 {published data only}

Logan CJ. The effect of topical ampicillin on wound‐infection rate after cholecystectomy. British Journal of Surgery 1973;60(5):355‐6. CENTRAL

Longmire 1987 {published data only}

Longmire AW, Broom LA, Burch J. Wound infection following high‐pressure syringe and needle irrigation. American Journal of Emergency Medicine 1987;5(2):179‐81. CENTRAL

Makvandi 2014 {published data only}

Makvandi S, Abbaspour M, Aminfar S. The effect of local Gentamicin solution on episiotomy healing: a randomized controlled clinical trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2014;16(88):21‐8. CENTRAL

Martins 2012 {published data only}

Martins EA, Meneghin P. Evaluation of three techniques for cleaning infected surgical site with physiological serum [Avaliação de três técnicas de limpeza do sítio cirúrgico infectado utilizando soro fisiológico]. Ciencia, Cuidado e Saude 2012;11(Suppl):204‐10. CENTRAL

Mathelier 1992 {published data only}

Mathelier AC. A comparison of postoperative morbidity following prophylactic antibiotic administration by combined irrigation and intravenous route or by intravenous route alone during cesarean section. Journal of Perinatal Medicine 1992;20(3):177‐82. CENTRAL

Mohamed 2017 {published data only}

Mohamed Sa‐B, Abdel‐Ghaffar HS, Kamal SM, Fares KM, Hamza HM. Effect of topical morphine on acute and chronic postmastectomy pain: what is the optimum dose?. Regional Anesthesia and Pain Medicine 2017;41(6):704‐10. CENTRAL

Morse 1998 {published data only}

Morse JW, Babson T, Camasso C, Bush AC, Blythe PA. Wound infection rate and irrigation pressure of two potential new wound irrigation devices: the port and the cap. American Journal of Emergency Medicine 1998;16(1):37‐42. CENTRAL

Nachamie 1968 {published data only}

Nachamie BA, Siffert RS, Bryer MS. A study of neomycin instillation into orthopedic surgical wounds. JAMA 1968;204:687‐9. CENTRAL

Nomikos 1986 {published data only}

Nomikos IN, Katsouyanni K, Papaioannou AN. Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial. Surgery 1986;99(1):20‐5. CENTRAL

Noon 1967 {published data only}

Noon GP, Beall AC, Jordan GL, Riggs S, De Bakey ME. Clinical evaluation of peritoneal irrigation with antibiotic solution. Surgery 1967;62:73‐8. CENTRAL

Pitt 1982 {published data only}

Pitt HA, Postier RG, Gadacz TR, Cameron JL. The role of topical antibiotics in 'high‐risk' biliary surgery. Surgery 1982;91(5):518‐24. CENTRAL

Plaumann 1985 {published data only}

Plaumann L, Ketterl R, Claudi B, Machka K. Pulsating spooler for cleaning contaminated and infected wounds (Jet Lavage) [Pulsierendes spulgerat zur reinigung kontaminierter und infizierter wunden (Jet Lavage)]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 1985;56:754‐5. CENTRAL

Pobereskin 2000 {published data only}

Pobereskin LH, Sneyd JR. Does wound irrigation with triamcinolone reduce pain after surgery to the lumbar spine?. British Journal of Anaesthesia 2000;84(6):731‐4. CENTRAL

Pollock 1978 {published data only}

Pollock AV, Froome K, Evans M. The bacteriology of primary wound sepsis in potentially contaminated abdominal operations: the effect of irrigation, povidone‐iodine and Cephaloridine on the sepsis rate assessed in a clinical trial. British Journal of Surgery 1978;65(2):76‐80. CENTRAL

Rogers 1983 {published data only}

Rogers DM, Blouin GS, O'Leary JP. Povidone‐iodine wound irrigation and wound sepsis. Surgery, Gynecology & Obstetrics 1983;157(5):426‐30. CENTRAL

Rosen 1985 {published data only}

Rosen RA. The use of antibiotics in the initial management of recent dog‐bite wounds. American Journal of Emergency Medicine 1985;3(1):19‐23. CENTRAL

Salvati 1988 {published data only}

Salvati EP, Rubin RJ, Eisenstat TE, Bohman H. Value of subcutaneous and intraperitoneal antibiotics in reducing infection in clean contaminated operations of the colon. Surgery, Gynecology & Obstetrics 1988;167(4):315‐8. CENTRAL

Sarr 1988 {published data only}

Sarr MG, Parikh KJ, Sanfey H, Minken SL, Cameron JL. Topical antibiotics in the high‐risk biliary surgical patient: a prospective, randomized study. American Journal of Surgery 1988;155(2):337‐42. CENTRAL

Sarzaeem 2014 {published data only}

Sarzaeem MM, Razi M, Kazemian G, Moghaddam ME, Rasi AM, Karimi M. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. Journal of Arthroplasty 2014;29(8):1521‐4. CENTRAL

Sauven 1986 {published data only}

Sauven P, Playforth MJ, Smith GM, Evans M, Pollock AV. Single‐dose antibiotic prophylaxis of abdominal surgical wound infection: a trial of preoperative latamoxef against peroperative tetracycline lavage. Journal of the Royal Society of Medicine 1986;79(3):137‐41. CENTRAL

Scammell 1985 {published data only}

Scammell BE, Phillips RP, Brown R, Burdon DW, Keighley MR. Influence of rectal washout on bacterial counts in the rectal stump. British Journal of Surgery 1985;72(7):548‐50. CENTRAL

Scheuerlein 2000 {published data only}

Scheuerlein H, Kube R, Gastinger I, Köckerling F. Prospective multicenter comparative study of the management of peritonitis. Quality assurance in severe intra‐abdominal infection [Prospektive multizentrische vergleichsstudies zur peritonitisbehandlung]. Zentralblatt fur Chirurgie 2000;125(Suppl 2):199‐204. CENTRAL

Seco 1990 {published data only}

Seco JL, Ojeda E, Reguilon C, Rey JM, Irurzun A, Serrano SR, et al. Combined topical and systemic antibiotic prophylaxis in acute appendicitis. American Journal of Surgery 1990;159:226‐30. CENTRAL

Shapiro 1986 {published data only}

Shapiro M, Wald U, Simchen E, Pomeranz S, Zagzag D, Michowiz SD, et al. Randomized clinical trial of intra‐operative antimicrobial prophylaxis of infection after neurosurgical procedures. Journal of Hospital Infection 1986;8(3):283‐95. CENTRAL

Sherman 1976 {published data only}

Sherman JO, Luck SR, Borger JA. Irrigation of the peritoneal cavity for appendicitis in children: a double‐blind study. Journal of Pediatric Surgery 1976;11(3):371‐4. CENTRAL

Sindelar 1985 {published data only}

Sindelar WF, Brower ST, Merkel AB, Takesue EI. Randomised trial of intraperitoneal irrigation with low molecular weight povidone‐iodine solution to reduce intra‐abdominal infectious complications. Journal of Hospital Infection 1985;6(Suppl A):103‐14. CENTRAL

Sood 1985 {published data only}

Sood S, Kapur BM, Gupta A, Shriniwas. Role of intra‐operative wound lavage in post‐operative wound infection. Indian Journal of Medical Research 1985;81:92‐5. CENTRAL

Terzi 2015 {published data only}

Terzi C, Arslan NC, Egeli T, Canda AE. Effect of irrigation with chlorhexidine gluconate on surgical site infections in pilonidal disease. European Surgery 2015;1(Suppl):S86. CENTRAL

Toki 1995 {published data only}

Toki A, Ogura K, Horimi T, Tokuoka H, Todani T, Watanabe Y, et al. Peritoneal lavage versus drainage for perforated appendicitis in children. Surgery Today 1995;25(3):207‐10. CENTRAL

Weiss 2013 {published data only}

Weiss E, Lin M, Oldham G. Tap water is equally safe and effective as sterile normal saline for wound irrigation; a double blind, randomized, controlled, prospective clinical trial. Society for Academic Emergency Medicine 2007;14(5 (Suppl 1)):S146‐7. CENTRAL
Weiss EA, Oldham G, Lin M, Foster T, Quinn JV. Water is a safe and effective alternative to sterile normal saline for wound irrigation prior to suturing: a prospective, double‐blind, randomised, controlled clinical trial. BMJ Open 2013;3(1):e001504. CENTRAL

White 2008 {published data only}

White RR, Pitzer KD, Fader RC, Rajab MH, Song J. Pharmacokinetics of topical and intravenous cefazolin in patients with clean surgical wounds. Plastic and Reconstructive Surgery 2008;122(6):1773‐9. CENTRAL

Wu 1992 {published data only}

Wu Y. Prevention of post‐operative infection by using antibiotics of 217 cases of cesarean section. Chung‐Hua fu chan ko tsa chih [Chinese Journal of Obstetrics & Gynecology] 1992;27(2):73‐5. CENTRAL

Xiao 2010 {published data only}

Xiao Y, Zhang GN, Wu B, Lin GL, Wu WM, Xu L, et al. Management of the perineal wounds after abdominalperineal resection: simple drainage only or with continuous irrigation?. Zhonghua wai ke za zhi [Chinese Journal of Surgery] 2010;48(14):1088‐91. CENTRAL

Yarussi 1999 {published data only}

Yarussi A, Sands R, Edge S, Lema MJ, De Leon‐Casasola OA. Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: a randomized, double‐blind, placebo‐controlled study. Regional Anesthesia and Pain Medicine 1999;24(2):142‐5. CENTRAL

De Cicco 2015 {published data only}

De Cicco C, Schonman R, Ussia A, Koninckx PR. Extensive peritoneal lavage decreases postoperative C‐reactive protein concentrations: A RCT. Gynecological Surgery 2015;12(4):271‐4. CENTRAL

De Kok 1998 {published data only}

De Kok EH, Rhijn LW, Rietra PJ. The effect of wound irrigation on bacterial contamination of suction instrumentation during joint prosthesis surgery. Nederlands Tijdschrift voor Orthopaedie 1998;5(1):22. CENTRAL
De Kok EH, Van Rhijn LW, Rietra PJ, Plasmans CM, Veraart BE. The effect of wound irrigation on bacterial contamination of suction instruments in prosthetic surgery. Acta Orthopaedica Scandinavica 1998;69(Suppl 282):14. CENTRAL

Kosuş 2010 {published data only}

Kosuş A, Kosuş N, Guler A, Capar M. Rifamycin SV application to subcutaneous tissue for prevention of post‐cesarean surgical site infection [Sezaryen sonrasi kesi yeri enfeksiyonunu onlemek icin ciltalti rifamisin SV uygulanmasi]. European Journal of General Medicine 2010;7(3):269‐76. CENTRAL

Munoz‐Mahamud 2011 {published data only}

Munoz‐Mahamud E, Garcia S, Bori G, Martinez‐Pastor JC, Zumbado JA, Riba J, et al. Comparison of a low‐pressure and a high‐pressure pulsatile lavage during debridement for orthopaedic implant infection. Archives of Orthopaedic and Trauma Surgery 2011;131(9):1233‐8. CENTRAL

Taylor 1999 {published data only}

Taylor GJ, Calder S, Vickers M. Surgical wound decontamination with chlorhexidine jet lavage. Journal of Bone and Joint Surgery 1999;81(Suppl 1):48. CENTRAL

ACTRN12610000423011 {published data only}

ACTRN12610000423011. Does peritoneal lavage influence the rate of complications in paediatric laparoscopic appendicectomy? A prospective randomised clinical trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12610000423011 (first received 26 May 2010). CENTRAL

NCT01175044 {published data only}

NCT01175044. Dilute Betadine lavage in the prevention of postoperative infection. clinicaltrials.gov/ct2/show/NCT01175044 (first received 2 August 2010). CENTRAL

NCT02186457 {published data only}

NCT02186457. Antibiotic irrigation for pancreatoduodenectomy. clinicaltrials.gov/ct2/show/NCT02186457 (first received 1 July 2014). CENTRAL

NCT02395614 {published data only}

NCT02395614. Surgical site infection with 0.05% chlorhexidine (CHG) compared with triple antibiotic irrigation. clinicaltrials.gov/ct2/show/study/NCT02395614 (first received 17 March 2015). CENTRAL

NCT02527512 {published data only}

NCT02527512. Bacterial contamination: iodine vs saline irrigation in pediatric spine surgery. clinicaltrials.gov/ct2/show/NCT02527512 (first received 7 August 2015). CENTRAL

NCT02714023 {published data only}

NCT02714023. Water and saline head‐to‐head in the blinded evaluation study trial (WASHITBEST). clinicaltrials.gov/ct2/show/NCT02714023 (first received 8 March 2016). CENTRAL

Allegranzi 2010

Allegranzi B, Nejad SB, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health‐care‐associated infection in developing countries: systematic review and meta‐analysis. Lancet 2010;377(9761):228‐41.

Anderson 2008

Anderson DJ, Chen LF, Schmader KE, Sexton DJ, Choi Y, Link K, et al. Poor functional status as a risk factor for surgical site infection due to methicillin‐resistant staphylococcus aureus. Infection Control and Hospital Epidemiology 2013;29(9):832‐9.

Astagneau 2009

Astagneau P, L'Hériteau F, Daniel F, Parneix P, Venier AG, Malavaud S, et al. ISO‐RAISIN Steering Group. Reducing surgical site infection incidence through a network: results from the French ISO‐RAISIN surveillance system. Journal of Hospital Infection 2009;72(2):127‐34.

Bailey 1992

Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after hernia surgery. BMJ 1992;304(6825):469‐71. [PUBMED: 1547415]

Barnes 2014

Barnes S, Spencer M, Graham D, Johnson HB. Surgical wound irrigation: a call for evidence‐based standardization of practice. American Journal of Infection Control 2014;42(5):525‐9.

Bruce 2001

Bruce J, Russell EM, Mollison J, Krukowski ZH. The measurement and monitoring of surgical adverse events. Health Technology Assessment 2001;5(22):1‐194.

Chemaly 2010

Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Waked A, et al. Characteristics and outcomes of methicillin‐resistant staphylococcus aureus surgical‐site infections in patients with cancer: a case‐control study. Annals of Surgical Oncology 2010;17:1499‐1506.

Coello 2005

Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site infections in English hospitals. Journal of Hospital Infection 2005;60(2):93‐103.

De Jonge 2017

De Jonge SW, Boldingh QJJ, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, et al. Systematic review and meta‐analysis of randomized controlled trials evaluating prophylactic intra‐operative wound irrigation for the prevention of surgical site infections. Surgical Infections 2017 April 27 [Epub ahead of print]. [DOI: 10.1089/sur.2016.272]

De Lissovoy 2009

De Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. American Journal of Infection Control 2009;37(5):387‐97.

Deeks 2011

Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Edwards 2008

Edwards C, Counsell A, Boulton C, Moran CG. Early infection after hip fracture surgery: risk factors, costs and outcome. Journal of Bone and Joint Surgery 2008;90:770‐7.

Eke 2016

Eke AC, Shukr GH, Chaalan TT, Nashif SK, Eleje GU. Intra‐abdominal saline irrigation at cesarean section: a systematic review and meta‐analysis. The Journal of Maternal‐Fetal & Neonatal Medicine 2016;29(10):1588‐94.

Fournel 2010

Fournel I, Tiv M, Soulias M, Hua C, Astruc K, Aho Glele LS. Meta‐analysis of intraoperative povidone‐iodine application to prevent surgical‐site infection. British Journal of Surgery 2010;97(11):1603‐13.

Gibbons 2011

Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, et al. Identification of risk factors by systematic review and development of risk‐adjusted models for surgical site infection. Health Technology Assessment 2011;15(30):1‐156.

HICPAC 1999

Hospital Infection Control Practices Advisory Committee (HICPAC). Guideline for prevention of surgical site infection 1999. Infection Control and Hospital Epidemiology 1999;20(4):259.

Higgins 2003

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60.

Higgins 2011a

Higgins JP, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Higgins 2011b

Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Horan 1992

Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections 1992: a modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology 1992;13(10):606‐8. [PUBMED: 1334988]

Horan 2008

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care‐associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008;36(5):309‐32.

Jenks 2014

Jenks PJ, Laurent M, McQuarry S, Watkins R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. Journal of Hospital Infection 2014;86(1):24‐33.

Kontopantelis 2012

Kontopantelis E, Reeves D. Performance of statistical methods for meta‐analysis when true study effects are non‐normally distributed. Statistical Methods Methodology Research 2012;21:409‐26.

Kontopantelis 2013

Kontopantelis E, Springate DA, Reeves D. A re‐analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta‐analysis. PLoS One 2013;8(7):e69930.

Korol 2013

Korol E, Johnston K, Waser N, Sifakis F, Jafri HS, Lo M, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS ONE 2013;8(12):e83743.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:b2700.

Mueller 2015

Mueller TC, Loos M, Haller B, Mihaljevic AL, Nitsche U, Wilhelm D, et al. Intra‐operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta‐analysis. Langenbecks Archives of Surgery 2015;400(2):167‐81.

NICE 2008

National Institute for Health and Care Excellence (NICE). Surgical site infections: prevention and treatment. NICE guidelines [CG74]. October 2008. www.nice.org.uk/guidance/cg74 (accessed 1 February 2016).

Oliveira 2008

Oliveira AS, Santos VL. Use of topic iodine in acute wounds [Uso de iodóforo tópico em feridas agudas]. Revista da Escola de Enfermagem da USP 2008;42(1):193‐201.

Omran 2007

Omran AS, Karimi A, Ahmadi SH, Davoodi S, Marzban M. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infectious Diseases 2007;7:112‐7.

Perencevich 2003

Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerging Infectious Diseases 2003;9(2):196‐203.

Public Health England 2014

Public Health England. Surveillance of surgical site infections in NHS hospitals in England: 2013 to 2014. www.gov.uk/government/uploads/system/uploads/attachment_data/file/386927/SSI_report_2013_14_final__3_.pdf (accessed 1 February 2016).

RevMan 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Ridgeway 2005

Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. The Journal of Bone and Joint Surgery 2005;87(6):844‐50. [PUBMED: 15911671]

Sandy‐Hodgetts 2015

Sandy‐Hodgetts K, Carville K, Leslie GD. Determining risk factors for surgical wound dehiscence: a literature review. International Wound Journal 2015;12(3):265‐75.

Schultz 2011

Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair and Regeneration 2011;19(2):134‐48. [PUBMED: 21362080]

Schünemann 2011a

Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Schünemann 2011b

Schünemann HJ, Oxman AD, Higgins JP, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

SIGN 2017

Scottish Intercollegiate Guidelines Network (SIGN). Search filters. www.sign.ac.uk/methodology/filters.html#random (accessed 24 May 2017).

Smaill 2014

Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD007482.pub3]

Smyth 2008

Smyth ET, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, et al. Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. The Journal of Hospital Infection 2008;69(3):230‐48. [PUBMED: 18550218]

Sterne 2011

Sterne JA, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Thompson 1999

Thompson SG, Sharp SJ. Explaining heterogeneity in meta‐analysis: a comparison of methods. Statistics in Medicine 1999;18:2693‐708.

WHO 2016

World Health Organization (WHO). Global guidelines for the prevention of surgical site infection. November 2016. www.who.int/gpsc/ssi‐prevention‐guidelines/en/ (accessed 3 May 2017).

Wilson 1986

Wilson AP, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986;1(8476):311‐3. [PUBMED: 2868173]

Smith 2016

Smith TA, Rowlands C, Dumville JC, Norman G. Intracavity lavage and wound irrigation for prevention of surgical site infection. Cochrane Database of Systematic Reviews 2016, Issue 6. [DOI: 10.1002/14651858.CD012234]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Al‐Shehri 1994

Methods

2‐arm RCT

Setting: NR; appears to be single hospital in Saudi Arabia

Participants reportedly followed up for 1 month, no additional details

Participants

254 adults and children (aged 5‐80 years, mean age 21 (Group I) and 24 years (Group II)) undergoing appendectomy for acute appendicitis were randomised; 249 analysed

Inclusion criteria: people undergoing appendectomy through gridiron incision for clinically suspected acute appendicitis

Exclusion criteria: allergy to ampicillin; systemic diseases requiring systemic antibiotic administration

Interventions

Group I: (saline): wound irrigation with 100 mL normal sterile saline at closure (134 participants randomised; 132 analysed; 2 participants withdrawn post‐randomisation)

Group II: (Ampicillin): wound irrigation with 1 g Ampicillin powder dissolved in 100 mL normal sterile saline (120 participants randomised; 117 analysed; 3 participants withdrawn post‐randomisation)

Co‐interventions: IV metronidazole (500 mg for adults; 15 mg/kg for children) and gentamicin (75 mg for adults and 1.5 mg/kg for children) 1 h before surgery. If appendix was found to be gangrenous or perforated antibiotics were continued for 5 ds postoperatively.

Outcomes

Primary outcome: SSI (defined as presence of purulent discharge in wound, regardless of culture results, or as occurrence of serous discharge with a positive culture) within 1 month

Group I (Saline): 7/132 (134 randomised)

Group II (Ampicillin): 1/117 (120 randomised)

Secondary outcome: adverse events including abscess:

Abscess

Group I (saline): 0/132

Group II (Ampicillin): 0/117

Other specific post‐operative complications were reported but total number of participants with adverse events was not clear.

Secondary outcome: hospital stay: reported to be reduced by 2.5 d by avoidance of wound infection. Median reported for participants with (5.5, range 3‐11 d) and without infection (3.0, range 2‐11 d) but not for each treatment group.

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "254 patients fulfilled the criteria and were randomized into two groups using sealed envelopes"

Comment: no information on how the randomisation sequence was generated.

Allocation concealment (selection bias)

Unclear risk

Quote: "254 patients fulfilled the criteria and were randomized into two groups using sealed envelopes that were opened intraoperatively"

Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no direct quote but it is clear that personnel were made aware of allocation once the envelopes were opened. Unclear if participants were aware

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no direct quote but it is unclear whether the outcome assessment was performed by individuals aware of group allocation.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Comment: there were a small number of post‐randomisation exclusions for protocol violations described. However there were low numbers of events relative to these exclusions, increasing the risk of attrition bias impacting the results.

Selective reporting (reporting bias)

Unclear risk

Comment: rhe data for one of the secondary outcomes (bed‐stay) were not reported on a per‐group base making this outcome difficult to evaluate.

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was not clear enough to be certain.

Baker 1994

Methods

2‐arm RCT

Setting: single centre; 1 surgical unit in UK

Follow‐up: close monitoring during hospital stay; full inquiry into possible infection signs at 6‐week outpatient clinic follow‐up

Participants

330 participants undergoing elective colorectal surgery (mean ages 61 (Group I) and 63 years (Group II)); 300 analysed

Inclusion criteria: participants undergoing elective colorectal surgery

Exclusion criteria: NR

Interventions

Group I (taurolidine PVP): peritoneal lavage in 2 stages with 250 mL 2% taurolidine in 5% PVP (150 participants)

Group II (saline): peritoneal lavage in 2 stages with 250 mL normal saline (150 participants)

In each group 250 mL lavage solution diluted in a further 250 mL normal saline was placed in the abdomen as a washout and then removed with suction. This was followed by instillation of a second 250 mL undiluted lavage solution, which was left in the abdomen. If abdominal drains were present these were clamped for at least 20 min.

Cointerventions: all participants (except 11 who had severe constricting colonic lesions and were in imminent danger of bowel obstruction) received up to 8 doses of magnesium sulphate (4 g by mouth) for 48 h starting 72 h before surgery followed by 2 sachets of sodium picosulphate (Picolax; Fering Pharmaceutical, Feltham, UK) given in the 24 h immediately before surgery. Participants with severe constricting colonic lesions were prepared according to the wishes of the surgeon; 8 received Klean‐Prep (Norgine, Oxford, UK) in place of Picolax and 3 no preparation. All participants received cefotaxime 1 g and metronidazole 500 mg IV at induction of anaesthesia, and 8 h and 16 h later. 5 participants with penicillin allergy received gentamicin 160 mg on induction, and 120 mg at 8 h and 16 h after induction; doses were individually adjusted according to body mass, renal function and age.

Outcomes

Primary outcome: SSI (defined as spontaneous or incisional discharge from the wound, either of pus or serous fluid, with an infective organism positively identified on culture)

Group I (taurolidine PVP): 17/150 (10 superficial, 7 deep)

Group II (saline): 17/150 (12 superficial, 5 deep)

Secondary outcome: 30‐day mortality

Group I (taurolidine PVP): 4/150

Group II (saline): 4/150

Secondary outcome: adverse events including abscess:

Pelvic abscess

Group I (taurolidine PVP): 2/150

Group II (saline): 1/150

Other specific post‐operative complications were reported but total number of participants with adverse events was not clear.

Secondary outcome: length of hospital stay

Group I (taurolidine PVP): median 11 d for 133 participants without infection; 18 d for 17 with infection (paper reports N = 134, error suspected)

Group II (saline): median 11 d for 133 participants without infection; 18 d for 17 with infection (mean NR, range NR)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "This paper reports a randomized controlled trial.....Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy with no stratification for severity of contamination or procedure. "

Comment: appears there was a computer‐generated randomisation sequence

Allocation concealment (selection bias)

Unclear risk

Quote: "Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy with no stratification for severity of contamination or procedure."

Comment: although the allocation sequence was held by the hospital pharmacy it is not clear whether it was adequately concealed.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy... The trial and control solutions were indistinguishable to users."

Comment: personnel appear to have been blinded; although there is no direct information on participants it is likely that they were also blinded.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "All patients were monitored closely after operation until hospital discharge for clinical signs of abdominal sepsis and wound infection by an independent (non‐operating) trained assessor (J.AJ.)."

Comment:

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "Sixteen patients were withdrawn from the trial after consent because the operative procedure performed did not constitute elective colorectal surgery ....... A further eight patients were withdrawn as lavage was not undertaken for logistical reasons, such as breakage of solution bottles. A further six patients were withdrawn at the time of surgery because of overt sepsis or severe faecal spillage, which rendered the intraoperative lavage a therapeutic rather than a prophylactic measure. Thus 300 patient reports were available for analysis."

Comment: almost 10% of randomised participants were not included in the analysis. Although full reasons are given for this the number of withdrawals is almost equivalent to the number of events.

Selective reporting (reporting bias)

Low risk

Comment: the data for one of the secondary outcomes (bed‐stay) were not fully reported (measure of variance lacking) but no other evidence of selective reporting

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was not clear enough to be certain.

Bourgeois 1985

Methods

Parallel‐group RCT

Setting: single hospital in USA

Follow‐up: 6 weeks (review of records after discharge)

Participants

223 women undergoing cesarean section

Inclusion criteria: women delivered by caesarean section

Exclusion criteria: allergy to penicillin or cephalosporins, taken an antibiotic within 7 d of surgery or required antibiotics around time of surgery for other reasons. Participants with temperature elevated to 38oC or with foul amniotic fluid prior to or immediately after surgery were considered to have infection and excluded.

High risk and low risk participants were separated according to duration of labor prior to cesarean section, with 6 h arbitrarily chosen as the division point. Each group contained both high risk (more than 6 h labour) and low risk (less than 6 h labour) participants

Interventions

Group I: irrigation with 2 g cefamandole in 1000 mL normal saline (73 participants)

Group II: irrigation with 1000 mL normal saline (75 participants)

Group III: no irrigation (75 participants)

Outcomes

Secondary outcome: length of stay

Group I: low risk: 5.2 (0.3) d (N = 46); high risk: 5.3 (0.2) (N = 27)

Group II: low risk: 5.9 (0.4) d (N = 40); high risk 6.8 (0.6) (N = 35)

Group III: low risk 5.8 (0.3) d (N = 44); high risk: 6.9 (0.4) (N = 31)

Secondary outcome: adverse events

Only a specific event (metritis) was reported

Group I: low risk: 2 (4.3% of 46); high risk: NR

Group II: low risk: 4 (10% of 40); high risk: NR

Group III: low risk: 9 (20.5% of 44); high risk: NR

Infection data were also reported but were not clearly SSI and were not reported for all participants

Group I: low risk: NR; high risk: 3 (11.1% of 27)

Group II: low risk: NR; high risk: 17 (48.6% of 35)

Group III: low risk: NR; high risk: 17 (54.8% of 31)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "members of each group were then assigned to a cohort according to a computer‐generated table of random numbers under the direction of the hospital pharmacy"

Comment: appropriate method used to generate randomisation sequence; randomisation stratified by duration of labour: > 6 h vs < 6 h

Allocation concealment (selection bias)

Unclear risk

Quote: "under the direction of the hospital pharmacy"

Comment: unclear whether adequate methods were used to conceal allocation

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "Physicians who performed the operation and provided postoperative care were unaware of the type of irrigation provided"

Comment: physicians were unaware of the type of irrigation used but are likely to have been aware of whether irrigation was used or not. It is unclear whether participants were aware of treatment allocation.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Patients were followed postoperatively by the resident and attending physicians on service"

Comment: not clear whether outcomes were determined by personnel blinded to treatment allocation.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Quote: "of all 451 patients who had cesarean sections during the study period, 223 were included"

Comment: it appears that the 223 participants described as included were all included in the analyses but it's not completely clear that this is the total number who were randomised.

Selective reporting (reporting bias)

High risk

Comment: not all data relating to outcomes of infection, adverse events and postoperative hospitalisations were reported.

Other bias

Unclear risk

Comment: no obvious source of additional bias but reporting insufficient to be certain

Brown 2007

Methods

Parallel‐group RCT

Setting: 16 referral centres in the USA

Follow‐up: 28‐56 d

Participants

449 women (age 32.6 years in Adept group vs 32.3 in lactated Ringer's solution group) undergoing laparoscopic gynaecological surgery. Primary diagnoses included pelvic pain, infertility endometriosis and known adhesions.

Inclusion criteria: aged > 18 years and in good health. Laparoscopic surgery was planned for a gynaecologic procedure that included adhesiolysis followed by a second follow‐up laparoscopy 4–8 weeks later.

Exclusion criteria: preoperative: the use of concomitant systemic corticosteroids, antineoplastic agents, and/or radiation; pregnancy; diagnosis of an active pelvic or abdominal infection, or cancer; and a known allergy to starch‐based polymers. Intraoperative exclusion criteria included women requiring an additional non obstetric/gynaecologic surgical procedure to be performed during the laparoscopic procedure; unplanned surgery necessitating opening the bowel (excluding appendectomy); any laparotomy procedure; and use of another adhesion reduction agent. Adhesion site exclusion criteria included women having < 3 of the available anatomical study sites with adhesions or, if fewer than three were lysed, removal of any anatomical sites being scored for the purposes of the study; and an inability to visualise clearly all available anatomical score sites.

Interventions

Group I: irrigated with a minimum 100 mL Adept (icodextrin 4% solution) solution every 30 min during surgery; any remaining solution at end of surgery was aspirated and then 1 L instilled from a fresh supply of solution (227 ITT, 205 PP participants)

Group II: irrigated with a minimum 100 mL lactated Ringer's solution every 30 min during surgery; any remaining solution at end of surgery was aspirated and then 1 L instilled from a fresh supply of solution (222 ITT 205 PP participants)

Outcomes

Postoperative infections were reported but unclear whether these referred to SSI

Group I (icodextrin): 1% of 227 calculated as 2
Group II (Ringer's solution): 3% of 222 calculated as 7

Secondary outcome: adverse events

Group I (icodextrin): 221/227 of which 44 serious; 55 considered related, reported as serious 8 participants (25 events)

Group II (Ringer's solution): 218/222 of which 36 serious; 38 considered related, reported as serious 11 participants (19 events)

Secondary outcome: mortality

Group I (icodextrin): 0/227

Group II (Ringer's solution): 0/222

Notes

Funding: Innovata Limited, Vectura Group

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Treatment was randomized by computer‐generated randomization on a 1:1 basis"

Comment: an appropriate method of generating the randomisation sequence was reported.

Allocation concealment (selection bias)

Low risk

Quote: "Patient numbers were allocated to treatment group before labelling of the blinded study treatment
bags. The study solutions were presented in identical 1 L infusion bags, and each bag had an outer wrap that contained
the study code and patient number on an identification label"

Comment: adequate method for concealment of treatment allocation reported

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "Double‐blinding was possible because Adept and LRS are both clear and odourless solutions
with similar viscosities to water."

Comment: blinding appears to have been undertaken for personnel and participants.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Safety was assessed by serious adverse events (SAEs), adverse events, and changes in laboratory values. Patients completed
diary cards between initial surgery and follow‐up surgery. At postoperative checkup (visits 3 and 4), cards
were assessed to monitor progress. They allowed the patient to record their well‐being and all concomitant medications.
All adverse events whether they were considered related to study solutions or not, were investigated, and the details of
nature, severity, duration, outcome, and relationship to study device were recorded"

Comment: safety outcomes were assessed by participants who were blinded to treatment allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "Safety was assessed in the intent‐to‐treat (ITT) population, which included all patients who had the study solution instilled.
Efficacy results are presented for the per protocol (PP) population. These patients were those who had completed both first‐ and second‐look laparoscopies without major protocol violations."

Comment: the outcomes relevant to this review were assessed using the ITT population so almost all randomised participants were included in the analyses.

Selective reporting (reporting bias)

Low risk

Comment: outcomes were prespecified; all planned outcomes appeared fully reported.

Other bias

Low risk

Comment: no evidence of other sources of bias and reporting is sufficient to be reasonably confident that this is the case

Browne 1978

Methods

Parallel‐group RCT

Setting: single hospital in UK

Follow‐up: NR

Participants

35 participants with gross peritonitis or frank fecal soiling and a positive culture swab at operation

Inclusion criteria: gross peritonitis or frank fecal soiling and a positive culture swab at operation

Exclusion criteria: NR

Interventions

Group I: 2% taurolin in 5% PVP solution (normal saline) up to 200 mL instilled prior to closure of abdomen or afterwards through a tube drain. Additional 200 mL could be instilled daily if required for 7 d (17 participants)

Group II: 5% PVP solution (normal saline) to 200 mL instilled prior to closure of abdomen or afterwards through a tube drain. Additional 200 mL could be instilled daily if required for 7 d (18 participants)

Additional antibiotic use was documented as including gentamycin, lincomycin, cephalosporin [cephalosporine], ampicillin

Outcomes

Secondary outcome: mortality

Group I (taurolin): 3/17

Group II (PVP): 0/18

Notes

Outcome was classed as "good" or "bad" where a normal recovery with normal wound healing and no sepsis was a good result and all other outcomes were bad
Funding NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Envelopes containing cards, previously randomly arranged were available in theatre for selection of solution A or solution B"

Comment: no information on how the random sequence arrangement was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "Envelopes containing cards, previously randomly arranged were available in theatre for selection of solution A or solution B"

Comment: no information on whether or how the random sequence arrangement was concealed.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "Two solutions were prepared ....in identical bottles labelled A and B"

Comment: it appears that measures were taken to blind personnel and participants.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Thirty‐five patients entered the trial. It was intended to include a much larger number but at this stage there was a marked difference in results which was statistically significant..... so the code was broken"

Comment: it appears that measures were taken to ensure blinded outcome assessment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: it appears that all randomised participants were included in the analysis. However many fewer participants than planned were randomised (see other sources of bias).

Selective reporting (reporting bias)

High risk

Outcomes were not prespecified and "a good result" was defined only in the results section.

Other bias

High risk

Quote: "For ethical reasons it was decided the trial should be stopped as soon as a statistically significant difference between the two groups emerged............Thirty‐five patients entered the trial. It was intended to include a much larger number but at this stage there was a marked difference in results which was statistically significant..... so the code was broken."

Trial was stopped very early (a long way short of planned recruitment). Although this was preplanned this approach to early stopping is highly likely to produce an artefactual difference between groups

Buanes 1991

Methods

Parallel‐group RCT

Setting: single hospital in Norway

Follow‐up: 6 weeks postoperatively

Participants

85 participants with perforated appendicitis and generalised peritonitis

Inclusion criteria: diagnosis of perforated appendicitis and generalised peritonitis verified at laparotomy

Exclusion criteria: age < 6 years; known allergy to ampicillin or tinidazole, localised infiltration or abscess around the appendix.

Interventions

Group I: 24 hs postoperative lavage with 0.9% saline 1 L x 20 for adults, 0.5 L for children (39 participants)

Group II: no postoperative lavage (44 participants)

Cointerventions: intra‐operative peritoneal lavage with 2 L of saline; 2 g ampicillin every 6 hs and 800 mg tinidazole daily until oral fluids commenced then pivampicillin 500 mg 3/d and 1 g tinidazole daily orally; children received pivampicillin 100 mg/kg/d and tinidazole 400 mg daily (rectal) for 5 d

Outcomes

Primary outcome: SSI (wound infection defined as temperature > 38.5 C for > 24 h plus localised, drainage‐confirmed accumulation of fluid in the abdominal incision

Group I (postoperative lavage): 9/39

Group II (no postoperative lavage): 2/44

Secondary outcome: length of stay

Group I (postoperative lavage): median 5 d (range 3‐11) 39 participants

Group II (no postoperative lavage): median 5 d (range 4 ‐12) 44 participants

Notes

Treatment (postoperative lavage) was discontinued early in 10/39 participants

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "As soon as the diagnosis of perforated appendicitis with generalized peritonitis was verified at laparotomy, the patient was randomized..."

Comment: no information on how the randomisation sequence was produced.

Allocation concealment (selection bias)

Unclear risk

Quote: "As soon as the diagnosis of perforated appendicitis with generalized peritonitis was verified at laparotomy, the patient was randomized..."

Comment: no information as to whether allocation was adequately concealed.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: allocation to postoperative lavage versus no postoperative lavage would be evident to both personnel and participants.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: unclear whether outcome assessment was performed by blinded individuals

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: 2/85 randomised participants were withdrawn for a documented reason (ampicillin allergy); although both were in the same group the number is low and is unlikely to have been a source of bias.

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes were not all prespecified in the methods although a priori definitions for intra‐abdominal and wound infection were given.

Other bias

Unclear risk

Comment: no evidence of other source of bias but reporting insufficient to be certain

Carl 2000

Methods

Parallel‐group RCT

Setting: appears to be single hospital in USA

Follow‐up: 4‐6 weeks postoperatively

Participants

40 women undergoing caesarean section at high risk of infection

Interventions

Group I: irrigation with cefazolin; 2 g in 1000 cc normal saline; 700 cc intrauterine 100 cc in each gutter and 100 cc subcutaneously (20 participants)

Group II: irrigation with 1000 cc normal saline 700 cc; intrauterine 100 cc in each gutter and 100 cc subcutaneously (20 participants)

Cointerventions: none reported

Outcomes

Primary outcome: SSI (defined only as "wound infection")

Group I (cefazolin): 1/20

Group II (saline): 1/20

Notes

Abstract only. Funding NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Patients at high risk of infection were randomly placed in two groups"

Comment: no information as to how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "Patients at high risk of infection were randomly placed in two groups"

Comment: no information as to whether there was adequate concealment of allocation

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no specific quote, no information as to whether these groups were blinded to treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: there is no information as to who performed the outcome evaluation or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "Only 2 of 40 high risk patients who received prophylactic irrigation developed...."

Comment: it appears that all randomised participants were included in the analysis.

Selective reporting (reporting bias)

Unclear risk

Quote: "The objective of this study is to determine the impact of copious antibiotic irrigation versus normal saline (ns) on the incidence of post‐cesarean wound infections"

Comment: the primary outcome was specified and reported but it is not clear from the abstract which other outcomes the study may have planned to assess.

Other bias

Unclear risk

Comment: there were no additional sources of bias noted but the abstract reporting was insufficient to be certain.

Case 1987

Methods

2‐arm RCT

Setting: single centre; 1 surgical unit in the UKm

Follow‐up: included outpatient assessment 6 weeks post‐surgery

Participants

54 women undergoing planned Patey mastectomy for carcinoma of the breast (mean age 56; range 32‐75 years) randomised (52 women and 53 breasts analysed)

Inclusion criteria: Patey mastectomy

Exclusion criteria: participants with allergy to tetracycline

Interventions

Group I (tetracycline): lavage of 1 g tetracycline in 100 mL saline (23 women)

Group II (saline): lavage of 100 mL saline (30 women)

Lavage was given at wound closure and was contained within the axilla and skin flaps as much as possible during closure.

Cointerventions: drainage was standardised to Vygon suction drains to axilla and skin flaps; drains removed at request of surgical staff when drainage for previous 24 hs appeared minimal

Outcomes

Primary outcome: SSI (not defined)

Group I (tetracycline): 0/23

Group II (saline): 1/30

Primary outcome: wound dehiscence
Group I (tetracycline): 0/23

Group II (saline): 1/30 (described as "minor")

Notes

One woman underwent bilateral mastectomy and was randomised for each breast.

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "....were randomized to receive at wound closure"

Comment: no information on how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "....were randomized to receive at wound closure"

Comment: no information on whether allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no direct quote but no information on whether participants and personnel were blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Records were kept on a standard form by the nursing staff, who were unaware of the patient's randomization."

Comment: no information on whether the blinded nursing staff performed outcome assessment at follow‐up.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "Two women were excluded after randomization because they subsequently did not undergo Patey mastectomy"

Comment: the number of exclusions was very small and both were accounted for by a substantive operative protocol deviation

Selective reporting (reporting bias)

Unclear risk

Comment: there is no evidence of selective reporting but because most outcomes were not specified in the methods section it is not clear whether it may have occurred

Other bias

Unclear risk

There may be a minor unit of analysis issue due to the randomisation of one woman twice for each breast. Otherwise there is no evidence of other bias but the reporting is not full enough to be sure.

Cervantes‐Sanchez 2000

Methods

2‐arm RCT

Setting: single centre, Emergency Department in Mexico

Follow‐up: 2 and 4 weeks after operation

Participants

350 participants entered into study; 283 considered evaluable (mean age of 27.99 years (SD 12.81 years), range from 9‐82 years); (67 rejected from final analysis due to finding of another pathology different from appendix)

Inclusion criteria: adults and children of both sexes admitted with a clinical diagnosis of acute abdomen suggestive of acute appendicitis with aid of laboratory and X‐ray, confirmed during operation and by histopathologic study

Exclusion criteria: age < 5 years, allergy to metronidazole or aminoglycosides, antibiotic therapy within 72 h preceding operation, pregnancy, those with other intraperitoneal bacterial infection not originating from the appendix, and those with any immune deficiency (diabetes mellitus, chronic renal insufficiency, malnourishment, chemotherapy, radiotherapy, corticosteroid therapy, asplenism)

Interventions

Group I: no irrigation (156 participants)

Group II: syringe pressure irrigation with saline: after closure of the fascial planes, subcutaneous fat tissue irrigated with 300 mL of normal saline solution, delivered with a 20‐mL syringe with a 19‐gauge IV catheter, applying to the embolus the force of one hand, at a distance of 2 cm from the wound tissues, aspirating the fluid collected in the wound with a bulb syringe (127 participants)

Cointerventions: each participant was administered metronidazole (30 mg/kg/day) 3/d, plus amikacin (15 mg/kg/d) once daily IV 30–45 min before skin incision. In cases of uncomplicated appendicitis they were stopped within the first 24 h, whereas in cases of complicated appendicitis they were maintained for a minimum of 7 d

Outcomes

Primary outcome: SSI (Definition: "A wound was considered to be infected...when there was a collection of pus or a positive bacteriologic culture from a wound discharge")

Group I: (no irrigation): 39/156

Group II: (syringe pressure irrigation): 11/127

Secondary outcome: adverse events. The authors stated that "Antibiotics used for prophylaxis were well tolerated without any case of allergy or intolerance." The proportion of participants with any adverse event was not reported.

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "All patients included were randomly assigned by a computerized assignment system into 2 groups of the trial."

Comment: randomisation sequence generated by computer

Allocation concealment (selection bias)

Low risk

Quote: "The randomization chart was kept by our statistician, who was blind to the follow‐up, until June 1995."

Comment: appears that allocation sequence was concealed from trial personnel

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "Statistical analysis of the results...was conducted by our statistician who was blind to the surgical procedures and follow‐up."

Comment: control arm did not include comparator intervention and so unable to conceal allocation to staff present at operation. Study design indicated as "double blind," so assumption that participants were not told of their treatment allocation

High risk of physicians not being blinded; unclear or low risk for participants

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "...sought by daily examination of all patients by one of the members of the research team who was blind to the random allocation and the surgical procedures, until discharge."

Quote: "...reevaluated at the outpatient consultation 2 and 4 weeks after operation by the responsible author who was blind to the random assignment and the surgical procedures."

Comment: appears that outcome assessment for SSI was conducted by blinded assessor

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "A total of 350 patients were entered into the study, and 283 (80.9%) were considered evaluable. The reason for rejection of the 67 (19.1%) patients from the final analysis was the finding of another pathology different from the appendix."

Comment: the number of exclusions was high and the study did not achieve its aim of including 133 participants in each arm. Therefore confirmation of appendicitis during surgery appears to be an inclusion criterion and so exclusions based on pathology do not violate inclusion criteria. There was a high rate of exclusion relative to event rate for the primary outcome.

Selective reporting (reporting bias)

Unclear risk

Comment: main end point (defined surgical wound infection) was reported overall and for complicated and uncomplicated types of appendicitis. It is unclear whether there were any other end points specified in the study protocol.

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was insufficient to be certain.

Chang 2006

Methods

2‐arm RCT

Setting: single centre at hospital in Taiwan

Follow‐up: at 2 weeks, 1 month and 3 months after operation, and then every 3 months until end of study (approximately 19 months)

Participants

244 participants (age range 20‐89 years; Group I: average 67.1 years, (range 20‐82 years); Group II: average 65.4 years (range 22‐89 years)).

Inclusion criteria: primary instrumented lumbosacral posterolateral fusion for degenerative spinal disorder with lumbar or lumbosacral segmental instability defined by chronic back, buttock and/or leg pain and degenerative spondylolisthesis, degenerative scoliosis or isthmic spondylolisthesis

Exclusion criteria: prior spinal surgery, spinal trauma, malignant tumour, infectious spondylitis, rheumatoid arthritis, ankylosing spondylitis, metabolic bone disease, skeletal immaturity or immunosuppressive treatment

Interventions

Group I (povidone‐iodine): wounds irrigated with 0.35% povidone‐iodine solution to soak for 3 min, followed by irrigation with 2000 cc normal saline to remove povidone‐iodine solution (120 participants)

Group II (saline): wounds irrigated with only 2000 cc normal saline (124 participants)

Cointerventions: wound closure by layer after suction drainage applied; drain removed 48 h or 72 h post‐operatively. Routine analgesic pain control applied for 3 d. Pre‐operative IV bolus injection of cefazolin (1000 mg) and gentamicin (60 mg); additional cefazolin (1000 mg/6 h) and gentamicin (60 mg/12 h) also given for 48 hs after surgery, and then oral cefazolin (500 mg/6 h) for 3 d

Outcomes

Primary outcome: SSI (Definition: "Infections were classified as superficial (above lumbosacral fascia) or deep (below lumbosacral fascia), and as early onset (within 2 weeks postoperatively) or late onset (otherwise). All deep infections were confirmed by laboratory parameters including erythrocyte sedimentation rate (ESR) and level of C‐reactive protein (CRP) and a positive culture of biopsy."

Group I (povidone‐iodine): 0/120

Group II (saline): 6/124 (2 early onset; 4 late onset)

Primary outcome: wound dehiscence within 30 d (time NR but it says all others healed with sutures removed on day 14 so can presume < 30 d. No infection found in wounds)

Group I: 1/120

Group II: 2/124

Secondary outcome: proportion of participants with postoperative SSI using systemic antibiotics within 30 d of surgery

Group II: (saline): "After radical debridement and parenteral antibiotics (according to sensitivities) for 6 weeks and oral antibiotics for 2 months, a satisfactory outcome has been reached except in two cases."

Secondary outcome: occurrence of infections showing antibiotic resistance

Group II: (saline): MRSA cultured from 5/6 cases

Secondary outcome: surgical re‐intervention rates

Group I: (povidone‐iodine): 3 participants underwent exploration of the non‐union site and re‐arthrodesis with autogenous bone graft

Group II: (saline): 4 participants underwent exploration of the non‐union site and re‐arthrodesis with autogenous bone graft

Group II: (saline): "After radical debridement and parenteral antibiotics (according to sensitivities) for 6 weeks and oral antibiotics for 2 months, a satisfactory outcome has been reached except in two cases." These 2 cases had implants removed 4 months post‐operatively as infection could not be eradicated

Notes

Interventions: no information given on duration of irrigation of wounds with normal saline for either group.

Funding: Quote: "No funds were received in support of this work. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this manuscript."

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients...were randomly assigned to either treatment group. An independent person unaware of the subject characteristics and the study design delivered pre‐coded sealed enveloped randomly (containing serial numbers from 1 to 300) to the assignment of the subjects into the two groups."

Comment: clearly states how sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "An independent person unaware of the subject characteristics an the study design delivered pre‐coded sealed enveloped randomly (containing serial numbers from 1 to 300) to the assignment of the subjects into the two groups. The sealed envelope was not opened until the middle of the surgery before wound irrigation."

Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no direct quote, but no information on how personnel might have been blinded to the treatment performed. Unclear whether participants were blinded, but report states it was "single blind"

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "All clinical and radiographic assessments were made by independent observers other than the treating surgeons."

Comment: unclear whether observers were aware of treatment group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: no direct quote, but no evidence of attrition

Selective reporting (reporting bias)

Unclear risk

Comment: no evidence of selective reporting but not enough information to be certain

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was insufficient to be certain

Cheng 2005

Methods

2‐arm RCT

Setting: single centre at hospital in Taiwan

Follow‐up: at 2 weeks, 4 weeks and 2 months after operation, and then every 3 months until end of study (mean follow‐up 15.5 months for both groups)

Participants

417 consecutive eligible participants enrolled. 3 who died during the follow‐up period were excluded (1 case in Group I and 2 cases in
Group II); 414 were included (average age 64 years (Group I) and 61 years (Group II))

Inclusion criteria: pre‐operative diagnosis of degenerative scoliosis or stenosis; degenerative disc disease; disc prolapse; traumatic spinal fracture; spinal metastasis lesion. Undergoing procedure such as decompression for degenerative stenosis; decompression, fusion and fixation for degenerative scoliosis or stenosis; fixation of traumatic spinal fracture; discectomy for disc prolapse; excision with fixation for spinal metastatic lesions.

Exclusion criteria: those with overt or suspected pyogenic vertebral osteomyelitis, discitis, or any form of pre‐operative spinal infection were excluded. Those with fever or other suspected sources of infection also excluded

Interventions

Group I (povidone‐iodine): surgical wound soaked with dilute povidone‐iodine solution for 3 min after operation. Commercially available Betadine solution used had a concentration of 10% povidone‐iodine (100 mg povidone‐iodine per 1 mL solution). Approximately 5 mL povidone‐iodine was diluted with normal saline to achieve a 0.35% povidone‐iodine (3.5% Betadine) solution for use during the operation. The wound was irrigated with copious amounts of normal saline (2000 mL) after Betadine solution irrigation (208 participants)

Group II (saline): irrigation with copious normal saline (2000 mL) performed alone (206 participants)

Cointerventions: each participant received 1 dose of parenteral cefazolin (1000 mg) and gentamicin (60 mg) 1 h before surgery. Cefazolin (1000 mg) every 6 hs and gentamicin (60 mg) every 12 hs were then given for 48 hs after surgery. Additional doses of antibiotics were given to maintain antibiotics levels during prolonged surgery. Following IV antibiotics, cefazolin (500 mg every 6 hs) was continued orally for 3 d. Drains were retained until < 100 mL of output was observed.

Outcomes

Primary outcome: SSI (Definition: "Infection was suspected when unusual pain, tenderness, erythema, induration, fever, or wound drainage was noted. Such findings were investigated with measurement of erythrocyte sedimentation rate, C‐reactive protein, and bacteriological cultures from the operative site or blood. Cultures were obtained from blood and wound discharge by aseptic methods.")

Group I (povidone‐iodine): 0/208

Group II (saline): 7/206 (one superficial and 6 deep)

Secondary outcome: occurrence of infections which show antibiotic resistance

Group II (saline): MRSA cultured from 5/7 cases

Secondary outcome: surgical re‐intervention rates

Group II (saline): 7/206 (all those with highly suspected wound infection underwent surgical debridement)

Notes

Funding: Quote: "No funds were received in support of this work. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this manuscript."

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were randomly assigned to two groups, using pre‐coded sealed envelopes containing serial numbers from 1 to 500. Patients with odd serial numbers were group 1 (study group) and those with even serial number were group 2 (controls)."

Comment: clearly states how sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "Patients were randomly assigned to two groups, using pre‐coded sealed envelopes containing serial numbers from 1 to 500. Envelopes were not opened until the end of surgery, before wound irrigation. Patients with odd serial numbers were group 1 (study group) and those with even serial number were group 2 (controls)

Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no direct quote, but no information on how personnel might have been blinded to the treatment performed. Unclear whether participants were blinded, but report states it was "single blind"

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no direct quote; no information given regarding who collected outcome assessment data

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "Three patients who died during the follow‐up period were excluded (one case in group 1 and two cases in
group 2)."

Comment: number of exclusions is low but similar to number of events

Selective reporting (reporting bias)

Unclear risk

Comment: no evidence of selective reporting but not enough information to be certain

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was not clear enough to be certain

Cho 2004

Methods

Parallel RCT

Setting: single centre in Republic of Korea

Follow‐up: 2 weeks

Participants

34 patients undergoing gastrectomy

Inclusion criteria: naive stomach cancer patients

Exclusion criteria: history of diabetes, pneumonia, urinary tract infection, chemotherapy

Interventions

Group I: saline exchange after gastrectomy (17 participants)

Group II: no saline exchange during surgery (17 participants)

Co‐interventions: preoperative cefametazol 1 g

Outcomes

Primary outcome: SSI

Superficial, deep SSI defined by Horan 1992

Group I (saline exchange): 1/17

Group II (no saline exchange): 3/17

Notes

Funding: NR

Reported in Korean. Data extraction and risk of bias assessment performed by translator

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Comment: random number table was used

Allocation concealment (selection bias)

Unclear risk

Comment: method of allocation concealment was not described

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: personnel were blinded because they were under anaesthesia but personnel would have been aware of the allocation due to the nature of the comparison

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Comment: outcome assessors were blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all participants were included

Selective reporting (reporting bias)

Low risk

Comment: pre‐specified outcomes were reported

Other bias

Low risk

Comment: not detected

Dashow 1986

Methods

Parallel‐group, 5‐arm RCT

Setting: single hospital in USA

Follow‐up: unclear

Participants

360 women undergoing caesarean section. Both caesareans in labour and without labour were included. Mean ages between 24.59 and 27.52 years. Gestational ages between 37.85 and 39.31 weeks

Inclusion criteria: women undergoing caesarean section

Exclusion criteria: history of penicillin or cephalosporin allergy, taking antibiotics, known infectious process (e.g. chorioamnionitis or urinary tract infection)

Interventions

Group 1: saline lavage (800 mL)

Group 2: 2 g cephapirin sodium lavage

Group 3: 2 g cefamandole nafate lavage

Group 4: 2 g moxalactam disodium lavage

Group 5: 2 g ampicillin sodium lavage

Inferred that each antibiotic lavage used 800 mL

Cointerventions: none reported

Outcomes

Primary outcome: SSI (wound breakdown with positive culture or presence of cellulitis)

Group 1 (saline): 3/77

Group 2 (cephapirin): 3/70

Group 3 (cefamandole): 2/64

Group 4 (moxalactam): 2/79

Group 5 (ampicillin): 0/70

Secondary outcome: adverse events including abscess

There were 0 abscess events; other adverse events reported were infection‐related morbidity as follows

Group 1 (saline): 22/77

Group 2 (cephapirin): 17/70

Group 3 (cefamandole): 8/64

Group 4 (moxalactam): 19/79

Group 5 (ampicillin): 10/70

Notes

Funding NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "A computer‐generated table of pseudo‐random numbers.... was used by the pharmacy to assign each patient to one of five groups"

Comment: an acceptable method of sequence generation was reported.

Allocation concealment (selection bias)

Unclear risk

Quote: "A computer‐generated table of pseudo‐random numbers.... was used by the pharmacy to assign each patient to one of five groups"

Comment: there was no information on how allocation concealment was undertaken.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "A vitamin .... was added to each solution for disguise"

"The patients and physicians were unaware of the group assignment until after completion of the study and chart review by the authors"

Comment: blinding of both participants and physicians was undertaken.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no specific quote but it was unclear who performed the outcome assessments and hence whether they were blinded to group allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analyses.

Selective reporting (reporting bias)

Unclear risk

Comment: the outcomes were not defined in the methods section so it is unclear whether all planned outcomes were fully reported.

Other bias

Unclear risk

Comment: no apparent sources of additional bias but reporting insufficient to be certain

De Jong 1982

Methods

2‐arm RCT with 2 phases

Setting: NR, but appears to be a general surgery department at a hospital in the Netherlands

Follow‐up: at 4, 8 and 14 d, and 4 weeks after surgery

Participants

592 participants, of which 34 excluded (18 in the control group and 16 in the povidone‐iodine group) because they died before the end of the control period or had to be operated upon again through the same wound during this period. 2 wounds were present in 21 participants (9 in the control group and 12 in the povidone‐iodine group). A total of 582 wounds were evaluated in 558 participants.

Inclusion criteria: all elective and acute patients who underwent intra‐abdominal operations or operations for inguinal hernia

Exclusion criteria: children < five years of age and those undergoing vascular reconstruction.

Interventions

Group I (control): quote "No special measures were taken"

Group II (povidone‐iodine): carried out in 2 phases. Subcutaneous tissues irrigated with a povidone‐iodine solution at the end of the operation. Lavage with an ample amount of 1% aqueous povidone‐iodine solution (Phase 1) or 10% aqueous povidone‐iodine solution (Phase 2). Lavage was performed after closure of the fascia with interrupted polyglactin 910 sutures. After lavage for 1 min, excess fluid was aspirated and skin closed with interrupted with nylon sutures. If present, drains were brought out through a second wound.

Outcomes

Primary outcome: SSI (Definition: "Diagnosis of wound infection made if a purulent discharge form the wound was seen within a period of four weeks after the operation or if culturing of fluid from the wound was positive.")

Group I (control): Phase 1: 21/142 wounds Phase 2: 15/137 wounds (270 participants? ‐ participant numbers unclear)

Group II (povidone‐iodine): Phase 1: 17/154 wounds Phase 2: 22/149 wounds (291 participants? ‐ participant numbers unclear)

Notes

Participants: age NR

Outcomes: these appear to refer to number of wounds, not participants

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "The patients were divided at random into two groups."

Comment: it is unclear how randomisation was performed.

Allocation concealment (selection bias)

Unclear risk

Quote: "The patients were divided at random into two groups."

Comment: no information on whether the randomisation sequence was concealed

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "In the first group, no special measures were taken."

Comment: the control arm did not involve an intervention as a comparator, and so unable to conceal allocation to staff present at the operation. Unclear whether all staff were aware of the different phases of the study (and concentrations of solution used as the intervention).

Unclear whether participants were aware of treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Postoperatively, all wounds were assessed by the same investigator..."

Comment: unclear as to whether the investigator was blinded to the treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "34, 18 in the control group and 16 in the povidone‐iodine group, were excluded because they either died before the end of the control period or had to be operated upon again through the same wound during this period."

Comment: number of exclusions is high. No reasons given for cause of death or re‐operations

Selective reporting (reporting bias)

Unclear risk

No evidence of reporting bias, but report is not complete enough to be sure

Other bias

Unclear risk

Comment: there was no evidence of other sources of bias but reporting was not clear enough to be certain

Elliott 1986

Methods

4‐arm RCT

Setting: 2 hospitals in USA

Follow‐up: 6 weeks

Participants

'High risk' patients (for developing post operative febrile morbidity) undergoing cesarean section for a variety of reasons

158 women included in study

Inclusion criteria: women in active labour or with ruptured membranes, at least one digital vaginal examination (i.e. high risk from developing postoperative febrile morbidity)

Exclusion criteria: allergy to cephalosporins or penicillin, presence of fever ≥ 37.8 C during labour with suspicion of chorioamnionitis, maternal use of antibiotics in 2‐week period before delivery

Interventions

Group I: 8 doses of IV cefoxitin 2 g (1st dose after umbilical cord clamp, then every 6 hs) (39 participants)

Group II: irrigation of uterus and peritoneum with 2 g cefoxitin (in 1000 mL of normal saline). After delivery of the placenta, the fundus of the uterus was irrigated with 300 mL, the uterine incision with 150 mL, after closure of the first layer 150 mL, bladder flap 150 mL, remainder used to irrigate peritoneal cavity and excess suctioned away before closure of the abdomen (42 participants)

Group III: combination of IV antibiotic (8 doses of 2 g cefoxitin) and irrigation with cefoxitin (in 1000 mL of normal saline) i.e. treatments of groups I and II combined (38 participants)

Group IV: control group who received no prophylactic antibiotics (39 participants)

Outcomes

Primary outcome: SSI (wound infection)

Group I (IV antibiotics only): 0/39

Group II (irrigation with antibiotics only): 0/42

Group III (IV antibiotics plus irrigation with antibiotics): 0/38

Group IV (no IV and no irrigation):1/39

Secondary outcome: hospital stay (mean (SD) d)

Group I: 4.8 (1.1)

Group II: 4.9 (1.0)

Group III 4.9 (1.2)

Group IV: 5.4 (1.4)

Secondary outcome: adverse events

Infectious (endomyometritis, urinary tract infection, wound infection (1 case, see above), pulmonary infection, septicaemia)

Group I: 2/39

Group II: 3/42

Group III: 2/38

Group IV: 14/39

Non‐infectious (seroma, transfusion reaction, atelectasis)

Group I: 1/39

Group II: 1/42

Group III: 1/38

Group IV: 0/39

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Randomization into one of four treatment groups was performed by using a table of random numbers"

Comment: an appropriate method appears to have been used

Allocation concealment (selection bias)

Unclear risk

Comment: there is no information about allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: there is no information about blinding. It is possible that participants were blinded, but personnel would be aware of treatment as the protocols are quite different.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: there is no information about blinding or who performed outcome assessment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all participants are accounted for in the results

Selective reporting (reporting bias)

Unclear risk

Comment: the outcomes do not appear to have been pre‐specified, although febrile morbidity was extensively defined

Other bias

Unclear risk

Comment: there is no evidence of additional sources of bias but the reporting is insufficient to be confident that there were none.

Greig 1987

Methods

2‐arm RCT

Setting: single hospital in UK

Follow‐up: 1 month

Participants

129 patients undergoing elective and emergency colorectal surgery

Age: unknown;

Type of operations: unknown

Inclusion criteria: NR

Exclusion criteria: NR

Interventions

Group I: 1000 mL saline lavage at the end of the operation (65 participants)

Group II: 1000 mL saline lavage with 1 g cefotetan at the end of the operation (64 participants)

Co‐interventions: Groups I and II both received 500 mg metronidazole and 120 mg gentamicin IV at anaesthesia induction

Outcomes

Primary outcome:

SSI (defined as discharge of pus from the wound "wound sepsis")

Group I (saline): 18/65

Group II (cefotetan): 15/64

Notes

Funding: NR

Limited information from paper

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Patients were randomly allocated to receive either 1 liter of saline lavage or 1 liter of saline containing 1g of cefotetan..."

Comment: the method of randomisation is not described

Allocation concealment (selection bias)

Unclear risk

Comment: there is no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: there is no mention of blinding of participants or personnel

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Post‐operatively, patients were assessed regularly by a single observer for the development of wound sepsis..."

Comment: there is no mention of blinding of the observer

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: participants are all accounted for in the outcome data of interest

Selective reporting (reporting bias)

Unclear risk

Comment: the outcome of interest (SSI) is reported but it is not clear that related results are fully reported

Other bias

Unclear risk

Comment: there is not enough methodological information to judge whether there were any additional sources of bias

Gungorduk 2010

Methods

2‐arm RCT

Setting: single hospital in Turkey

Follow‐up: participants were examined at 2 and 6 weeks after surgery. Wounds examined twice daily during hospitalisation. After discharge, women were instructed to contact investigators immediately if any of the listed symptoms appeared. Women who contacted the investigators were examined within 12 h

Participants

520 women with indications for elective or emergency caesarean section (incidence of emergency surgery (45.5 vs 51.5%; P  = 0.53))

Inclusion criteria: past 37 weeks' gestation and required a caesarean section (elective or emergency).

Exclusion criteria: anaemia (haemoglobin: < 7 g/dL), chorioamnionitis and fever on admission

Interventions

Group I: underwent wound irrigation before wound closure with 100 mL of sterile saline with a 30–60 mL syringe (260 participants)

Group II: no wound irrigation before wound closure (260 participants)

Outcomes

Primary outcomes: SSI (wound drained purulent material or serosanguineous fluid in association with induration, warmth and tenderness)

Group I (saline): 17/260

Group II (no irrigation): 19/260

Secondary outcomes: mean length of hospital stay

Group I (saline): 2.05 (0.21) d

Group II (no irrigation): 2.04 ( 0.20)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Consenting patients were preoperatively randomised using numerically ordered cards in sealed envelopes"

Comment: method of sequence generation is not reported

Allocation concealment (selection bias)

Unclear risk

Quotes: "Consenting patients were preoperatively randomised using numerically ordered cards in sealed envelopes" "The investigator was not blinded to the procedure allocation" "The allocated envelope was opened by the clinician just before surgery"

Comment: the use of sealed envelopes suggests an attempt to conceal some aspect of allocation but the authors state that the investigator was not blinded to allocation; envelopes are not stated to be opaque

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "The allocated envelope was opened by the clinician just before surgery. The procedure allocation was recorded in the women's charts"

Comment: personnel and participants were both aware of treatment

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "The procedure allocation was recorded in the women's charts" "The investigator was not blinded to the procedure allocation"

Comment: it is not explicitly stated but the report suggests the outcome assessors were not blinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: data are reported for all participants

Selective reporting (reporting bias)

Unclear risk

Comment: apart from SSI, it is unclear which outcomes were prespecified

Other bias

Low risk

Comment: there is no evidence of other bias

Halsall 1981

Methods

Parallel‐group RCT

Setting: single hospital in UK

Follow‐up: 4 weeks postoperatively

Participants

192 participants undergoing appendectomy via grid iron incision

Inclusion criteria: appendectomy via a right iliac fossa incision

Exclusion criteria: female participants of child bearing age not adequately protected by contraceptive practice

Interventions

Group I: 50 mL 2% taurolin in 5% PVP in "saline sufficient to produce solutions of equal tonicity"; wound irrigated for 2 min; then 10 mL instilled through a quill after closure of the skin

Group II 50 mL of 5% PVP in "saline sufficient to produce solutions of equal tonicity" wound irrigated for 2 min; then 10 mL instilled through a quill after closure of the skin

Cointerventions: antibiotics and drains as required

Outcomes

Primary outcome: SSI (wound sepsis) defined as a wound discharging pus

Group I (taurolin): 18/99

Group II (placebo): 29/93

Secondary outcome: length of stay

Group I (taurolin): 6.4 d (mean, no SD)

Group II (placebo): 6.6 d (mean, no SD)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "the taurolin and placebo being randomly allocated to sequential numbers 1 to 200"

Comment: no information on how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "the taurolin and placebo being randomly allocated to sequential numbers 1 to 200"

Comment: no information on whether allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "neither solution was distinguishable to users"

Comment: it appeared that personnel (and participants) were blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote:"During the hospital stay the wound was observed be a member of the medical staff participating in trial"

Comment: it was unclear whether the individual who assessed the outcomes was blinded to treatment group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: the 8 participants who were not included in the analyses were clearly documented. Although 7 of these were placebo group‐allocated participants it appears unlikely that these exclusions would have affected the results.

Selective reporting (reporting bias)

Unclear risk

Comment: the primary outcome was specified but it was unclear which other outcomes were planned to be recorded

Other bias

Unclear risk

Comment: there is no evidence of other sources of bias but reporting was insufficient to be certain.

Hargrove 2006

Methods

2‐arm RCT

Setting: multicentre trial: 4 UK hospitals in the "South of England"

Study period: 18‐months

Follow‐up: 30 d post surgery or discharge from unit (1 assessor in each hospital reviewed participants' wounds twice a week until discharge)

Participants

356 participants with a displaced intracapsular fractured neck of femur, due to be treated with a hemiarthroplasty, were randomised into 2 groups

Inclusion criteria: displaced intracapsular fractured neck of femur, due to be treated with a hemiarthroplasty

Exclusion criteria: NR

Interventions

Group I: the ‘pulse lavage’ group had a 2‐L normal saline wash delivered via pulsatile lavage in stages throughout the procedure (164 participants)

Group II: the control group had a 2‐L normal saline wash delivered by a jug or a syringe according to the surgeon's preference with 1 L being given before prosthesis insertion and 1 L after insertion (192 participants)

Co‐interventions: NR

Outcomes

Primary outcome: SSI

Wound infections were diagnosed using criteria from the Nosocomial Infection National Surveillance Survey and graded as superficial or deep.

Group I (pulse lavage): 9/164 (3/164 'deep')

Group II (control): 30/192 (10/192 'deep')

Secondary outcome: occurrence of infections with antibiotic resistance

No group data but quote: "Half of the deep space infections were due to methicillin‐resistant Staphylococcus aureus"

Secondary outcome: mortality

NR by group. There were 25 deaths within the study period (7%); 18 of these were associated with American Society of Anaesthesiologists (ASA) scores of 3 or below

Notes

Funding: no records

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "...all patients... were randomized into two groups"

Comment: no details about method

Allocation concealment (selection bias)

Unclear risk

Comment: no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no mention of blinding, but nature of intervention and control means personnel would not be blind to treatment

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "One assessor in each hospital reviewed patients' wounds twice a week until discharge"

Comment: no mention of blinding and it is unclear if the assessor would have been aware of treatment

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "the difference in size between the two groups was due to 'start up' problems within the hospitals where pulse lavage had not been previously associated with hemiarthroplasty operations" "In cases where hemiarthroplasties were due to have pulse lavage but this was forgotten, the cases were struck from the study"

Comment: the authors describe issues with implementing the pulse lavage intervention and although they describe participants being excluded at some point for this reason (presumably post‐randomisation) there are no details about them. It is probable that this introduced bias to the study.

Selective reporting (reporting bias)

High risk

Comment: data are fully reported for some outcomes but others are not reported by group

Other bias

Unclear risk

Comment: there is insufficient information to judge

Harrigill 2003

Methods

2‐arm, parallel‐group RCT

Setting: single centre in USA

Follow‐up: NR

Participants

196 women undergoing caesarean delivery. 94 were elective repeat procedures, age 27.5 vs 28.2 years

Inclusion criteria: women presenting with term (> 37 weeks) singleton pregnancies undergoing routine caesarean delivery for arrest of dilation, arrest of descent, foetal malpresentation or as an elective repeat procedure

Exclusion criteria: women diagnosed with chorioamnionitis, type I diabetes, placenta previa, placenta accreta, maternal coagulopathy, multiple gestation, HIV–positive status, prior severe gastrointestinal disease, or non‐reassuring fetal monitoring requiring immediate delivery

Interventions

Group I: irrigation with 500‐1000 mL warm saline after closure of the uterine incision but before closure of the abdominal wall (97 participants)

Group II: no irrigation (99 participants)

Outcomes

Primary outcome: SSI (undue tenderness, erythema, discharge, or separation of the incision accompanying maternal fever)

Group I (saline irrigation): 1/97

Group II (no irrigation): 2/99

Secondary outcome: length of stay (d)

Group I (saline irrigation): 2.9 (1.0)

Group II (no irrigation): 2.8 (0.9)

Secondary outcome: adverse events (postpartum complications including SSI)

Group I (saline irrigation): 14/97

Group II (no irrigation): 13/99

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Assignment was performed by pulling sequentially numbered opaque envelopes containing computer‐randomized individual allocations."

Comment: an appropriate method of random sequence generation was reported

Allocation concealment (selection bias)

Low risk

Quote: "Assignment was performed by pulling sequentially numbered opaque envelopes containing computer‐randomized individual allocations."

Comment: an appropriate method of allocation concealment was reported

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "This randomization was carried out by research staff before initiation of the study, and the patients were blinded to treatment once assigned."

Comment: although participants were blinded to treatment allocation it is unclear whether personnel were also blinded, the nature of the intervention groups suggests that they were not.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperative care providers were blinded to group assignment to minimize potential bias. .... The randomizing physician collected the initial data. Data entry was performed by data technicians who did not participate in the design or execution of the study; these technicians also reviewed the charts of each randomized patient to assess the accuracy of information provided by the treating physician. The senior investigator performed periodic reviews of data entry to ensure completeness and accuracy of information in the computer database. The data analysis was performed by an investigator blinded to group assignment."

Comment: blinded outcome assessment was conducted

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analyses

Selective reporting (reporting bias)

Low risk

Quote: "The primary outcome measure was the incidence of maternal morbidity, defined as the presence of at least one of the following:..."

Comment: primary and secondary outcomes were clearly specified and fully reported.

Other bias

Low risk

Comment: there were no other sources of bias evident and reporting was sufficient to be reasonably confident that this was the case.

Kokavec 2008

Methods

2‐arm RCT

Setting: single hospital in Slovakia

Follow‐up: 7.8 months (mean) 2‐14 months (range): follow‐up at 2 weeks, 6 weeks and then 3‐monthly

Participants

162 children (undergoing 182 surgical procedures on soft and bone tissues in the proximal femur, hip and pelvic regions. mean age was 7.9 vs 7.5 years Types of procedures: adductor tenotomy, femoral or pelvic osteotomy, extraction of metal materials, open reductions, epiphysiodesis, resection or biopsy. Children had the following long‐term conditions: developmental dysplasia of the hip, cerebral palsy, tumours, Perthes disease

Inclusion criteria: children undergoing surgery of the femur, hip or pelvis

Exclusion criteria: NR

Interventions

Group I: lavage with 3.5% Betadine solution (0.35% povidone iodine) diluted in 30 mL sterile saline

Group II: lavage with 30 mL sterile saline

Cointerventions: antibiotic prophylaxis begun preoperatively in participants with femoral or pelvic osteotomy or massive surgery of soft tissues and continued for 48‐72 hs postoperatively (dose determined by weight). Drains left in until second postoperative day where necessary

Outcomes

Primary outcome: SSI (positive bacteriological examination)

Group I (Betadine lavage): 0/89

Group II (saline lavage): 2/73

Notes

Funding: NR

Slovak; data entry and risk of bias based on information provided by translator

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Comment: no information about the sequence generation process but stated that the participants were allocated to 2 groups randomly

Allocation concealment (selection bias)

Unclear risk

Comment: no information on whether the allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no information on whether personnel or participants were blinded to the interventions

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no information on who assessed the presence of SSI or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote "In the first group (89 patients) [we] found no peri‐ or post‐operative infection. In the second group of patients (73) [we] brought to light two surface infection[s] (2.7%)"

Comment: it appears that all participants were included in the analysis

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes were not specified in the methods section so difficult to be certain whether all planned outcomes were assessed

Other bias

Unclear risk

No evidence of additional bias but reporting insufficient to be certain

Kubota 1999

Methods

2‐arm RCT

Setting: NR, appears to be single centre in Japan

Follow‐up: NR

Participants

16 children (aged 2‐12 years) undergoing appendectomy for perforated appendicitis

Inclusion criteria: generalised peritonitis or nonlocalised abscess

Exclusion criteria: NR

Interventions

After appendectomy, the peritoneal cavity was lavaged with 100 mL/kg (1500‐4000 mL) of the following warmed lavage solutions:

Group I : normal saline (8 participants)

Group II: acidic oxidative water (AOPW), a strong acidic water produced by the electrolysis of tap water containing 10% W/V sodium chloride (8 participants)

Co‐interventions: antibiotics moxalactam [reported as LMOX] (100 mg/kg/d) or cefazolin [reported as CEZ] (50 mg/kg/d) were given in both groups for 5 d or until serum C‐reactive protein was at a normal level

Outcomes

Primary outcome: SSI

No definition given for wound infection

Group I (saline): 4/8

Group II (APOW): 1/8

Secondary outcome: adverse events: abscess formation

Group I (saline): 1/8

Group II (APOW): 0/8

Secondary outcome: length of hospital stay (mean (SD) d)

Group IS (saline): 22.7 (11.1)

Group II (APOW): 12.1 (5.1)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "They were randomly divided into two groups"

Comment: no details of randomisation method

Allocation concealment (selection bias)

Unclear risk

Comment: no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no mention of blinding

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no mention of who performed the assessment of outcomes or whether blinding occurred

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all participants are included in the results

Selective reporting (reporting bias)

High risk

Comment: outcomes were not prespecified beyond "effectiveness and safety"

Other bias

Unclear risk

Comment: there is not enough methodological detail to judge

Kubota 2015

Methods

2‐arm RCT

Setting: appears to be multiple centres, Japan ("our affiliated hospitals")

Follow‐up: 30 d

Duration of study: 2008‐2012

Participants

44 children aged 3‐14

Group I: 16 boys and 4 girls, ranging in age from 4‐11 years

Group II: 12 boys and 12 girls, ranging in age from 3‐14 years

Inclusion criteria: children (age not defined) appendectomy for perforated appendicitis with extensive or panperitonitis

Exclusion criteria: pre‐operative antibiotics or requirement of antibiotics due to massive abscess formation

Interventions

After appendectomy, the peritoneal cavity was lavaged with 100 mL/kg saline or SAEW (strong acid electrolysed water, generated by electrolysis of tap water containing 0.2% NaCl), in Groups I and II, respectively. After closure of the fascial layer, the wound was washed out with 200 mL same solution before skin suture

Group I: 100 mL/kg saline (20 participants)

Group II: 100 mL/kg SAEW (24 participants)

Co‐intervention: cefmetazole, 100 mg/kg/d, was given initially to both groups, which was replaced by the most sensitive antibiotics after identification of causative pathogens for 5 or 7 d depending on response. The abdominal wall was disinfected with povidone iodine, and laparotomy was performed via a pararectal incision, saving the muscle layers, followed by appendectomy, carried out in the same manner in both groups.

Outcomes

Primary outcome: SSI

Defined as infection at the operation site, occurring up to 30 d after surgery, with confirmed causative pathogen(s) identical to those of the appendicitis.

Group I (saline): 4/20

Group II (SAEW): 0/24

Secondary outcome: adverse events (intraperitoneal abscess)

Group I (saline): 1/20

Group II (SAEW): 1/24

Secondary outcome: length of hospital stay (mean (SD) d)

Group I (saline): 9.4 (4.7)

Group II (SAEW): 8.7 (4.0)

Notes

34 participants were excluded from the study because some had received antibiotics before the operation and some had required antibiotics for massive abscess formation to be resected primarily with appendectomy

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Patients were allocated randomly to one of two treatment groups"

Comment: no details about method of randomisation

Allocation concealment (selection bias)

Unclear risk

Comment: no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no mention of blinding

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no mention of who performed the outcome assessment or whether blinding occurred

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "34 patients were excluded from the study..."

Comment: it is unclear if the exclusions were before or after randomisation

Selective reporting (reporting bias)

Low risk

Comment: all outcomes of interest appear to be reported

Other bias

Unclear risk

Comment: there is not enough methodological information to judge

Levin 1983

Methods

3‐arm RCT

Setting: Kaiser‐Permanente Medical Center ‐ Santa Clara, USA

Follow‐up: at least 8 weeks

Participants

128 women undergoing cesarean section for various indications including repeat, breech and cephalopelvic disproportion. (132 entered study but 4 were excluded for irrigation protocol deviation and data are only presented for 128)

Inclusion criteria: undergoing cesarean section

Exclusion criteria: fever or other evidence of infection in labour, history of sensitivity to cephapirin or cefoxitin

Interventions

Group I: following delivery of the placenta, the uterine cavity and incision, bladder flap, pelvic gutters, and subcutaneous tissue were irrigated with 2 mg cephapirin in 1000 mL normal saline (44 participants)

Group II: irrigation with 2 mg cefoxitin in 1000 mL normal saline (41 participants)

Group III: irrigation with 1000 mL normal saline only (43 participants)

Outcomes

Primary outcome: SSI (defined as purulent wound discharge with or without wound separation)

Group I (cephapirin): 0/44

Group II (cefoxin): 0/41

Group III (saline): 3/43

Secondary outcome: endometritis (defined as persistent fever, uterine tenderness, foul‐smelling lochia, with no other obvious source of infection)

Group I (cephapirin):4/44

Group II (cefoxin): 1/41

Group III (saline): 5/43 (one of these also had wound infection)

Secondary outcome: length of hospital stay (mean (SD) d)

Group I (cephapirin): 4.8 (1.2)

Group II (cefoxin): 4.9 (1.9)

Group III (saline): 5.2 (2.1)

Notes

4 excluded from the analysis for protocol deviation

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "... bags were sequenced randomly by a lottery method and used in numerical order"

Comment: the method is not explained in enough detail to know whether it was appropriate

Allocation concealment (selection bias)

Unclear risk

Quote: "... bags were sequenced randomly by a lottery method and used in numerical order"

Comment: there is not enough detail about the method of randomisation and allocation concealment to judge

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "...bags of irrigant were prepared by pharmacy personnel" "One millilitre of multivitamin infusion was added to create an identical appearance of all solutions" "Patients, physicians, operating room personnel, and data collectors were thus blinded to the group assignment."

Comment: steps were have been taken to ensure blinding of participants and personnel

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Patients, physicians, operating room personnel, and data collectors were thus blinded to the group assignment."

Comment: steps appear to have been taken to ensure blinding of outcome assessors

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Quote: "One hundred thirty‐two patients were entered in the study. Four patients were eliminated from the statistical analysis because of deviations from the protocol of irrigation technique"

Comment: there are only a few participants lost during the study but no details of these participants are reported and since numbers of events are small this could potentially have an impact.

Selective reporting (reporting bias)

Low risk

Comment: the outcomes of interest appear to be fully reported

Other bias

Low risk

Comment: there is no evidence of other bias

Lord 1983

Methods

2‐arm RCT

Setting: NR; appears to be single hospital in USA

Follow‐up: NR

Participants

200 participants undergoing elective and emergency gastrointestinal surgery (procedures on biliary tract 63/100 vs 57/100; gastroduodenal 14 vs 19 and colon 23 vs 24). Mean age was 61.7/61.6 years (range 17‐93). Malignancy present in 29/100 versus 25/100; diabetes 6/100 vs 8/100; obesity 30/100 vs 18/100

Inclusion criteria: elective or emergency procedures on the gastrointestinal tract

Exclusion criteria: parenteral antibiotics had been administered preoperatively or intraoperatively; a colostomy was required; if frank pus was encountered at operation

Interventions

Group I (kanamycin sulphate and cephalothin sodium): operative site was irrigated intermittently from the beginning to completion of the operation with a solution containing 1 g of kanamycin sulphate and 1 g of cephalothin sodium in 1000 mL of normal saline solution (100 participants)

Group II (saline): operative site was irrigated intermittently from the beginning to completion of the operation with a solution of normal saline (100 participants)

Cointerventions: the average volume of irrigant used for each operation was 750 mL. No cointerventions were reported

Outcomes

Primary outcome: SSI (postoperative wound infection)

Group I (kanamycin sulphate and cephalothin sodium): 3/100

Group II (saline): 9/100

Secondary outcome: mortality (postoperative deaths‐ last recorded 43 d post‐op)

Group I (kanamycin sulphate and cephalothin sodium): 5/100

Group II (saline): 3/100

Note: 2 participants who died had wound infections but sepsis was not the cause of the deaths

Secondary outcome: antibiotic resistance

Details of individual species recovered from wounds of participants with SSI were reported together with their sensitivity or resistance where this was tested for. Multiple species reported for each participant

Secondary outcome: adverse events

Postoperative peritonitis:

Group I (kanamycin sulphate and cephalothin sodium): 0/100

Group II (saline): 1/100

Secondary outcome: antibiotic resistance

Resistance of specific organisms to kanamycin sulphate and cephalothin sodium reported for each type of surgery. Large numbers of samples reported as not tested

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Designation was made by computer‐generated listing using a standard table of random numbers."

Comment: sequence generation used an appropriate method

Allocation concealment (selection bias)

Unclear risk

Quote: "Designation was made by computer‐generated listing using a standard table of random numbers."

Comment: no indication as to whether allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "a prospective, randomized, double‐blind study"

Comment: it was unclear who was blinded; while participants would probably be blinded it is unclear if personnel were

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "a prospective, randomized, double‐blind study"

Comment: it was unclear whether the double‐blinding referred to outcome assessors

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analyses

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes were not defined in the methods section so it is difficult to be sure whether all planned outcomes were fully reported.

Other bias

Unclear risk

Comment: no evidence of other sources of bias but reporting insufficient to be certain

Magann 1993

Methods

Parallel‐group RCT (factorial)

Setting: single hospital in the USA

Follow‐up: NR

Participants

100 women undergoing caesarean section

Inclusion criteria: women undergoing caesarean section; indications for surgery included elective repeat caesarean, failed trial of labour after prior caesarean, abnormal presentation, failure to progress, cephalopelvic disproportion, and severe pre‐eclampsia without thrombocytopenia or coagulopathy
Exclusion criteria: chorioamnionitis at caesarean, emergency caesarean for foetal distress with inadequate time for skin preparation

Interventions

Group I: saline irrigation (500 mL) of pelvis and subcutaneous tissue at uterine and fascial closure (50 participants)

Group II: cefazolin irrigation (1 g in 500 mL saline) of pelvis and subcutaneous tissue at uterine and fascial closure (50 participants)

Cointerventions: factorial randomisation to 2 alternative skin preparations: povidone iodine 7.5% scrub followed by povidone iodine 10% solution (standard skin preparation) versus 5‐min scrub with parachlorometaxylenol followed by povidone iodine scrub and solution (special skin preparation). No additional interventions were reported.

Outcomes

Primary outcome: SSI (hyperemic skin incision and fluctuant mass which when opened contained purulent material)

Group I (saline): 4/50 (3/25 with standard skin preparation; 1/25 with special skin preparation)

Group II (cefazolin): 2/50 (2/25 with standard skin preparation)

Secondary outcome: adverse events (endometritis)

Group I (saline): 30/50 (16/25 with standard skin preparation; 14/25 with special skin preparation)

Group II (cefazolin): 11/50 (8 with standard skin preparation; 3/25 with special skin preparation)

Notes

Funding: supported in part by the Vicksburg Hospital Medical Foundation

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Random assignment was achieved by card selection from sealed opaque envelopes with group appointment derived from a random number table"

Comment: it appeared that an appropriate method was used to generate the randomisation sequence

Allocation concealment (selection bias)

Unclear risk

Quote: "Random assignment was achieved by card selection from sealed opaque envelopes with group appointment derived from a random number table"

Comment: it was not clear that enough measures were taken to ensure adequate concealment of allocation

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: there was no information on whether personnel and participants were blinded to treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: there was no information on who performed the outcome assessment or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analyses

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes were not clearly prespecified so difficult to determine if all planned outcomes were fully assessed

Other bias

Unclear risk

Comment: no obvious additional sources of bias but reporting insufficient to be certain

Mahomed 2016

Methods

2‐arm RCT

Setting: single hospital in Australia

Follow‐up: letter or text message 4 weeks after surgery (following discharge from hospital)

Participants

3270 women undergoing caesarean section. Of those followed up 1508 had elective surgery and 1519 had surgery during labour. Mean age was 28.5 years in the Betadine group vs 28.6 years in the no Betadine group. 13.8% versus 12.9% had diabetes

Inclusion criteria: women undergoing caesarean section either elective or during labour (stratified randomisation)

Exclusion criteria: suspected or known allergy to iodine

Interventions

Group I: wound irrigation with 50 mL of 10% aqueous povidone iodine (Betadine) solution just before skin closure (1634 participants randomised; 1634 received allocated intervention; 1520 analysed)

Group II: no irrigation (1636 participants randomised; 1636 received allocated intervention; 1507 analysed)

Cointerventions: alcoholic povidone iodine for skin preparation unless an allergy to iodine present, in which case chlorhexidine was used. Prophylactic cephalothin administered to all women soon after spinal anaesthesia

Outcomes

Primary outcome: SSI (wound abscess or wound draining pus or sero‐sanguinous fluid, or redness, induration, warmth and tenderness or if woman’s general practitioner had seen her and prescribed antibiotics for presumed infection)

Group I (povidone iodine irrigation): 144/1520

Group II (no irrigation): 147/1507

Secondary outcome: return to theatre

Group I (povidone iodine irrigation): 7/1520

Group II (no irrigation): 9/1507

Secondary outcome: hospital readmission

Group I (povidone iodine irrigation): 39/1520

Group II (no irrigation): 30/1507

Completed case analyses reported here: ITT population 1634 vs 1636 ‐ used in analyses for SSI

Notes

Funding: states "we had no funding for this study..."

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The allocation was prepared using computer generated list of random numbers using a variable block of 10 and performed by a staff member not part of the clinical team"

Comment: acceptable method of sequence generation; randomisation also stratified by elective versus non‐elective procedure

Allocation concealment (selection bias)

Low risk

Quote: "Women were randomised to ‘Betadine’ or ‘no Betadine’ group using sequentially numbered sealed opaque envelopes that contained the allocation..... After all layers were sutured and just prior to starting skin closure, the envelope with the allocation was opened by one of the theatre nurse[sic]"

Comment: appropriate measures appear to have been taken to ensure allocation concealment.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote "In the control group (no Betadine group), layers would be sutured in exactly the same manner right up to the point of skin closure as it was only at this point that the allocation was revealed to the surgical team."

Comment: surgical personnel were aware of group allocation; unclear whether participants were blinded

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Information on outcome measures was obtained by the research team blinded to the allocation and also not involved in clinical care of the women"

Comment: blinded outcome assessment for all outcomes

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Quote: "Of the total number randomised, 243 women were inadequately followed up either due to change of address, wrong telephone number or just not receiving the text messages"

Comment: 7% of women were lost to follow‐up; this was balanced between the arms (114 versus 129) and between the types of surgery (elective versus non‐elective) undertaken. Although this is close to the wound infection rate it does not appear likely to have impacted on the risk ratio of infection.

Selective reporting (reporting bias)

Low risk

Quote "Primary outcome was the incidence of SSI as a whole but also specifically readmission for intravenous antibiotics and/ or return to theatre for wound infection"

Comment: The outcomes were specified in the methods section and then fully reported

Other bias

Low risk

Comment: no specific quote but no evidence of other bias and reporting sufficient to be reasonably confident.

Marti 1979

Methods

Three‐arm RCT

Setting NR; appears to be single hospital in Switzerland

Follow‐up: not clear beyond 4 d/discharge from hospital

Participants

162 participants with appendicitis

Inclusion criteria: people undergoing appendectomy carried out through an incision at McBurney's point, without the use of drains and without the use of pre‐, peri‐ or post‐operative systemic antibiotics

Exclusion criteria: people with perforated or gangrenous appendices or with peritonitis

Interventions

Group I (saline): irrigation with 500 mL saline (0.9%) after the closure of the peritoneum. The liquid was re‐aspirated and the wound was not swabbed. The skin was then closed.

Group II: (epicillin): irrigation with 500 mL saline with 1 g epicillin (Spectacilline) in solution as for Group I

Group III: (lincomycine): irrigation with 500 mL saline with 600 mL lincomycine (Lincocin) in solution as for Group I

Cointerventions: NR

Outcomes

Primary outcome: SSI (septic complications with spontaneous or induced purulent discharge): results only reported for all groups together (1/162) compared with a non‐randomised group without irrigation (7/158)

Secondary outcome: adverse events including abscess: results only reported for all groups together: 1/162 abscess from one of the antibiotic groups

Notes

Funding: NR

Paper in French; data extracted by one review author, checked by a fluent speaker

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "162 appendicectomies were randomised to treatment by blindly drawn lots"

Comment: acceptable method of sequence generation

Allocation concealment (selection bias)

Unclear risk

Quote: "162 appendicectomies were randomised to treatment by blindly drawn lots"

Comment: unclear whether there was adequate concealment of allocation

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No direct quote; no information on whether any personnel were blinded after the treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote "In the irrigated groups a questionnaire was sent to the treating physician to establish whether postoperative wound infections developed"

Comment: no information as to whether the physicians were aware of treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants appeared in the analysis

Selective reporting (reporting bias)

High risk

Comment: the results for the three randomised groups were reported together and contrasted only with a non‐randomised comparison group

Other bias

Unclear risk

No other sources of bias were apparent but reporting insufficient to be certain

Mirsharifi 2008

Methods

2‐arm RCT

Setting: a single hospital in Iran

Follow‐up: 1, 2, 4 and 6 weeks post surgery

Participants

102 participants (mean age: Group I: 50.63 years, Group II: 50.28 years) undergoing open cholecystectomy surgery

Inclusion criteria: cholecystitis diagnosed by surgeon

Exclusion criteria: age > 80 years, diabetes, immunosuppression (acquired or hereditary), history of immunosuppressive therapy, use of antibiotics during referral time for other reasons, history of recurrent cholecystitis, laparoscopic cholecystectomy, limitation for follow up [sic]

Interventions

Group I: open cholecystectomy, then before wound closure irrigation with 1 g cefazolin IV [sic] antibiotics (51 participants)

Group II: open cholecystectomy with no antibiotic irrigation before wound closure (51 participants)

Co‐interventions: same surgery and general anaesthesia

Outcomes

Primary outcome: SSI

Signs of infection included erythema, induration, tenderness, warmth, suppurative discharge

Group I: 6/51

Group II: 6/51

Notes

Funding: none reported

Reported in Persian. Data extraction and 'Risk of bias' assessment performed by translator

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Comment: they used a random number table

Allocation concealment (selection bias)

Unclear risk

Translator did not identify any information

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Translator did not identify any information

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Translator did not identify any information

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Translator judged all randomised participants included in analysis

Selective reporting (reporting bias)

Unclear risk

Translator did not identify any information

Other bias

High risk

Comment: had a potential source of bias related to the specific study design used, they did not have well‐defined outcome, the evaluation of some participants by telephone!

Mohd 2010

Methods

2‐arm RCT

Setting: NR; appears to be single hospital in Malaysia

Follow up at 2, 4 and 6 weeks post‐operatively for wound infection and adverse events

Participants

190 participants (178 analysed) undergoing CABG surgery. Mean age was 61.6 (7.6) years. Comorbidiities documented were diabetes (44.4%), chronic obstructive pulmonary disease (37.1%), end stage renal failure (18%) and obesity (11.2%)

Inclusion criteria: scheduled for elective CABG

Exclusion criteria: emergency cases, those who underwent other surgical procedures in addition to CABG, those allergic to Dermacyn, and those who had infective or other skin lesions over anterior chest wall area

Interventions

Group I (Dermacyn): Dermacyn wound irrigation (15‐min soak) upon chest closure and after insertion of sternal wires before subcutaneous tissue and skin closure (88 participants analysed)

Group II (povidone‐iodine): povidone‐iodine would irrigation (15‐min soak) upon chest closure and after insertion of sternal wires before subcutaneous tissue and skin closure (90 participants analysed)

Cointerventions: IV prophylaxis with 1.2 g Augmentin (amoxicillin and clavulanate) at induction. 2 drains were normally left in the mediastinal cavity.

Outcomes

Primary outcome: SSI (sternotomy wound infection, which was defined according to the Centers for Disease Control and Prevention system. Wound infections were graded as superficial (involving the skin and subcutaneous tissue of the incision), deep (involving fascia, muscle layers, and sternum), or deep organ space.

Group I (Dermacyn): 5/88 (5 superficial; 0 deep)

Group II (povidone‐iodine): 14/90 (10 superficial; 4 deep)

Secondary outcome: need for reoperation

Group I (Dermacyn): 0/88

Group II (povidone‐iodine): 4/90 (sternal dehiscence requiring surgical debridement and repair)

Secondary outcome: mortality

12 participants were described as having "dropped out"; 4 owing to postoperative mortality and 8 dropped for re‐opening of chest due to bleeding

Group I (Dermacyn): 7/95

Group II (povidone iodine): 5/95

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "patients were consecutively randomized into 2 groups"

Comment: no information on how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "patients were consecutively randomized into 2 groups"

Comment: no information on whether allocation concealment was adequate

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no information on whether the participants or personnel were blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "The sternotomy wounds were inspected on postoperative day 2 and daily until discharge. Patients were then followed up at 2, 4, and 6 weeks postoperatively to assess for the presence of wound infection and Dermacyn side effects."

Comment: no information on whether the inspections and follow‐up were carried out by blinded assessors

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "We recruited 190 patients for this trial, 95 patients in each group. Twelve patients, however, dropped out owing to postoperative mortality (4 cases, 2 deaths due to poor left ventricular function of < 20% and 2 deaths due to cerebrovascular accident) and chest re‐opened for bleeding (8 cases)"

Comment: the number of dropouts (exclusions) was close to the number of primary outcome events. The outcome of mortality can be assessed using the ITT population so is at low risk but the SSI outcome is at high risk.

Selective reporting (reporting bias)

Unclear risk

Quote: "The primary outcome was the presence of sternotomy wound infection,"

Comment: only the primary outcome was prespecified and it is difficult to be certain whether other planned outcomes were fully reported.

Other bias

Unclear risk

Comment: no evidence of other bias but reporting insufficient to be certain

Moylan 1968

Methods

2‐arm RCT

Setting: single hospital in USA

Follow‐up: carried out daily until discharge

Participants

260 randomised participants undergoing enterotomy during abdominal surgery. No further information on participant characteristics.

Inclusion criteria: enterotomy during abdominal surgery

Exclusion criteria: NR

Interventions

Group I (kanamycin): lavage prior to closure of the abdominal incision with 100 mL of 1% kanamycin; excess allowed to enter the peritoneal cavity (124 analysed participants; number randomised unclear)

Group II (saline): lavage prior to closure of the abdominal incision with 100 mL of saline; excess allowed to enter the peritoneal cavity (116 analysed participants; number randomised unclear)

Cointerventions: concomitant systemic antibiotics in approximately one fifth of wounds

Outcomes

Primary outcome: SSI (not defined)

Group I (kanamycin): 12/124

Group II (saline): 23/116

Secondary outcomes: mortality, reoperation

20 participants were excluded for early postoperative death, reoperation or delayed primary closure. Group allocations and numbers excluded for each reason were not reported

Secondary outcome: antibiotic resistance to kanamycin in wound culture

Group I (kanamycin): 12/12

Group II (saline): "over half" of 23

Secondary outcome: adverse events

Respiratory depression was only event reported on:

Group I (kanamycin): 2/124

Group II (saline):4/116

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "The solution, either 1% kanamycin or saline, was administered according to an established randomized schedule"

Comment: no information on how the randomisation schedule was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "The solution, either 1% kanamycin or saline, was administered according to an established randomized schedule"

Comment: no information on whether the allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "an established randomized schedule under a double‐blind protocol"

Comment: unclear who was blinded to the allocations

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "The appearance of the wound was graded daily until discharge by a single observer and any deviation from optimal healing was documented serially with photographs"

Comment: unclear whether the single observer was blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "of the 260 patients admitted to the study, 20 were excluded for reasons of early postoperative death, reoperation or delayed primary wound closure"

Comment: the number of exclusions was comparable to the numbers of infections in each group; the group allocation of excluded participants was not reported.

Selective reporting (reporting bias)

High risk

Comment: outcomes were not defined in the methods section so it is difficult to be sure whether all planned outcomes were fully reported. Some outcomes were not fully reported with data for each treatment group.

Other bias

Unclear risk

Comment: no evidence of other sources of bias but reporting insufficient to be certain

Neeff 2016

Methods

2‐arm RCT

Setting: unclear but appears to be a single centre in Germany

Follow up: NR

Participants

197 participants undergoing elective colorectal resection

Inclusion criteria: NR

Exclusion criteria: NR

Interventions

Group I: irrigation with polyhexanide 0.04% solution before final wound closure (101 participants)

Group II: irrigation with Ringer's solution before final wound closure (concentration not given) (96 participants)

Cointerventions: NR

Outcomes

Primary outcome: SSI (not defined)

Group I (polyhexanide): 19/101

Group II (Ringer's solution): 22/96

Notes

Funding: NR

Abstract only

States "interim analysis was done after 250 patients were screened and is presented here."

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote "This study was conducted as a double blind, randomized, single center study"

Comment: no information on how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote: "This study was conducted as a double blind, randomized, single center study"

Comment: no information on whether the allocation sequence was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote "This study was conducted as a double blind, randomized, single center study"

Comment: although described as double‐blind it is unclear who was blinded and whether the blinding was adequate

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote "This study was conducted as a double blind, randomized, single center study"

Comment: although described as double‐blind it is unclear who was blinded and whether the blinding was adequate

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "A total number of 197 elective colorectal resections were randomized. 101 patients received verum. Univariate analysis was followed by multivariate analysis where appropriate. Results: There were 41 wound infections in 197 patients (20.8%). 19 in the verum group, 22 in the control group (p=0.478)."

Comment: it appeared that all randomised participants were included in the analysis.

Selective reporting (reporting bias)

Unclear risk

Quote: "Primary endpoint was the rate of SSI in each group"

Comment: there is too little information to be sure if all planned outcomes were assessed and reported.

Other bias

High risk

Comment: an interim analysis. This is an abstract and there is too little information to determine if there were other additional sources of potential bias.

Nikfarjam 2014

Methods

Setting: 2 tertiary hepatobiliary and pancreatic surgery units in Australia

Follow‐up: at 1 and 2 weeks following surgery, and thereafter as indicated. Minimum follow‐up 1 month after surgery

Participants

137 consecutive participants enrolled, undergoing major elective open abdominal operative procedures; 128 assigned to treatment (median age 63 years, range 18‐86 years)

Inclusion criteria: adults undergoing an elective open abdominal operation anticipated to extend beyond 2 h

Exclusion criteria: those undergoing laparoscopic procedures

Interventions

In all cases, prior to abdominal closure, the peritoneal cavity was irrigated with least 3 L of warm saline without any added antibiotics. participants then received the following treatment after randomisation:

Group I (pulse irrigation): surgical irrigation device (Stryker Instruments, Portage, MI) used after fascia closure to irrigate the surgical wound with 2 L of normal saline at room temperature; pressure close to (but not exceeding) 15 psi delivered through cone‐shaped applicator

Group II (saline): following closure of the fascia in the standard group, 2 L of normal saline at room temperature was poured into the subcutaneous tissue without any agitation

Excess fluid was removed from the subcutaneous tissue with application of a dry pack. Subcutaneous drainage or closure was not undertaken. The skin was reapproximated with continuous subcuticular 3/0 Monocryl sutures. Skin staples were not used in any case. A Duoderm dressing was applied to the wound.

Cointerventions: all participants received dexamethasone phosphate 8 mg IV as part of routine antiemetic prophylaxis.

At induction of anaesthesia all participants received ampicillin 1 g IV, gentamicin IV (2 mg/kg), and metronidazole 500 mg IV. Antibiotics were continued for 24 h postoperatively. In cases of penicillin allergy, vancomycin 1 g IV or cefazolin [cephazolin] 1 g IV was administered according to the particular sensitivity reaction.

Outcomes

Primary outcome: SSI

Wound infection defined as: (1) purulent drainage, with or without laboratory confirmation, from the superficial incision; (2) organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision; (3) at least one of the following signs or symptoms of infection: pain or tenderness, localised swelling, redness, or heat and superficial incision is deliberately opened by surgeon, unless the incision was culture‐negative; (4) diagnosis of superficial incisional SSI by the surgeon or the attending physician

Group I (pulse irrigation): 4/66 (all superficial)

Group II (saline): 12/62 (2 required major debridement with prolonged course of dressings; one had partial abdominal wall dehiscence)

Primary outcome: wound dehiscence within 30 d of operation

Group I (pulse irrigation): 0/4

Group II (saline): 1/12

Secondary outcome: participants with postoperative SSI using systemic antibiotics within 30 d of surgery

14/16 participants; no data regarding which treatment group these were associated with

Secondary outcome: antibiotic‐resistant infections

Details of organisms isolated but not of resistance were reported, this was not group data

Secondary outcome: adverse events

Cellulitis (without wound cultures): 1/16; no data regarding which treatment group this was associated with

Any non‐wound‐related complication

Group I (pulse irrigation): 32/66

Group II (saline): 23/62

Secondary outcome: surgical reintervention

Relaparotomy

Group I (pulse irrigation): 3/66

Group II (saline): 3/62

Debridement of wounds with SSI

Group I (pulse irrigation): 0/4

Group II (saline): 2/12

Secondary outcome: length of stay

Group I (pulse irrigation): median 9 (range 4‐71) d

Group II (saline): median 9 (range 5‐45) d

Secondary outcome: hospital readmissions

Group I (pulse irrigation): 9/66

Group II (saline): 6/62

Notes

Funding: supported by a University of Melbourne, Early Career Development Grant, awarded to lead author. No supplementary support was provided by Stryker

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Grouping allocation was determined by a sealed envelope selection. Blocks of 20 patients were randomized at one time. Diabetic patients were randomized separately to achieve close to even distribution in each group."

Comment: no information on how randomisation schedule was generated.

Allocation concealment (selection bias)

Unclear risk

Quote: "Grouping allocation was determined by a sealed envelope selection."

Comment: unclear whether opaque envelopes were used

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No direct quote; no information on blinding

Comment: it is unclear whether participants and personnel were blinded; personnel unlikely to be blinded after randomisation due to difference in intervention procedures between arms

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Patients were monitored by a dedicated acute pain service and reviewed daily for any complications arising from their analgesic regime."

Comment: unclear whether personnel were blind to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "A total of 137 patients were enrolled, as 8 cases did not reach the 2 h duration required for randomization."

Comment: study flow diagram indicates that 9 were excluded because they did not conform to inclusion criterion of needing to be > 2 h in duration; there is a discrepancy in the report text stating 8 were excluded for this reason. Attrition bias judged to be low risk given that all others conforming to inclusion criteria were analysed

Selective reporting (reporting bias)

Unclear risk

Comment: unclear whether all prescribed outcomes were reported

Other bias

Unclear risk

Comment: no evidence of other sources of bias but reporting insufficient to be certain

Oestreicher 1989

Methods

2‐arm RCT

Setting: single hospital in Switzerland

Follow‐up: NR

Participants

540 randomised participants undergoing surgery

Inclusion criteria: participants undergoing surgery

Exclusion criteria: oto‐rhino‐laryngeal surgical cases; thyroid surgeries; day‐case surgeries

Interventions

Group I (saline): irrigation with saline. 2 rinses were performed; the first of the operative site, and the second performed before skin closure (273 participants ‐ information derived from graph)

Group II (povidone‐iodine): irrigation with Betadine‐R solution (10% PVP‐iodine with 1% available iodine, diluted in a 1/10 solution). 2 rinses were performed; the first of the operative site, and the second performed before skin closure. (267 participants ‐ information derived from graph)

Cointerventions: after 1 min the excess liquid was re‐aspirated. In all participants skin disinfection was carried out using a standard Betadine‐R solution.

Outcomes

Primary outcome: SSI (not defined)

Group I (saline): 15/273

Group II (Betadine): 16/267

Notes

Paper in French; data extracted by one review author, checked by a fluent speaker

SSI data presented graphically across 2 figures; these data extracted using graph‐reader software

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote "A prospective randomized study was undertaken......a draw of two groups on the basis of a pre‐established list, was carried out at entrance to theatre"

Comment: not clear how the randomisation sequence was established

Allocation concealment (selection bias)

Unclear risk

Quote "A prospective randomized study was undertaken......a draw of two groups on the basis of a pre‐established list, was carried out at entrance to theatre"

Comment: not clear whether allocation sequence was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote " all information about the participant, the type of interventions, the personnel, the bacteriological findings and the antibiotic therapies was stored on a computer"

Comment: no information as to whether personnel were blinded to interventions

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

No direct quote but no information as to who determined the presence of SSI or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No direct quote: no attrition is reported but results are presented only graphically and it is difficult to determine whether all randomised participants were represented in the results.

Selective reporting (reporting bias)

High risk

No direct quote: results are not adequately reported for each group and it is very unclear if all outcome data are fully reported.

Other bias

Unclear risk

No other source of bias was apparent but the reporting was insufficient to be certain.

Oleson 1980

Methods

Parallel‐group RCT

Setting: single hospital in Denmark

Follow‐up: mean 8 d (5‐16 d)

Participants

33 participants undergoing surgery for perforated appendix

Inclusion criteria: all patients admitted for surgery for perforated appendix with diffuse peritonitis. Visible perforation of appendix with free pus in peritoneum, verified by microbiological culture of extracted peritoneal material. Normal function of kidneys in serum‐creatinin concentration demanded.

Exclusion criteria: pregnant women, < 15 and > 75 years, with malignant disorders and known allergy to penicillin

Interventions

Group I: no irrigation

Group II: postoperative peritoneal flushing with 1 g ampicillin per L flushing fluid

Group III: postoperative peritoneal flushing without ampicillin in the flushing fluid

Cointerventions: all participants had systemic antibiotics: ampicillin 2 g 4/d IV, gentamycin 1.5 mg/kg weight as the first dose – then 1 mg/kg weight 3/d IM, and clindamycin 600 mg 3/d IM

Outcomes

Primary outcome: SSI

Group I (no irrigation): 4/10

Group II (ampicillin irrigation): 3/10
Group III (saline irrigation): 2/10

Secondary outcome: adverse events (intra‐abdominal abscess)

Group I (no irrigation): 1/10

Group II (ampicillin irrigation): 010
Group III (saline irrigation): 0/10

Secondary outcome: length of stay

Group I (no irrigation): 14 d (8‐22)

Group II (ampicillin irrigation): 13 d (9‐20)
Group III (saline irrigation): 13 d (10‐22)

Notes

Funding: NR

Data extraction and 'Risk of bias' assessment performed by translator from the Danish; some aspects discussed with a review author

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Comment: described by one Danish word; the envelope system

Allocation concealment (selection bias)

Unclear risk

Comment: described by one Danish word; the envelope system

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: Groups II and III had additional catheter added for flushing fluids. Group II also had ampicillin added to the flushing fluid. Personnel would therefore be aware of allocation, unclear if participants were also aware

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no description of whether assessors were the same as the personnel

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all 30 participants were included in analysis

Selective reporting (reporting bias)

Low risk

Comment: all outcomes mentioned in the methods section were reported. In the discussion they reported that no kidney or liver dysfunction was observed

Other bias

Unclear risk

Comment: none identified

Oller 2015

Methods

Three‐arm RCT

Setting: single hospital in Spain

Follow‐up: unclear

Participants

51 women undergoing axillary lymph node dissection for breast neoplasm. Mean age 55.6 years

Inclusion criteria: diagnosis of breast neoplasm and plans to undergo an elective axillary lymph node dissection of Berg’s levels I and II because of axillary metastases determined pre‐operatively by core biopsy or evidence of metastasis in the sentinel lymph node biopsy (SLNB) in the intra‐operative or differential analysis

Exclusion criteria: allergy to any of the antibiotic drugs to be used, chronic renal failure secondary to possible toxicity of gentamicin, and planned modified radical mastectomy

Interventions

Group I: 2 lavages with 500 mL of physiologic saline (17 participants)

Group II: lavage with 500 mL of saline followed by lavage with 500 mL of a 240‐mg gentamicin solution (17 participants)

Group III: lavage with 500 mL of saline followed by lavage with 500 mL of a 600‐mg clindamycin solution (17 participants)

Cointerventions: pre‐operative systemic antibiotics (amoxicillin‐clavulanic acid 2 g IV; a single dose within 30 min of incision) were employed in all groups. Once the dissection was finished, a Redon drain was placed and connected to a low‐pressure vacuum device (primary closure was undertaken)

Outcomes

Primary outcome: SSI (incisional, not further defined)

Group I (2 x saline lavages) 0/17

Group II (saline then 240 mg gentamicin lavages) 0/17

Group III (saline then 600 mg clindamycin lavages) 0/17

Secondary outcome: mortality

Group I (2 x saline lavages) 0/17

Group II (saline then 240 mg gentamicin lavages) 0/17

Group III (saline then 600 mg clindamycin lavages) 0/17

Secondary outcome: length of hospital stay

Group I (2 x saline lavages) median 3 d (range 1‐3)

Group II (saline then 240 mg gentamicin lavages) median 3 d (range 1‐3)

Group III (saline then 600 mg clindamycin lavages) median 3 d (range 1‐3)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote "The patients were randomized by means of an Internet module into three groups"

Comment: mechanism of the internet module used for randomisation unclear

Allocation concealment (selection bias)

Unclear risk

Quote "The patients were randomized by means of an Internet module into three groups"

Comment: no information as to whether the allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "The patients were blinded as to whether they received saline, gentamicin, or clindamycin."

Comment: participants were blinded but unclear whether personnel were also blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: there is insufficient information to determine who performed the assessment of outcomes and whether they were blinded to treatment allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: it appears that all the randomised participants were included in the analyses.

Selective reporting (reporting bias)

Unclear risk

Comment: the outcomes reported were not prespecified in the methods so it is difficult to determine whether all planned outcomes were fully reported.

Other bias

Unclear risk

Comment: there is no evidence of other sources of bias but reporting is insufficiently detailed to be sure.

Ozlem 2015

Methods

2‐arm RCT

Setting: NR but appears to be a hospital in Turkey

Follow‐up: NR

Participants

14 participants with perforated appendix (among 279 undergoing appendectomy for acute appendicitis)

Inclusion criteria: perforated appendix, undergoing appendectomy for acute appendicitis

Exclusion criteria: appendix not perforated

Interventions

Group I: peritoneal lavage with irrigation and aspiration (7 participants)

Group II: aspiration alone (7 participants)

Co‐interventions: NR

Outcomes

Primary outcome: SSI

Wound infection

Group I (lavage): 2/7

Group II (aspiration only): 0/7

Secondary outcome: adverse events

(1 intra‐abdominal abscess, 1 postoperative ileus)

Group I (lavage): 1/7

Group II (aspiration only): 1/7

Notes

Abstract only but further information received via study author correspondence

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote (via correspondence): "The randomisation method is envelope method"

Comment: unclear how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Comment: insufficient information on use of envelopes to be sure whether allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no information on whether participants or personnel were blinded but personnel must have been aware due to differences in intervention

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no information on who performed the assessment or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

It appears that all randomised participants were included in the analysis.

Selective reporting (reporting bias)

Unclear risk

It is unclear whether all planned outcomes were fully reported; we contacted the study author in order to fully report SSI outcome on a per‐group basis.

Other bias

Unclear risk

Abstract only and reporting insufficient to be certain there were no other sources of bias.

Peterson 1990

Methods

Parallel‐group RCT

Setting: single medical centre in USA

Follow‐up: at least 2 weeks postoperatively

Participants

207 women undergoing caesarean section

Inclusion criteria: non elective caesarean section

Exclusion criteria: allergic to penicillin or cephalosporins, already on antibiotics, ongoing infection, requiring bacterial endocarditis prophylaxis

Interventions

Group I: cefazolin lavage; 2 g in 1000 mL saline administered to the uterine incision (300 mL), bladder flap (200 mL), abdominal gutters (200 mL) and abdominal incision (remaining fluid)

Group II: cefamandole lavage; 2 g in 1000 mL saline administered to the uterine incision (300 mL), bladder flap (200 mL), abdominal gutters (200 mL) and abdominal incision (remaining fluid)

2 additional groups were included in the trial using the same antibiotics delivered IV with saline lavage. These groups are not relevant to this review and we did not extract any data relating to them.

Cointerventions: normal saline bolus IV after cord clamped

Outcomes

Primary outcome: SSI (presence of cellulitis and/or purulent exudate)

Group I (cefazolin): 2/59

Group II (cefamandole) 0/54

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Patients were randomly assigned to one of four treatments"

Comment: no information on how the randomisation sequence was generated or whether an appropriate method was used.

Allocation concealment (selection bias)

Unclear risk

Quote: "Patients were randomly assigned to one of four treatments"

Comment: no information on whether there was adequate allocation concealment.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "The operating‐room nurses prepared the 1000 mL lavage solutions, to which all surgeons and patients were blinded"

Comment: participants and personnel were blinded to treatment allocation.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no specific quote but it was not clear who performed the outcome assessment and whether they were blinded to treatment allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all 207 randomised participants were included in the analyses.

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes were not clearly specified in the methods so it is unclear whether all planned outcomes were fully reported.

Other bias

Unclear risk

Comment: no obvious sources of additional bias but reporting insufficient to be certain

Platt 2003

Methods

Within‐subject design ‐ all participants received both treatment and control

Setting: single hospital in UK

Follow‐up: 1, 4 and 8 weeks

Participants

30 women undergoing bilateral breast reduction. Participants had breasts randomised to the 2 treatment groups. Mean age 33 years (range 18‐65), mean BMI 26.3

Inclusion criteria: BMI ≤ 30, undergoing bilateral breast reduction

Exclusion criteria: NR

Interventions

Group I (saline): breast washed out with saline for approximately 2 min just prior to wound closure (30 participants, 30 breasts)

Group II (control): no wash out with saline (same 30 participants as Group I, 30 breasts)

Co‐interventions: each breast was preinfiltrated with 300 mL saline containing adrenaline diluted to 1:500,000, lignocaine and hyaluonidase. Infiltration was performed uniformly through the breast using a spinal needle and syringe, sparing the pedicle. All wounds were closed over corrugated drains which were removed 24 hs after surgery.

Outcomes

Primary outcome: SSI

Wound discharge, invasive infection

Group I (saline): 0/30

Group II (control): 0/30

Primary outcome: wound dehiscence

Minor wound breakdown in 13/60 breasts (7 < 1 cm wide, 6 > 1 cm)

11/60 participants affected, 9 unilaterally, 2 bilaterally

Group I (saline): 7/30

Group II (control): 6/30

Notes

Generalisability: outcomes were related to BMI and this group were preselected based on BMI

Some methodological details were provided via study author correspondence

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote (from text): "The side to be washed out with normal saline was randomised so that the contralateral breast acted as each patient's own control"

Quote (from author correspondence): "I think we used sealed envelopes"

Comment: not enough detail about the method to judge whether appropriate method of sequence generation was used.

Allocation concealment (selection bias)

Unclear risk

Quote (from author correspondence): "I think we used sealed envelopes"

Comment: not enough detail about the method to judge whether there was adequate allocation concealment.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: there is no mention of blinding. The participants may have been blinded but the personnel would be aware of the different treatments.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote (from author correspondence): "Assessors were blind to the side washed out but could include the surgeons."

Comment: although some assessors were blind to treatment, they could also have included the surgeons who were not blinded.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote (from author correspondence): "All people enrolled were included in the study."

Comment: all participants accounted for in the results

Selective reporting (reporting bias)

Unclear risk

Comment: there is insufficient information to judge whether all planned outcomes were appropriately assessed.

Other bias

Unclear risk

Comment: the study design means that the 2 groups are not independent. It's not clear whether the analysis was adjusted for paired data.

Rambo 1972

Methods

2‐arm RCT

Setting: single hospital in USA

Follow‐up: NR

Participants

94 patients undergoing surgery for peritonitis. Mean age Group I: 40.1 years, Group II: 40.3 years

Inclusion criteria: participants deemed by surgeon, at time of operation, that irrigation would be helpful for mechanical cleansing of peritoneal cavity or for direct application of an antibiotic to a grossly contaminated peritoneum.

Exclusion criteria: NR

Interventions

Group I (cephalothin): irrigation with solution containing 4 g/L cephatholin (43 participants irrigated with 4 L of solution, 1 participant irrigated with 2 L of solution)

Group II (saline and multivitamin): irrigation with 0.9% saline solution containing 0.25 mL/L of IV multivitamin solution (Betalin, Eli Lilly, Indiana) (48 participants irrigated with 4 L of solution, 2 participants irrigated with 2 L of solution)

Cointerventions: use of concomitant antibiotics (cephaolthin; cephalothin plus other antibiotic; penicillin and streptomycin; miscellaneous) was at surgeon's discretion

Outcomes

Primary outcome: SSI (no definition provided)

Group I (cephalothin): 11/44

Group II (saline and multivitamin): 13/50

Secondary outcome: mortality

Group I (cephalothin): 5/44

Group II (saline and multivitamin): 8/50

Secondary outcome: antibiotic‐resistant infections

Group I (cephalothin): 7 organisms reported to be resistant; 28 to be sensitive

Group II (saline and multivitamin): 12 organisms reported to be resistant; 49 to be sensitive

It was not clear how this related to participant‐level data; individual organism types were reported

Secondary outcome: adverse events

Abscess/peritonitis:

Group I (cephalothin): 8/44

Group II (saline and multivitamin): 10/50

Notes

Participants: "Two patients had irrigation of the peritoneal cavity on two separate occasions, each of which was counted as a distinct clinical entity unto itself"

Funding: NR

Time points for all assessments unknown

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were assigned by the pharmacy to the cephalothin or to the control group by use of a table of random numbers."

Comment: sequence generation used an appropriate method.

Allocation concealment (selection bias)

Unclear risk

Quotes: "Patients were assigned by the pharmacy to the cephalothin or to the control group by use of a table of random numbers;" "The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy;"

Comment: participants allocated to treatment group by pharmacy who held the randomisation schedule, but unknown whether pharmacy staff were blinded to the allocation sequence

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quotes: "The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy."

Comment: appears that treating staff and participants were unaware of treatment allocation until after data collection

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy."

Comment: appears that staff were unaware of the allocation until after data collection

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: no evidence of attrition, as data reported for all randomised patients

Selective reporting (reporting bias)

Unclear risk

Comment: all outcomes specified in study methods are reported in the results, but not enough information to determine whether all outcomes in the study protocol are reported

Other bias

High risk

Quote: "Patients were admitted to the study if their surgeon, at the time of operation, believed that irrigation would be helpful for mechanical cleansing of the peritoneal cavity or for direct application of an antibiotic to a grossly contaminated peritoneum."

Comment: potential bias relating to participant selection, based on subjective rather than objective criteria.

Ruiz‐Tovar 2011

Methods

2‐arm RCT

Setting: single hospital in Spain

Follow‐up: NR

Participants

128 participants

Inclusion criteria: colorectal surgery for neoplasms

Exclusion criteria: NR

Interventions

Group I: intraperitoneal irrigation with normal saline (64 participants)

Group II: intraperitoneal irrigation with solution containing gentamicin (240 mg) and clindamycin [clindamicin] (600 mg) (64 participants)

Outcomes

Primary outcome: SSI (not defined)

Wound infection (unsure of calculation to numbers as whole numbers/64 do not round to these %)

Group I (saline): 41.9%; 27/64 (extrapolated from percentage and rounded to nearest whole number)

Group II (antibiotic): 9.5%; 6/64 (extrapolated from percentage and rounded to nearest whole number)

Intra‐abdominal infection (excluding 5% cases diagnosed with anastomotic leak) (intra‐abdominal abscess?)

Group I (saline): 16.3%; 10/64 (extrapolated from percentage and rounded to nearest whole number)

Group II (antibiotic): 0%; 0/64

Notes

Abstract only

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote "A prospective randomized study of all the patients undergoing colorectal surgery for neoplasms at Hospital General Universitario de Elche during 2010 was performed. Patients were divided in 2 groups..."

Comment: not clear how the randomisation sequence was generated

Allocation concealment (selection bias)

Unclear risk

Quote "A prospective randomized study of all the patients undergoing colorectal surgery for neoplasms at Hospital General Universitario de Elche during 2010 was performed. Patients were divided in 2 groups..."

Comment: not clear whether allocation was adequately concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no direct quote but no information on blinding of either participants or personnel

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no direct quote but no information on how the outcomes were assessed or whether the assessors were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Quote: "128 patients were analyzed, 64 in each group."

Comment: the number of participants randomised is not stated, only the number analysed

Selective reporting (reporting bias)

Unclear risk

Quote: "Wound infection and intrabdominal abscess were investigated."

Comment: both these outcomes were reported but it is not clear whether they were the only planned outcomes

Other bias

Unclear risk

Comment: no evidence of other bias but reporting insufficient to be confident (abstract only)

Ruiz‐Tovar 2012

Methods

2‐arm RCT

Setting: single hospital in Spain

Follow‐up: 30 d after discharge

Participants

108 participants with adenocarcinoma (5 excluded postoperatively due to anastomotic leak). Mean (SD) age 69.9 (11.3) years. Comorbidities: diabetes mellitus (34%), high blood pressure (48%), dyslipedaemia (32%), cardiopathies (21%), chronic obstructive pulmonary diseases (11%), nondecompensated liver cirrhosis (1%).

Inclusion criteria: diagnosis of colorectal neoplasms and due to undergo elective operation with curative aims

Exclusion criteria (preoperative): diagnosis of chronic renal failure

Exclusion criteria (postoperative): anastomotic leak identified by computed tomography (CT) scan with rectal contrast enema

Interventions

Group I (saline): irrigation of entire abdominal cavity with 500 mL normal saline, followed by aspiration of the liquid and abdominal wall closure (54 participants)

Group II (antibiotics): irrigation with 500 mL normal saline, aspiration, then lavage with antibiotic solution (gentamicin 240 g and clindamycin 600 mg dissolved in 500 mL normal saline) for 3 min, aspiration and abdominal wall closure (54 participants)

Co‐interventions: perioperative antibiotics given to all (ciprofloxacin 400 mg and metronidazol 1500 mg, single dose within 30 min of incision with redose after 4 h if surgery prolonged)

Outcomes

Primary outcome: SSI

Wound infection defined as presence of purulent discharge from the surgical wound, confirmed with microbiologic culture

Group I (saline): 14% (calculated as7/51 analysed participants)

Group II (antibiotic): 4% (calculated as 2/52 analysed participants)

Secondary outcome: mortality

Group I (saline): 2 (unclear whether this is out of 51 analysed or 54 randomised participants) [we will assume completed case here]

Group II (antibiotic): 1 (unclear whether this is out of 52 analysed or 54 randomised participants)

Secondary outcome: intra‐abdominal abscess

Defined as the presence of a fluid collection at CT scan in symptomatic participant (fever, abdominal pain, prolonged postoperative ileus or septic status)

Group I (saline): 6% (calculated as 3/51 analysed participants)

Group II (antibiotic): 0 (presumably 0/52 analysed participants)

Secondary outcome: length of hospital stay (median (range) d)

Group I (saline): 6 (5‐32)

Group II (antibiotic): 6.5 (5‐14)

Notes

Funding: financial support provided by Fundacion Navarro Tripodi

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The patients were randomized by means of an Internet randomization module"

Comment: appropriate method of sequence generation appears to have been used

Allocation concealment (selection bias)

Unclear risk

Comment: no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: there is no mention of blinding participants or personnel but differences in treatment mean personnel would not have been blinded

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Wound infection was determined by an epidemiology nurse blinded to treatment groups" "The diagnosis of intra‐abdominal abscess was determined by a radiologist blinded to the treatment groups"

Comment: outcome assessors were blinded

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: "Exclusion criteria were... or an anastomotic leak in the postoperative course, which would represent a bias in the diagnosis of intra‐abdominal infection"

Comment: 5 participants were excluded from the analysis as they were considered to be at high risk of infection and represent a bias ‐ however it is not clear what bias they would introduce as their results are not reported.

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes are not clearly reported as they are presented as percentages and do not clarify participant numbers.

Other bias

Low risk

Comment: there is no evidence of other bias.

Ruiz‐Tovar 2013

Methods

2‐arm RCT

Setting: single breast unit at hospital in Spain

Follow‐up: 2 weeks after surgery

Participants

40 female participants (mean age 54.8 (SD 13.7) years) undergoing axillary lymph node dissection

Inclusion criteria: diagnosis of breast neoplasms and plans to undergo elective axillary lymph node dissection (ALND) of Berg’s levels I and II due to axillary metastasis determined preoperatively by core biopsy or evidence of metastasis in the sentinel lymph node biopsy (SLNB) in the intraoperative or in the differed analysis.

Exclusion criteria: chronic renal failure due to possible toxicity of gentamicin and participants undergoing a modified radical mastectomy.

Interventions

Group I (saline): lavage performed immediately prior to closure, after placement of drain and a first swab for microbiological culture. First lavage with 500 mL normal saline, which was aspirated and a second swab for culture obtained. Second lavage with 500 mL normal saline, which was aspirated prior to third swab for culture

Group II (gentamicin): lavage performed immediately prior to closure, after placement of drain and a first swab for microbiological culture. First lavage with 500 mL normal saline, which was aspirated and a second swab for culture obtained. Second lavage with 240 mg gentamicin dissolved in 500 mL normal saline, which was aspirated prior to third swab for culture.

Cointerventions: perioperative systemic antibiotics (single dose amoxicillin/clavulanic acid 2 g IV, within 30 min of incision) were administered in both groups. Redon drain was left in place and connected to a low pressure vacuum device, and removed when drainage volume was < 30 mL/d

Outcomes

Primary outcome: SSI ("wound infection" ‐ not defined)

Group I (saline): 0/20

Group II (gentamicin): 0/20

Secondary outcome: length of hospital stay (median (range) d)

Group I: 3 (1‐3)

Group II: 3 (1‐3)

Secondary outcome: mortality

Group I (saline): 0/20

Group II (gentamicin): 0/20

Secondary outcome: adverse events (all types)

Group I (saline): 0/20

Group II (gentamicin): 0/20

Notes

Funding: Fundación Navarro Tripodi

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were randomized by means of an Internet randomization module into 2 groups."

Comment: sequence generation used an appropriate method

Allocation concealment (selection bias)

Unclear risk

Quote: "Patients were randomized by means of an Internet randomization module into 2 groups."

Comment: unclear whether randomisation schedule was concealed from staff

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "Patients were blinded as to whether they received gentamicin or not."

Comment: unclear whether staff were blinded to treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no direct quote; no information on who performed outcome assessment or whether they were blinded to treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: no evidence of attrition bias

Selective reporting (reporting bias)

Unclear risk

Comment: no evidence of selective reporting but not enough information to be certain

Other bias

Unclear risk

Comment: no evidence of other sources of bias, but reporting is not sufficient to be certain

Ruiz‐Tovar 2016a

Methods

2‐arm RCT

Setting: several hospitals in Spain and 1 hospital in UK ("at our institutions" ‐ not stated how many ‐ it isn't clear from authorship)

Follow‐up: minimum 42 months post surgery (infection surveillance was for 30 d following discharge)

Participants

106 participants undergoing elective surgery for colon neoplasms (data only presented for 104 as 2 who died perioperatively were excluded). Mean (SD) age: Group I 69.1 (10.2) years, Group II 68.5 (10.2) years. Co‐morbidities included diabetes mellitus (Group I 33%, Group II 29%), high blood pressure (Group I 46%, Group II 50%), dyslipidemia (Group I 33%, Group II 29%), cardiopathy (Group I 23%, Group II 27%). Groups were balanced in terms of tumour stage and surgical technique used.

Inclusion criteria: diagnosis of colon neoplasms, undergoing elective surgery with curative aims

Exclusion criteria: pre‐operative diagnosis of renal failure, allergy to gentamicin or clindamycin, diagnosis of rectal cancer

Interventions

Group I: immediately prior to closure of the abdominal wall, lavage was performed with an antibiotic solution (gentamicin 240 mg and clindamycin 600 mg dissolved in 500 mL normal saline). The solution was allowed to sit in the abdominal cavity for 3 min, then aspirated (53 participants)

Group II: as above but with 500 mL normal saline (53 participants)

Co‐interventions: perioperative systemic antibiotics (ciproflaxin 400 mg and metronidazole 1500 mg, single dose given within 30 min of incision, additional dose after 4 h if surgery prolonged)

Outcomes

Primary outcome: SSI

Incisional SSI (defined as the presence of a purulent discharge from the surgical incision and confirmed with microbiological culture)

Group I (antibiotic): 3.8% (calculated as 2/52)

Group II (saline): 13.5% (calculated as 7/52)

Organ‐space SSI

Group I (antibiotic): 0% (0/52)

Group II (saline): 5.8% (calculated as 3/52)

Secondary outcome: length of hospital stay (median (range) d)

Group I (antibiotic): 6.5 (5‐14)

Group II (saline): 6 (5‐32)

Secondary outcome: adverse events

Anastomotic leak

Group I (antibiotic): 2/52

Group II (saline): 3/52

Secondary outcome: mortality

1 participant from each group died perioperatively and was excluded from the analysis. Survival analysis is reported for remaining participants as the primary outcome of the study was disease‐free survival, but 30‐day survival is not reported.

30‐day mortality

Group I (antibiotic): 1/53

Group II (saline): 1/53

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were randomly assigned using a random number table"

Comment: appropriate method used

Allocation concealment (selection bias)

Unclear risk

Comment: no mention of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: There is no mention of blinding of participants and personnel. It is unlikely that personnel were blinded but possible

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Incisional SSI was determined by an epidemiology nurse blinded to the treatment groups"

Comment: outcome assessor was blinded (for SSI)

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Comment: 1 participant in each group died perioperatively and was excluded from analysis. This is unlikely to have biased results but no details about these participants are included so it is difficult to judge.

Selective reporting (reporting bias)

Low risk

Comment: there does not appear to have been selective outcome reporting and the primary outcomes of the study are reported in detail

Other bias

Low risk

Comment: there is no evidence of other bias

Ruiz‐Tovar 2016b

Methods

Parallel‐group RCT

Setting: single hospital in Spain

Follow‐up: 30 d after discharge

Participants

80 participants undergoing laparoscopic sleeve gastrectomy (LSG) as a bariatric procedure. Mean age 43.1 years; mean BMI 47.8 kg/m2

Inclusion criteria: BMI either > 40 kg/m2 or > 35 kg/m2 with comorbidities associated with obesity and undergoing laparoscopic sleeve gastrectomy (LSG) as a bariatric procedure.

Exclusion criteria (preoperative): documented gastroesophageal reflux (these underwent laparoscopic Roux‐en‐Y gastric bypass), uncontrolled psychiatric disorders, active infection or malignant disease, and any other concomitant pathology considered to be a contraindication to bariatric surgery diagnosis of chronic renal failure. Post‐operative complications were also excluded from the analysis.

Interventions

Group I: intra‐abdominal lavage with 500 mL saline (40 participants)

Group II: intra‐abdominal lavage with a gentamicin–clindamycin solution: gentamicin (240 mg) and clindamycin (600 mg) dissolved in 500 mL (40 participants)

Cointerventions: Peri‐operative systemic antibiotics (cefuroxime 3 g; single dose pre‐operatively within 30 min of incision, repeated after 4 h when the surgery exceeded that time)

Outcomes

Secondary outcome: mortality

Group I (saline): 1/40

Group II (clindamycin‐gentamicin): 0/40

Secondary outcome: adverse events ‐ complications of surgery

Group I (saline): 2/40

Group II (clindamycin‐gentamicin): 1/40

Notes

Declaration of no competing financial interests, funding otherwise NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The patients were randomized by means of an Internet randomization module into two groups"

Comment: appropriate means of randomisation sequence generation reported

Allocation concealment (selection bias)

Unclear risk

Quote: "The patients were randomized by means of an Internet randomization module into two groups"

Comment: unclear if appropriate measures were taken to conceal allocation

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: there was no information on whether personnel and participants were blinded to group allocation

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Incisional SSI was determined by an epidemiology nurse blinded to the treatment groups. Infection surveillance was extended for 30 d after discharge. The diagnosis of organ‐space SSI and leak was determined by a radiologist blinded to the treatment group."

Comment: outcome assessment was performed in a blinded manner

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Exclusions due to postoperative complications (3 participants) from some analyses were fully reported and accounted for; all participants could be included in analysis of SSI

Selective reporting (reporting bias)

Low risk

Outcomes were clearly predefined and appeared to be fully reported

Other bias

Low risk

No evidence of other sources of bias and reporting sufficient to suggest there were none

Schein 1990

Methods

3‐arm RCT

Setting: 1 surgical unit in South Africa

Follow‐up: at least 2 weeks after operation

Participants

87 participants undergoing surgery for peritonitis (mean age 53 years, range 18‐91 years)

Inclusion criteria: confirmed diffuse or localised intra‐abdominal infection

Exclusion criteria: those with nonruptured, localised abscesses and those participants undergoing appendectomy through right iliac fossa incisions; those with diffuse fecal peritonitis, infected pancreatic necrosis, or postoperative peritonitis

Interventions

Group I (control): all peritoneal contamination was sucked out or picked out manually; the peritoneal cavity was then swabbed gently with large abdominal swabs (29 participants)

Group II (saline): all peritoneal contaminants were sucked out, and the peritoneal cavity was generously irrigated with no less than 5 L of saline solution (29 participants)

Group III (chloramphenicol succinate): all peritoneal contaminants were sucked out, and the peritoneal cavity was generously irrigated with no less than 5 L of saline solution; 2 g of chloramphenicol succinate was added to the last L of the lavage fluid (29 participants)

Cointerventions: all participants received systemic antibiotics penicillin G potassium, amikacin sulfate and metronidazole. Therapy with antibiotics was started preoperatively and continued after operation for 24 hs and more, depending on the operative finding and each participant's clinical course. Intraperitoneal drains were placed only when abscesses were found.

Outcomes

Primary outcome: SSI

"Wound infection" defined as a discharge of pus from the wound; considered to be minor in cases where no early removal of sutures was necessary and primary healing was achieved; considered to be major when wounds required premature removal of sutures and drainage of pus and that healed by secondary intention.

Group I (control): 6/29 (4 minor, 2 major)

Group II (saline): 5/29 (3 minor, 2 major)

Group III (chloramphenicol succinate): 5/29 (3 minor, 2 major)

Secondary outcome: mortality

Group I (control): 6/29

Group II (saline): 6/29

Group III (chloramphenicol succinate): 3/29

Secondary outcome: adverse events

Surgical complications

Group I (control): 3/29 (one pelvic abscess)

Group II (saline): 7/29 (one pelvic abscess)

Group III (chloramphenicol succinate): 2/29

Medical complications

Group I (control): 8/29

Group II (saline): 9/29

Group III (chloramphenicol succinate): 5/29

Secondary outcome: mean length of hospital stay

Group I (control): 13 d

Group II (daline): 13 d

Group III (chloramphenicol succinate): 10 d

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Patients were randomized into one of the following three treatment groups..."

Comment: unclear how randomisation was performed

Allocation concealment (selection bias)

Unclear risk

Quote: "Patients were randomized into one of the following three treatment groups..."

Comment: unclear whether randomisation schedule was concealed

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no direct quote; no information on whether participants or personnel were blinded to treatment

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "Patients were monitored closely after operation and followed up in the outpatient clinic for at least 2 weeks after the operation."

Comment: Nno information on whether personnel performing outcome assessments were blinded to treatment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: no evidence of attrition bias

Selective reporting (reporting bias)

Unclear risk

Comment: no evidence of selective reporting, but not enough information to be certain

Other bias

Unclear risk

Comment: no evidence of other sources of bias, but reporting not sufficient to be certain

Shimizu 2011

Methods

2‐arm RCT

Setting: neurosurgical department in Japan

Follow up: 10 d post surgery

Participants

20 participants (mean age 60 years) admitted for clipping surgery for unruptured cerebral aneurysms; indications for clipping surgery are age < 70 years, no significant systemic risk for general anaesthesia, and aneurysm size > 5 mm. In 2 participants, 2 aneurysms were clipped in one surgery.

Inclusion criteria: age between 20 and 70 years; planned surgery for aneurysm(s) of the internal carotid artery territory through a unilateral pterional approach; no steno‐occlusive lesions (> 50%) in cerebral arteries as evaluated by magnetic resonance (MR) angiography and/or conventional angiography; and aneurysms that presented no significant surgical difficulty

Exclusion criteria: aneurysms presenting more surgical difficulty than usual; aneurysms suitable for approaches other than the pterional approach; aneurysms suitable for intravascular surgery; history of cerebrovascular diseases causing any disability (modified Rankin scale score 1 or worse); and significant medical problems

Interventions

Group I (artificial CSF): brain surfaces and basal and sylvian cisterns irrigated during surgery with Artcereb, an artificial CSF (10 participants)

Group II (saline): brain surfaces and basal and sylvian cisterns irrigated during surgery with physiological saline (10 participants)

Outcomes

Primary outcome: SSI

NR

Secondary outcome: adverse events: (postoperative, all types, includes MRI findings)

Group I (artificial CSF): 2/10

Group II (saline): 2/10 (2/10 participants with 2 events each)

Notes

Published paper does not report any of specified primary outcomes for this review

Funding: Nihon Medi‐Physics Co, Ltd, Tokyo, Japan, provided N‐isopropyl‐p‐[123I]iodoamphetamine and Otsuka Pharmaceutical Co., Tokyo, Japan, provided Artcereb. The study did not receive any other financial support.

Contacted lead study author to find out if there are any further data relating to our outcomes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "The patient was randomly assigned to irrigation fluid A or B during surgery to irrigate the basal and sylvian cisterns and the brain surface."

Comment: unclear how randomisation was performed

Allocation concealment (selection bias)

Unclear risk

Quote: "A total of 20 bottles each containing 500 mL of Artcereb (Artcereb group, n = 10) or physiological saline (saline group, n = 10) were prepared. The bottles of Artcereb were labelled A, and those of physiological saline were labelled B, without the knowledge of the study participants. The assignment was kept in a shielded envelope and only opened after all study data were collected."

Comment: unclear whether allocation sequence was concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "The bottles of Artcereb were labelled A, and those of physiological saline were labelled B, without the knowledge of the study participants. The assignment was kept in a shielded envelope and only opened after all study data were collected."

Comment: unclear whether personnel were blind to treatment allocation

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "All 20 patients were serially evaluated on postoperative days 1, 3 to 5, and 7 to 10." Potentially amend this after obtaining more information from study authors, as it may not specifically relate to assessment of wound.

Comment: study author contacted to determine if this relates to wound assessment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: no evidence of attrition

Selective reporting (reporting bias)

Unclear risk

Comment: no evidence of selective reporting, but not enough information to be certain

Other bias

Unclear risk

Comment: no evidence of other sources of bias, but reporting not sufficient to be certain

Silverman 1986

Methods

2‐arm RCT

Setting: a general hospital, UK

Follow‐up: 6 weeks post surgery (close monitoring in post‐operative period, then outpatient review at 6 weeks) Also a 1‐year follow‐up (see notes)

Participants

159 patients undergoing elective or emergency transperitoneal intestinal surgery of various types and for a range of conditions (e.g. colorectal neoplasm, inflammatory bowel disease, diverticular disease). Mean (range) age: Group I (saline): 51 (16‐89) years, Group II (tetracycline): 50 (19‐85) years. Stratification 1) high risk and low risk operation category 2) IV antibiotic used (three regimes)

Inclusion criteria: elective or emergency transperitoneal intestinal surgery (small bowel, colon and rectum)

Exclusion criteria: allergy to penicillin or cephalosporins

Interventions

Group I (saline): prior to closing the abdomen at the conclusion of the operation, peritoneal lavage was performed with 2 L 0.9% sterile saline. The lavage fluid was washed around the peritoneal cavity for at least 2 min and then sucked out with a sump sucker (74 participants)

Group II (tetracycline): same method as above but with lavage fluid 2 L 0.9% sterile saline containing 2 g tetracycline (85 participants)

Co‐interventions: all participants received IV antibiotic at the beginning of the operation (metronidazole 1.5 g and either gentamicin 120 mg (55 participants), ceftriaxone 2 g (55 participants), or mezlocillin 5 g (49 participants)). All participants had abdomen closed with a mass suture technique and primary skin closure with suction drainage to the pelvis

Outcomes

Primary outcome: SSI

Wound infection was defined as a discharge of pus from the wound.

(Abdominal minor/major and perineal infection, and IV antibiotic groups also reported separately)

Group I (saline): 24/74

Group II (tetracycline): 10/85

Secondary outcome: adverse events

Intra‐abdominal abscess

Group I (saline): 10/74

Group II (tetracycline): 11/85

Septicemia

Group I (saline): 0/74

Group II (tetracycline): 2/85

Secondary outcome: surgical re‐intervention rate

Reoperation for adhesive obstruction within 1 year of surgery (reported in the discussion rather than results)

Group I (saline): 0/74

Group II (tetracycline): 3/85

Notes

Surgical re‐intervention rate was reported in the discussion rather than the results and is from 1‐year follow‐up.

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Each patient was assigned a study number on a consecutive basis. The hospital pharmacist then dispensed... according to a computed‐generated randomization code." "Randomization was stratified so that patients classified as 'high risk' or 'low risk' were distributed equally between the two lavage groups and also among the three intravenous antibiotic regimens"

Comment: appropriate methods used to generate the sequence

Allocation concealment (selection bias)

Low risk

Quote: "The hospital pharmacist then dispensed the intravenous antibiotics and the lavage fluid according to a computer‐generated randomization code. All drugs were in numbered ampoules, the pharmacist being the sole possessor of the code"

Comment: the allocation sequence appears to have been concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Quote: "The hospital pharmacist then dispensed the intravenous antibiotics and the lavage fluid according to a computer‐generated randomization code. All drugs were in numbered ampoules, the pharmacist being the sole possessor of the code"

Comment: suggests that there may have been blinding of participants and personnel but not explicitly stated

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "All patients were monitored... by assessors independent of the surgical team"

Comment: suggests they may have been blind to treatment but not explicitly stated

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all participants are included in the results

Selective reporting (reporting bias)

High risk

Comment: some outcomes were NR by group, or were only reported in the discussion (re‐operation rate) and it is not clear which outcomes were decided prospectively

Other bias

Unclear risk

Comment: no evidence of other bias but reporting insufficient to be certain

Sindelar 1979

Methods

2‐arm RCT

Setting: single hospital in USA

Follow‐up: 12 weeks post surgery (daily examination for 7 d, then at least weekly)

Participants

500 patients undergoing operative procedures (age reported as groups rather than mean ‐ there are participants of all age groups from < 9 years to > 80 years). Surgery categories included clean, potentially contaminated, contaminated and dirty.

Inclusion criteria: elective or emergency surgery, abdominal and gastrointestinal procedures, oncologic procedures, vascular reconstructions, head and neck operations, thoracic procedures, genitourinary procedures, trauma operations

Exclusion criteria: amputations for ischaemic disease, drainage of subcutaneous abscesses, skin grafting, anorectal procedures, a history of iodine sensitivity, thyroid disease or significant renal impairment

Interventions

Group I (povidone‐iodine): following closure of the fascia, subcutaneous tissues were irrigated for 60 s with 10% povidone‐iodine solution (242 participants)

Group II (saline): following closure of the fascia, subcutaneous tissues were irrigated for 60 s with saline solution (258 participants)

Co‐interventions: wounds categorised as dirty had close system suction wound catheters placed in the subcutaneous space, which were removed 48 h postoperatively. Systemic antibiotics (clindamycin and gentamycin, or doxycycline for those with a history of allergy or suspected early impaired renal function) were given preoperatively to participants in potentially contaminated, contaminated, and dirty wound categories. If there were clinical indications of sepsis, systemic antibiotics were continued in some participants beyond 48 h postoperatively.

Outcomes

Primary outcome: SSI

An incision was considered infected if any amount of pus was discharged within 12 weeks of operation. Serous drainage from questionable wounds was cultured and the wound was classified as infected if any bacterial growth was recovered.

Group I (povidone‐iodine): 7/242

Group II (saline): 39/258

Results also reported by wound category (clean, potentially contaminated, contaminated, dirty) for both groups

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "...eligible patients...were randomly allocated into treatment and control groups"

Comment: there are no details on how participants were randomly allocated

Allocation concealment (selection bias)

Unclear risk

Comment: there is no information about allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: there is no mention of blinding

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "All wounds were examined daily by a single observer"

Comment: there is no mention of blinding

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: data from all randomised participants are included in the analysis

Selective reporting (reporting bias)

Low risk

Comment: the only outcome of interest was SSI and these data are fully reported

Other bias

Unclear risk

Comment: there is not enough methodological detail to judge

Snow 2016

Methods

2‐arm equivalence RCT

Setting: single hospital (2 sites) in Australia

Follow‐up: 6 weeks by phone call and state‐wide record searching

Participants

83 adults with intraoperative finding of acutely inflamed appendix undergoing laparoscopy for suspected appendicitis. Mean age 20 years (suction only group) versus 32 years (irrigation and suction group)

Inclusion criteria: adult patients (English‐speaking), > 18 years, undergoing laparoscopy for clinically or radiologically suspected appendicitis meeting the following intra‐operative case definition: "Intra‐operative finding of an acutely inflamed appendix, with suppuration or perforation localized to the right iliac fossa, paracolic gutter or pelvis, and when the surgery is completed via a laparoscopic approach."

Exclusion criteria: pathology not satisfying the case definition, pregnant, interval appendectomy, appendectomy following percutaneous drainage for abscess, appendectomy for reasons other than appendicitis (for example, tumour)

Interventions

Group I: saline irrigation and suction. Median volume 675 mL (minimum 500 mL); irrigation deployment to contaminated areas at surgeon's discretion (41 participants allocated; 40 received intervention; 40 analysed)

Group II: suction only (no irrigation) (42 participants allocated; 41 received intervention; 41 analysed)

Cointerventions: all participants were treated with pre‐operative, IV, broad‐spectrum antibiotics. Continuation post‐operatively for purulent or perforated appendicitis, with transition to oral antibiotics recommended for 5 d but at the discretion of the treating surgeon: 17/41 vs 21/40 received these

Outcomes

Primary outcome: SSI

Group I (saline irrigation): 0/40

Group II (no irrigation): 0/41

Secondary outcome: length of stay

Group I (saline irrigation): 2.0 (1 ‐ 3)

Group II (no irrigation): 2.0 (1 ‐ 2.25)

Secondary outcome: adverse events ‐ abscess formation

Group I (saline irrigation): 2/40

Group II (no irrigation): 2/41

Notes

Funding: no funding was received

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Following enrolment, patients underwent simple randomization to either “suction only” (SO) or “irrigation and suction” (IS), with the use of computer‐generated random number sequencing."

Comment: it appears that an appropriate method was used to generate the randomisation sequence.

Allocation concealment (selection bias)

Low risk

Quote: "Group allocation and data‐collection forms were stored in identical, opaque sealed envelopes"

Comment: it appears that an appropriate method was used to conceal the allocation sequence.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: personnel (surgeons) were aware of the allocation to intervention groups. It is unclear if participants were also aware of allocation.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote "Data collection was performed by an individual not involved in clinical treatment of enrolled patients."

Comment: it appears that blinded outcome assessment was undertaken

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "All enrolled patients were accounted for in follow‐up through hospital medical records and searching the statewide admission database"

Comment: 1 participant in each group converted to open surgery and therefore did not receive the intended intervention. All other participants were included in the analysis.

Selective reporting (reporting bias)

Low risk

Comment: both primary and secondary outcomes were predefined and appear to be fully reported

Other bias

Low risk

There were no other sources of bias apparent, and reporting was sufficiently detailed to be reasonably confident that this was the case.

St Peter 2012

Methods

2‐arm RCT

Setting: single study in USA

Follow‐up: early follow‐up by clinic follow‐up or phone call at 2‐4 weeks

Participants

220 children < 18 years with perforated appendicitis undergoing laparoscopic appendectomy

Inclusion criteria: children < 18 years who were found to have perforated appendicitis. Perforation was defined as a hole in the appendix or fecalith in the abdomen

Exclusion criteria: NR

Interventions

Group I: saline irrigation, minimum 500 mL volume plus suction, mean volume 867 (327) (110 participants)

Group II: no irrigation, suction only (110 participants)

Cointerventions: 50 mg/kg dose of ceftriaxone (maximum dose 2 g) and 30 mg/kg dose of metronidazole (maximum dose 1 g) before the operation. Once daily dosing of ceftriaxone and metronidazole continued postoperatively

Outcomes

Secondary outcome: adverse events ‐ abscess formation

Group I (saline irrigation): 20/110 (calculated from 18.3% of 110)

Group II (no irrigation): 21/110 (calculated from 19.1% of 110)

Secondary outcome: length of stay

Group I (saline irrigation): 5.4 (2.7)

Group II (no irrigation): 5.5 (3.0)

Secondary outcome: readmission

Group I (saline irrigation): 0/110

Group II (no irrigation): 3/110

Secondary outcome: reoperation

Group I (saline irrigation): 0/110

Group II (no irrigation): 1/110

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "A computer‐generated individual unit of randomization was utilized in a nonstratified sequence in blocks of 10"

Comment: an appropriate method was used to generate the randomisation sequence.

Allocation concealment (selection bias)

Unclear risk

Quote: "After consent for study enrolment was obtained, the randomization sequence was accessed to identify the next allotment. The attending surgeon did not obtain consent and was blind to the allotment throughout the enrolment process."

Comment: it seems that allocation concealment was used but procedures are not clear enough to be sure it was adequate.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no specific quote but it appears that personnel could not be blinded; it is unclear whether participants were blinded.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no specific quote; no information on whether outcome assessors were blinded to treatment allocation. It is stated that "Surgeons were not blinded during the postoperative course" but it is unclear if they were performing the outcome assessment.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all eligible randomised participants were included in the analysis. There were a large number of participants who consented but were excluded because of the intraoperative inclusion criterion. As this was prespecified this is unlikely to be a source of bias.

Selective reporting (reporting bias)

Unclear risk

Quote: "This was a definitive trial design using postoperative abscess as the primary outcome variable."

Comment: only the primary outcome was prespecified in the methods so it is difficult to determine if all planned outcomes were fully reported.

Other bias

Unclear risk

Comment: there is no evidence of other sources of bias but the reporting is insufficiently detailed to be certain.

Takesue 2011

Methods

2‐arm RCT

Setting: a single centre in Japan

Follow‐up: 3 months post surgery. (After the operation, there was wound inspection daily by nurses, once a week by an infection control nurse and surgeon during hospital stay, and at 4 week and 3 month post operative visits)

Participants

400 participants undergoing elective colorectal surgery for a variety of conditions (e.g. colorectal cancer, ulcerative colitis and Crohn's disease). 37 randomised participants were excluded for protocol violations (e.g. inappropriate bowel preparation, inappropriate antimicrobial prophylaxis, colon was not opened) therefore baseline data include 363 participants. Mean (SD) age: Group I (ESAAS) 51.8 (17.4) years, Group II (saline) 51.9 (17.7) years; diabetes 14/180 vs 13/183; colorectal cancer 82/180 vs 90/183

Inclusion criteria: participants undergoing elective colorectal surgery

Exclusion criteria: dirty/infected wound, emergency surgery, laparoscopic surgery, stoma creation without bowel resection, transrectal operation, use of antibiotics within 10 d preceding surgery

Interventions

Group I (ESAAS): the surgical wound was irrigated with at least 500 mL of ESAAS (electrolysed strongly acidic aqueous solution, produced by the electrolysis of tap water containing 0.12% NaCl) after the completion of fascial suture (200 participants, of whom 20 excluded due to protocol violation)

Group II (saline): the surgical wound was irrigated with at least 500 mL of saline solution after the completion of fascial suture (200 participants, of whom 17 excluded due to protocol violation)

Co‐interventions: all participants received Magcorol P (68 g magnesium citrate) for bowel preparation, antimicrobial prophylaxis 30 min before surgery with 1 g of second generation cephalosporins IV. If surgery was > 3 h, these were redosed. The same antibiotics were continued for 24 h after the operation (3‐4 doses). Povidone‐iodine was used for skin preparation.

Outcomes

Primary outcome: SSI

Diagnosis based on guidelines issued by the National Nosocomial Infections Surveillance system. Infection had to occur within 30 d of the operation.

Group I (ESAAS): 19/180

Group II (saline): 29/183

Incisional SSI

Group I (ESAAS): 11/180

Group II (saline): 21/183

Organ/space SSI

Group I (ESAAS): 8/180

Group II (saline): 8/183

Primary outcome: wound dehiscence

Superficial wound dehiscence defined as > 1 cm separation of the incision above the fascia with or without infection that required packing and healing by secondary intention. Fascial dehiscence involved disruption of the fascia. (Superficial incisions deliberately opened to treat SSI were excluded.)

Group I (ESAAS): 17/180 (15 superficial; 2 fascial)

Group II (saline): 12/183 (10 superficial; 2 fascial)

Secondary outcome: antibiotic resistance

MRSA

Group I (ESAAS): 4/14

Group II (saline): 8/24

MSSA

Group I (ESAAS): 0/14

Group II (saline): 3/24

(other organisms are reported but without sensitivity)

Notes

Funding: none reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Computer generated sequence allocation was used"

Comment: approriate methods appear to have been used

Allocation concealment (selection bias)

Low risk

Quote: "concealment was achieved by use of opaque envelopes opened at operating room by a third party"

Comment: appropriate steps were taken to conceal allocation with opaque envelopes and third party

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "some surgeons could make the distinction between ESAAS and saline solution during application to the wound"

Comment: authors state that personnel were not blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: "the diagnosis of SSI was made by our infection control team"

Comment: it is not clear whether personnel knew treatment allocation

Incomplete outcome data (attrition bias)
All outcomes

High risk

Comment: 37/400 randomised participants were excluded at baseline due to protocol violation. This is a large number and it is possibly biased as personnel were not blinded, even though reasons for exclusion appear similar in the 2 treatment groups. No participants were lost to follow‐up.

Selective reporting (reporting bias)

Low risk

Comment: all results are reported for the stated outcomes of interest

Other bias

Low risk

Comment: there is no evidence for other sources of bias

Tanaka 2015

Methods

2‐arm RCT

Setting: single centre in Japan

Follow‐up: 4 weeks post surgery

Participants

193 participants undergoing elective liver resection surgery (200 randomised, 7 excluded due to complications during surgery). Median age 68.5 years (range 21‐87 years), mean age 66.4 (11.2) vs 66.8 (11.3) years. Diabetes mellitus co‐morbidity: Group I 24.0%, Group II 19.6%. Hepatocellular carcinoma: Group I 35/96, Group II 37/97. Cholangiocellular carcinoma: Group I 3/96. Group II 2/97. Liver metastases: Group I 45/96, Group II 52/96

Inclusion criteria: elective liver resection without resection/reconstruction of the bile duct or intestine

Exclusion criteria: resection/reconstruction of the bile duct and/or intestine, an operation designated Class III or higher according to CDC guidelines, detection of peritoneal dissemination of cancer

Interventions

Group I (lavage): after removal of resected liver and confirmation of haemostasis, irrigation with sterile saline (37º C) directed at the dissected area. 3000 mL was used in open surgery and 1000 mL in laparoscopic surgery (96 participants)

Group II (no lavage): no intraoperative lavage performed (97 participants)

Co‐interventions: prophylactic antibiotic (flomoxef sodium) 1 g IV 30 mins before surgery, 1 g every 3 h during surgery, 1 g 2h after surgery, then 2 g daily for 4 d. A closed suction drain was placed near the transection plane of the liver parenchyma for all participants, and wound washout was performed using sterile saline after fascial closure but before skin closure

Outcomes

Primary outcome: SSI

Incisional infection (either superficial or deep) or organ/space infection. Incisional infection defined by clinically apparent cellulitis, induration, or purulent discharge from the closure site. Organ/space infection defined by radiologic evidence of a fluid collection necessitating drainage or antibiotic therapy.

Total SSI

Group I (lavage): 21/96

Group II (no lavage): 13/97

Superficial/deep SSI

Group I (lavage): 7/96

Group II (no lavage): 6/97

Organ/space SSI

Group I (lavage): 16/96

Group II (no lavage): 7/97

Secondary outcome: mortality (90 d)

Group I (lavage): 2/96

Group II (no lavage): 1/97

Secondary outcome: morbidity (post‐operative complications)

Group I (lavage): 37/96

Group II (no lavage): 36/97

Secondary outcome: hospital stay (mean (SD) d) (median (range) also reported)

Group I (lavage): 15.2 (13.4)

Group II (no lavage): 15.2 (13.1)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "..simple randomization was carried out by comparing a number within a sealed envelope with numbers in a computer‐generated random number table"

Comment: use of a random number table

Allocation concealment (selection bias)

Unclear risk

Quote: "...a number within a sealed envelope.."

Comment: it appears that steps were taken to conceal allocation in some way, but it is not known if envelopes were opaque and consecutively numbered

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "By its nature this study was unblinded"

Comment: no blinding of personnel, appears to state that participants were also unblinded

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "By its nature this study was unblinded"

Comment: no blinding of personnel, appears to state that outcome assessors were also unblinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all participants reported at baseline accounted for in analysis (but 7 excluded during surgery; probably too few to impact analysis

Selective reporting (reporting bias)

Low risk

Comment: all outcomes of interest appear to have been reported for all participants

Other bias

Low risk

Comment: there is no evidence of other sources of bias

Tanphiphat 1978

Methods

3‐arm RCT

Setting: a single hospital in Thailand

Follow‐up: minimum 2 weeks post surgery

Participants

374 participants randomised in total, 252 in the 2 arms of interest. Mean age (range): Group I (control) 27 (15‐65) years, Group II (Savlon) 24.5 (15‐55) years

Inclusion criteria: > 15 years of age with acute appendicitis requiring emergency operation

Exclusion criteria: known penicillin sensitivity, preoperative antibiotics received, microscopically normal appendices, periappendicitis due to inflammation elsewhere

Interventions

Group I (control): no local treatment during operation (124 participants)

Group II (Savlon): each layer was irrigated with 1% solution of cetyl trimethyl ammonium bromide (Savlon) and possibly also chlorhexidine, but this is unclear; and swabbed dry before closure (128 participants)

Co‐interventions: "The use of peritoneal drainage and postoperative antibiotics was left to the surgeon's discretion" drains were used for 4 participants in group I (control) and 8 in group II (Savlon), all but 1 were for participants with a perforated appendix

Outcomes

Primary outcome: SSI

"A wound was considered to be infected when there was a collection of pus which emptied itself spontaneously or after incision"

Group I (control): 3/108 participants with non‐perforated appendix, 9/16 participants with perforated appendix

Total 12/124

Group II (Savlon): 5/111 participants with non‐perforated appendix, 8/17 participants with perforated appendix

Total 13/128

Notes

There is an additional trial arm in which ampicillin powder is applied to wounds.

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Quote: "At operation patients were randomly allocated into three groups by drawing cards" "randomisation may not have been adequate because more perforated appendices were found in the ampicillin group, which suggests that a large number of junior staff on rotation may have disregarded randomisation in what they took (rightly) to be the patient's interest"

Comment: it is not clear whether allocation was random, the study authors express doubt

Allocation concealment (selection bias)

High risk

Quote: "At operation patients were randomly allocated into three groups by drawing cards" "randomisation may not have been adequate because more perforated appendices were found in the ampicillin group, which suggests that a large number of junior staff on rotation may have disregarded randomisation in what they took (rightly) to be the patient's interest"

Comment: it is not clear whether allocation was random, the study authors express concern

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: there is no information about blinding. The participants may have been blinded to treatment, but it is clear the personnel were not.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: there is no information about blinding of outcome assessment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants are accounted for in the results

Selective reporting (reporting bias)

Unclear risk

Comment: there is not enough information to judge

Other bias

Unclear risk

Comment: there is not enough information to judge

Temizkan 2016

Methods

2‐arm RCT

Setting: single hospital in Turkey

Follow up: NR

Participants

430 women undergoing elective caesarean section. Mean age was 27.7 years (irrigation group) vs 28.2 years (mean number of previous births was 1)39% vs 36% had a comorbidity such as asthma or thyroid dysfunction.

Inclusion criteria: women with gestational age > 38 weeks and elective cesarean delivery. Elective caesarean was defined as being performed before the presence of labour with or without previous history of caesarean delivery

Exclusion criteria: women with emergency cesarean delivery, chorioamnionitis, type I diabetes, placenta previa, placenta accreta, maternal coagulopathy, or prior severe gastrointestinal disease

Interventions

Group I: saline irrigation of the abdominal cavity using 500 mL of warm normal saline after closure of the uterine incision but before closure of the abdominal wall. All blood clots, vernix, and other debris were evacuated from the paracolic gutters, anterior and posterior cul‐de sacs, and under the bladder flap when employed.

Group II: no irrigation; all clots, vernix and other debris were left in place.

Cointerventions: 5 IU IV bolus of oxytocin over 5–10 s when the umbilical cord was clamped. Then, 30 IU of oxytocin in 500 mL lactated Ringer solution administered at a rate of 125 mL/h, and continued for 4 h. A total of 1 g cefazolin diluted in 20 mL normal saline administered over a 5‐min period

Outcomes

Primary outcome: SSI (partial or total separation of the incision, as well as the presence of purulent or serous wound discharge with induration, warmth, and tenderness)

Group I (saline irrigation): 1/215

Group II (no irrigation): 2/215

Notes

Funding: Departmental funds only

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The participants were randomized to either an irrigation group or a control group. Assignment to one of the two treatment groups was determined using a random number table."

Comment: an appropriate method was used to generate the randomisation sequence

Allocation concealment (selection bias)

Low risk

Quote: "The assigned treatments were written on cards and sealed in secure opaque envelopes numbered in sequence."

Comment: appropriate measures to ensure allocation concealment appear to have been followed.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "The surgeons were not blinded to the procedure allocation. The allocated envelope was opened by the surgeon just before surgery, and the procedure allocation was recorded on each woman’s chart."

Comment: personnel were not blinded; unclear if participants were blinded

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quotes: "Postoperative physicians were blinded to group assignment to avoid any potential bias; however, the surgeon who performed the operative procedure cared for the patient in the postoperative period, thus, was not blinded to the study group."

"All data were recorded and analyzed by another researcher, who was blinded to the group assignments."

Comment: some elements of outcome assessment were undertaken by a blinded assessor but it's not clear whether all assessment was.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analysis.

Selective reporting (reporting bias)

Unclear risk

Quote: "The primary outcome measured was the rate of antiemetic drugs required in the postoperative period following cesarean delivery. Secondary outcome measures included the rate of PIM. Other outcomes evaluated were nausea and emesis occurring during the postoperative hospitalization."

Comment: additional outcomes to those specified were also reported so it is difficult to determine whether all planned outcomes were assessed and reported.

Other bias

Low risk

Comment: there is no evidence of any other bias and reporting is detailed.

Tighe 1982

Methods

3‐arm RCT

Setting: a single hospital in Ireland

Follow‐up: not stated

Participants

131 participants undergoing appendectomy (age range 3.5‐74 years)

Inclusion criteria: all participants undergoing appendectomy over a stated time period

Exclusion criteria: NR

Interventions

Group I (Betadine): following appendectomy, participants were irrigated with 150 mL 1% Betadine (main constituent povidone iodine) solution intraperitoneally and 50 mL to the wound following closure of the peritoneum (49 participants)

Group II (sterile water): participants were irrigated with approximately 150 mL sterile water intraperitoneally and 50 mL to the wound following closure of the peritoneum (31 participants)

Group III (no irrigation): no irrigation following appendectomy (51 participants)

Outcomes

Primary outcome: SSI

"Wound infection was defined as the presence of pus either spontaneously or on probing. All infections were confirmed bacteriologically"

There were 17 wound infections among the 131 participants. Results are not given by trial arm. The authors state "when broken down according to type of irrigation, there was no significant difference between the three groups"

Secondary outcome: systemic antibiotic use

53/131 participants "distributed evenly across the groups"

Secondary outcome: length of hospital stay

Participants with infection: 10 d

Participants without infection 6 d

Results NR by group

Notes

Results are only provided for the whole group, by appendix histology or for participants with infected wounds vs uninfected, not by treatment group.

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "The randomization took place in theatre following induction of anaesthesia by selecting a disc from a box"

Comment: not enough information to judge whether this method was adequate

Allocation concealment (selection bias)

Unclear risk

Quote: "The randomization took place in theatre following induction of anaesthesia by selecting a disc from a box"

Comment: not enough information to judge whether this method was adequate

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Comment: no information provided about blinding. The participants may have been blinded but personnel would be aware of treatment

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no information provided about who performed outcome assessment

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Comment: no participants appear to have dropped out of the study

Selective reporting (reporting bias)

High risk

Comment: results are not reported for study arms so there are no data provided to back up authors' claim of no difference between groups.

Other bias

Unclear risk

Comment: not enough information to judge

Trew 2011

Methods

2‐arm RCT

Setting: 25 centres in Europe

Follow‐up: 4‐16 weeks post surgery (follow‐up laparoscopy)

Participants

498 participants randomised, of whom 72 were excluded from study before or during surgery due to failure to meet pre‐operative or intra‐operative inclusion criteria

Inclusion criteria: female, aged 18‐45 years, undergoing primary removal of myomas or endometriotic cysts, using adequate contraceptive and not pregnant (negative test and agreement to use adequate contraception)

Exclusion criteria (pre‐operative): pregnancy, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase and/or bilirubin > 20% above normal range and considered clinically significant; blood urea nitrogen and creatinine > 30% above normal range and considered clinically significant; systemic corticosteroids, antineoplastic drugs and/or radiation; gonadotropin‐releasing hormone agonist/antagonist (except oral contraceptive) in 4 weeks prior to study; active pelvic/abdominal infection; known allergy to starch polymers; known/suspected intolerance to study materials; prior surgery for endometriotic cysts or myomas; non‐gynaecological surgical procedure planned during laparoscopic procedure; > 4 myomas, largest myoma < 2 or > 8 cm diameter, or endometriotic cysts < 3 or > 7 cm on pre‐operative ultrasound; history of alcohol or other substance abuse within last year; use of another investigational agent; participation in another clinical trial within last 30 d; (at centres in France, diabetes mellitus was also an exclusion criterion)

Exclusion criteria (intra‐operative and post‐operative): clinical evidence of cancer, pregnancy, rectovaginal endometriosis, endometriosis class III or IV other than endometrial cysts (American Fertility Society (AFS) classification), conversion to laparotomy, unplanned surgery involving opening of the bowel (excluding appendectomy), extensive pelvic adhesions (AFS scores moderate or severe), use during procedure of any anti‐adhesion agent, use of O2 enhanced insufflation, adhesions requiring lysing during planned myomectomy or planned endometrial cyst removal (other than those around the ovarian fossa), endometriotic cysts not removed and ovary not left open, suturing the ovarian capsule, pedunculated cysts, use of glue, peritoneum sutured to fascia, use of drains, and post‐operative ovarian histology consistent with a non‐endometriotic cyst

Interventions

At surgery, the abdomen was washed with warm study solution and this washing/irrigation of the abdominal cavity was repeated/continued with a minimum of 100 mL at intervals of at least once every 30 min. At the end of surgery, after a final irrigation with a minimum of 100 mL and evacuation of intraoperative solution, a final 1000 mL was instilled from a fresh treatment bag.

Group I (Adept): study solution was Adept, a 4% icodextrin solution (217 participants) (non‐antibacterial)

Group II (LRS): study solution was lactated Ringer's solution (209 participants) (non‐antibacterial)

Co‐interventions: none specifically mentioned. There was standardised surgical management and all trocar ports ≥ 10 mm were double sutured to the fascia to help minimise any leakage.

Outcomes

Primary outcome: SSI

'Wound infection' listed in treatment‐related adverse events table VII

Group I (Adept): 1/217

Group II (LRS): 1/209

'Wound infection and vomiting' listed in adverse events designated serious table VIII (none deemed treatment‐related)

Group I (Adept): 2/217 (1 with faecal impaction)

Group II (LRS): 0/209

Secondary outcome: mortality

Mentioned within adverse events section

Group I (Adept): 0/217

Group II (LRS): 0/209

Secondary outcome: adverse events

Group I (Adept): 71/217 of which 18 considered treatment‐related

Group II (LRS):72/209 of which 15 considered treatment‐related

Notes

Outcomes: the objective of the study was to examine the effect of irrigation on adhesion formation hence this was the primary outcome and infection and mortality were only mentioned among adverse events and are reported for the designated safety population

Funding: Shire Pharmaceutical Development Ltd was the original study sponsor, providing research funding to all hospital departments involved, and funding was also provided by Baxter BioSurgery (Shire and Baxter are the previous and current distributors of Adept)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Treatment was randomized through a 24‐h central randomisation telephone system" "Patients were stratified according to their diagnosis of either myomas or endometriotic cysts and were randomised in a 1:1 ratio to separate randomisation lists" "The system was administered by the study Clinical Research Organisation"

Comment: method of sequence generation is not explicitly stated but appropriate service and method for stratification appear to have been used

Allocation concealment (selection bias)

Low risk

Quote: "The system was administered by the study Clinical Research Organisation" "the treatment pack assigned was not permitted for allocation to any other patient in the study"

Comment: use of 3rd party and other steps to conceal allocation

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Quote: "Double‐blinding was possible as both fluids are clear and odourless solutions with similar viscosities to water and they were packaged identically"

Comment: adequate methods used to blind participants and personnel

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Quote: (referring to primary outcome) "Reviewers were blinded to the study treatment assignment"

Comment: it appears steps were taken to blind outcome assessors for the primary outcome however blinding is not mentioned for safety assessment (our outcomes of interest)

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Quote: "The safety population consisted of all consenting patients who received randomized treatment"

Comment: 72/498 randomised participants were excluded from the study before (27) or during (45) surgery. There does not appear to be any bias in this exclusion but it is possible.

Selective reporting (reporting bias)

Unclear risk

Comment: our primary outcome of interest (infection) is not clearly defined or reported as it not a primary outcome of the study.

Other bias

Unclear risk

Comment: the study was funded by pharmaceutical companies which may have influenced reporting of safety data.

Vallance 1985

Methods

3‐arm RCT

Setting: 2 hospitals in the UK

Follow‐up: 3, 7, 10 d, and 1 month post‐surgery

Participants

53 participants undergoing operations for generalised purulent or faecal peritonitis. Mean (range) age: Group I 56.1 (10‐84) years, Group II 49.7 (10‐83) years, Group III 56.0 (18‐79) years

Inclusion criteria: generalised purulent or faecal peritonitis confirmed at laparotomy

Exclusion criteria: NR

Interventions

Following completion of surgical procedure, participants were given a thorough peritoneal toilet and lavage until solutions ran clear with the following protocols:

Group I (saline): warm saline solution lavage, with a further 100 mL saline inserted into the abdominal cavity before wound closure (20 participants)

Group II (chlorhexidine): warm chlorhexidine gluconate (Hibitane) 1:5000 solution lavage, with 100 mL inserted before wound closure (19 participants)

Group III (PVP‐I): warm saline solution lavage, with 100 mL PVP‐I solution ('Betadine' peritoneal lavage solution) inserted before wound closure (14 participants)

Co‐interventions: broad spectrum antibiotics (metronidazole and either gentamicin or cefuroxime) were given pre‐operatively and continued for at least 5 d postoperatively. Abdominal drains were inserted in all participants as required by the focus of primary sepsis or nature of surgery performed

Outcomes

Primary outcome: SSI

Wound abnormalities indicative of infection presented (can be added as each participants is only counted once)

Pus in wound

Group I (saline): 5/16

Group II (chlorhexidine): 4/16

Group III (PVP‐I): 4/13

Sero‐sanguinous discharge

Group I (saline): 4/16

Group II (chlorhexidine): 6/16

Group III (PVP‐I): 5/13

Inflammation or induration

Group I (saline): 1/16

Group II (chlorhexidine): 2/16

Group III (PVP‐I): 2/13

Summed data

Group I (saline):10/16

Group II chlorhexidine): 12/16
Group III: (PVP‐I): 11/13

Secondary outcome: mortality

12 participants died, 8 within 4 d of the operation (data below), and 4 died 8‐52 d postoperatively but group assignment was not reported. Authors state "all deaths were due either to the severity of the presenting disease or co‐existing complicating conditions"

Mortality (within 4 d of surgery)

Group I (saline): 4/20

Group II (chlorhexidine): 3/19

Group III (PVP‐I): 1/14

Secondary outcome: length of hospital stay

Mean (SD) d (unclear on numbers of participants in groups (see mortality) 41 survivors included in total)

Group I (saline): 11.4 (4.4)

Group II (chlorhexidine): 9.3 (4.3)

Group III (PVP‐I): 12.6 (3.8)

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote "Patients were randomized to receive..."

Comment: no details about method of randomisation

Allocation concealment (selection bias)

Unclear risk

Comment: no information in report

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Comment: no information in report

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Comment: no information in report

Incomplete outcome data (attrition bias)
All outcomes

High risk

Comment: 12/53 participants died, thus removing some outcome data e.g. length of hospital stay. Causes of death were reported and there was no attrition for other reasons.

Selective reporting (reporting bias)

High risk

Comment: details of deaths are provided but it is not reported which groups some of these participants were assigned to. Outcomes are not fully reported and may have been selectively reported.

Other bias

High risk

Quote: "the random allocation of patients to the different lavage groups resulted in an uneven distribution of the causes of peritonitis between the groups"

Comment: due to small numbers of participants and broad inclusion criteria the groups may be too different to demonstrate a treatment effect.

Viney 2012

Methods

Parallel‐group RCT

Single hospital in the USA
Follow‐up: NR

Participants

236 women undergoing caesarean section

Inclusion criteria: "pregnant English‐speaking women, ≥ 18 years, presenting for labour or scheduled cesarean delivery

Exclusion criteria: "declining consent or urgent and emergent clinical situations in which the staff caring for the patient determined the
time required for the consent process could adversely affect the potential participant’s clinical care"

Interventions

Group I: lavage with 500‐1000 mL warm saline after closure of the hysterotomy, but before the closure of the abdominal wall (110 participants)

Group II: no lavage (126 participants)

Cointerventions: blood clots and other debris manually evacuated. 1 g cefazolin IV as antibiotic prophylaxis before the start of surgery. Participants with cefazolin allergy received 900 mg clindamycin.

Outcomes

Secondary outcome: length of stay (reported as day of discharge)

Group I (saline lavage): 3 d

Group II (no lavage): 3 d

Notes

Funding: NR

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Assignment was performed by opening a sequentially numbered opaque envelope containing
computer‐randomized individual allocations"

Comment: appropriate method of sequence generation reported

Allocation concealment (selection bias)

Low risk

Quote: "Assignment was performed by opening a sequentially numbered opaque envelope containing
computer‐randomized individual allocations"

Comment: appropriate method of allocation concealment reported

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "The original randomization was performed by research staff before the initiation of the study using a random number table generator, and the participants were blinded to treatment once assigned." "The envelope was opened by the circulation nurse in the operating room and silently viewed by the surgeons after closure of the hysterotomy."

Comment: participants were blinded to the treatment allocation but personnel were not.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "This was recorded by nursing staff not blinded to the randomization....Postoperative nursing staff were blinded to group assignment to avoid any potential bias; however, the surgeon who performed the operative procedure cared for the patient in the postoperative period and, thus, was not blinded to the study group".

Comment: some outcome assessors were not blinded.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Comment: all randomised participants were included in the analysis.

Selective reporting (reporting bias)

Unclear risk

Comment: outcomes assessed were clearly prespecified and mostly fully reported but measures of variance were not given for some outcomes.

Other bias

Unclear risk

Quote "Our study was stopped halfway through to allow for planned midpoint data analysis for resident research day"

Comment: unclear if the study was stopped early and if so whether this was on the basis of a specific stopping rule. No evidence of other sources of bias and reporting sufficient to be reasonably confident of this.

BMI: body mass index; CABG: coronary artery bypass graft; CDC: Centers for Disease Control and Prevention; CSF: cerebrospinal fluid; ITT: intention‐to‐treat; IM: intramuscular; IV: intravenous; MRI: magnetic resonance imaging; MRSA: methicillin‐resistant Staphylococcus aureus; MSSA: methicillin‐susceptible Staphylococcus aureus; NR: not reported; PP: per‐protocol; PVP: polyvinyl pyrrolidine; RCT: randomised controlled trial; SSI: surgical site infection

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Akay 2006

Different indication: healing by delayed primary or secondary intention in some or all participants

Al‐Ramahi 2006

Quasi‐randomised RCT

Alcantara 2011

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Anglen 2005

Different indication: healing by delayed primary or secondary intention in some or all participants

Angobaldo 2008

Different indication: healing by delayed primary or secondary intention in some or all participants

Badia 1994

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Bennett‐Guerrero 2016

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Bertheussen 1980

Quasi‐randomised RCT

Bhargava 2006

Quasi‐randomised RCT

Boothby 1984

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Cherian 2000

Different indication: used for anaesthesia purposes

Chisholm 1992

Ineligible population: some or all participants did not undergo surgery

Donnenfeld 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Ducharme 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Dwivedi 2009

Ineligible intervention: extremely small volume of liquid

Everett 1969

Different intervention: lavage was not the intervention of interest

FLOW 2011

Different indication: healing by delayed primary or secondary intention in some or all participants

Fountas 1999

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Freischlag 1984

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Galle 1980

Different indication: healing by delayed primary or secondary intention in some or all participants

Garg 2013

Ineligible intervention: differences in lavage procedure were not the only difference between the groups

Georgiadis 2013

Different indication: used for anaesthesia purposes

Geraghty 1984

Quasi‐randomised RCT

Ghafouri 2016a

Ineligible population: some or all participants did not undergo surgery

Ghafouri 2016b

Ineligible population: some or all participants did not undergo surgery

Givens 2002

Different indication: used for anaesthesia purposes

Gonen 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Granick 2007

Ineligible population: some or all participants did not undergo surgery

Hesami 2014

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Horn 1999

Different indication: used for anaesthesia purposes

Hunt 1982

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Iqbal 1998

Quasi‐randomised RCT

Iqbal 2015

Ineligible intervention: extremely small volume of liquid

Keblawi 2006

Different indication; study author contact confirmed that no relevant outcome data were collected and purpose of study was to evaluate pain and WBC

Kellum 1985

Quasi‐randomised RCT

Ko 1992

Quasi‐randomised RCT

Kothuis 1981

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Lau 1986

Ineligible intervention: extremely small volume of liquid

Lavery 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Logan 1973

Ineligible intervention: extremely small volume of liquid

Longmire 1987

Ineligible population: some or all participants did not undergo surgery

Makvandi 2014

Quasi‐randomised RCT

Martins 2012

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Mathelier 1992

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Mohamed 2017

Different indication: used for anaesthesia purposes

Morse 1998

Ineligible population: some or all participants did not undergo surgery

Nachamie 1968

Quasi‐randomised RCT

Nomikos 1986

Quasi‐randomised RCT

Noon 1967

Quasi‐randomised RCT

Pitt 1982

Use of peri‐operative irrigation/lavage was not the difference between the groups

Plaumann 1985

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Pobereskin 2000

Different indication: used for anaesthesia purposes

Pollock 1978

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Rogers 1983

Quasi‐randomised RCT

Rosen 1985

Ineligible population: some or all participants did not undergo surgery

Salvati 1988

Quasi‐randomised RCT

Sarr 1988

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Sarzaeem 2014

Different indication: used for anaesthesia purposes

Sauven 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Scammell 1985

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Scheuerlein 2000

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Seco 1990

Ineligible intervention: extremely small volume of liquid

Shapiro 1986

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Sherman 1976

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Sindelar 1985

Ineligible indication: healing by delayed primary or secondary intention in some or all participants

Sood 1985

Quasi‐randomised RCT

Terzi 2015

Quasi‐randomised RCT

Toki 1995

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Weiss 2013

Ineligible population: some or all participants did not undergo surgery

White 2008

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Wu 1992

Quasi‐randomised RCT

Xiao 2010

Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups

Yarussi 1999

Different indication: used for anaesthesia purposes

RCT: randomised controlled trial; WBC: white blood count

Characteristics of studies awaiting assessment [ordered by study ID]

De Cicco 2015

Methods

2‐arm RCT

Participants

20 women undergoing surgery for endometriosis

Interventions

Group I: lavage performed routinely

Group II: lavage performed until liquid was clear

Outcomes

Primary outcome: C‐reactive protein concentration

White blood cell count

Temperature

Complications

Notes

We have contacted study author who confirms relevant outcome data were collected; these are currently unpublished although a publication is being prepared. Study author unable to supply data in advance of publication

De Kok 1998

Methods

2‐arm RCT

Participants

80 people receiving knee or hip replacement surgery

Interventions

Group I: iodophore irrigation of wound during surgery (40 participants)

Group II: physiologic salt solution irrigation of wound during surgery (40 participants)

Outcomes

Primary outcome: contamination of suction device used during surgery

Group I: 13/40

Group II: 14/40

Notes

2 records for this study; one in Dutch. Notes from translator on methodology, "The authors say it is randomised, however there is no description as to how this was done and the allocation is not reported" "Very low quality, bad methodology, baseline not clearly described"

Unclear whether any relevant outcomes were collected. Unable to contact study author to date

Kosuş 2010

Methods

2‐arm RCT

Setting: "private hospital" in Turkey

Follow‐up: 40 d

Duration of study: 2004‐2007

Participants

1272 women undergoing cesarean section

Loss to follow‐up: 17 participants were lost from follow‐up

Age range: 23.1‐33.7 years

Inclusion criteria: women undergoing cesarean section

Exclusion criteria: coincident remote site infections or colonisation, diabetes, cigarette smoking, systemic steroid use, obesity (> 20% ideal body weight), excessive subcutaneous scar tissue due to previous operations, perioperative transfusion of blood products and altered immune response were excluded from the study (33 women). Operation time, > 2 h or blood loss > 1 L or having premature rupture of membrane > 6 hs were discharged from the study (26 women)

Interventions

Group I: povidone‐iodine 10% was used for preoperative antisepsis of skin and after closure of skin (600 participants)

Group II: povidone‐iodine was used in the same way but also subcutaneous tissue was irrigated with rifamycin SV/ 250 mg, before closure of subcutaneous tissue (596 participants)

Amount of irrigation fluid: not stated

Cointervention: single dose of 1 g ceftriaxone was given to all participants for prophylaxis in perioperative period after clamping of umbilical cord

Outcomes

Primary outcome: SSI

Group I: 12/600. All of them were superficial incisional SSI

Group II: 0/596

Secondary outcome: cost [costs were given in dollars, we have assumed these to be USD]

Group I: total cost of 12 participants with SSI was USD 5386
Group II: total cost of the rifamycin SV used for washing of subcutaneous tissue was USD 876.12

P value: not stated for cost alone

When groups were compared, surgical site infection and cost were significantly lower in study group ( P <0.05)

Notes

Funding: not stated

Not clear whether randomisation was adequate. Study author contact attempted but so far unsuccessful

Munoz‐Mahamud 2011

Methods

2‐arm RCT

Setting: appears to be single hospital in Spain

Follow‐up: 1 year

Participants

79 Participants with orthopaedic (hip and knee) implant infection undergoing surgery for the infection

Interventions

Group I: low‐pressure pulsatile lavage

Group II: high‐pressure pulsatile lavage

Cointerventions: after open debridement, a broad‐spectrum intravenous antimicrobial regimen was started and maintained until obtaining definitive microbiological results. The definitive oral antibiotic treatment was selected according to the antibiogram. The duration of intravenous and oral antibiotics was not standardised and this was decided according to the clinical manifestations and the C‐reactive protein values of each case

Outcomes

Remission of infection; relapse of infection; retention of prosthesis; reinfection; success rate

Notes

The source of funding did not play any role in the investigation. Unclear whether any relevant outcomes were reported. Study author contact attempted but so far unsuccessful.

Taylor 1999

Methods

2‐arm RCT

Setting: single UK hospital

Follow‐up: none reported

Participants

44 participants undergoing hip fracture fixation

Inclusion and exclusion criteria not reported

Interventions

Group I: 0.05% chlorhexidine jet lavage (number of participants not reported)

Group II: no intervention (number of participants not reported)

Co‐interventions: not reported

Outcomes

Air bacterial counts and mean operating times

Notes

Unclear whether any relevant outcomes were reported. Unable to contact study author to date

No funding reported

RCT: randomised controlled trial

Characteristics of ongoing studies [ordered by study ID]

ACTRN12610000423011

Trial name or title

Does Peritoneal lavage influence the rate of complications in paediatric laparoscopic appendicectomy? A prospective randomised clinical trial

Methods

Parallel‐group (2‐arm) RCT

Participants

Children with perforated appendicitis

Interventions

Peritoneal lavage with 0.9% saline then suction

No lavage (suction only)

Outcomes

Length of hospital stay in days, including any days of re‐admission

Intra‐abdominal abscess

Starting date

20 May 2010

Contact information

Charles Keys

Department of Paediatric Surgery

Southern Health

Monash Medical Centre

246 Clayton Road

Clayton

Vic 3168

Australia

Notes

No updates registered

NCT01175044

Trial name or title

Dilute Betadine lavage in the prevention of postoperative infection

Methods

Parallel‐group (2‐arm) RCT

Participants

People who are scheduled to undergo a revision total knee arthroplasty

Interventions

Betadine lavage: dilute Betadine lavage prior to surgical closure for 3 min followed by 2000 mL of sterile saline irrigation

Saline lavage: (2000 mL) prior to closure

Outcomes

Infection

Starting date

2 August 2010

Contact information

Darren R Plummer, BBA, MBA; [email protected]

Rush University Medical Center

Chicago, Illinois, United States, 60612

Notes

Currently recruiting

NCT02186457

Trial name or title

Antibiotic irrigation for pancreatoduodenectomy

Methods

Parallel‐group (2‐arm) RCT

Participants

Adults undergoing pancreatoduodenectomy (Whipple procedure)

Interventions

Antibiotic irrigation via peritoneal lavage (polymyxin B (500,000 U) in 1 L of 0.9% normal saline)

Placebo irrigation via peritoneal lavage (0.9 % normal saline)

Outcomes

Infections

Fistulas

Starting date

1 July 2014

Contact information

Michael G. House, Associate Professor of Surgery, Indiana University

Indianapolis, Indiana, United States, 46202

[email protected]

Notes

Recruiting

NCT02395614

Trial name or title

Incidence of surgical site infection after irrigation of surgical pocket with 0.05% chlorhexidine compared with triple antibiotic solution in post‐mastectomy breast reconstruction

Methods

Intra‐individual (split‐body) (2‐arm) RCT

Participants

Women with breast cancer undergoing bilateral breast reconstruction

Interventions

0.05% chlorhexidine solution (IrriSept®) commercially prepared in 450 mL bottles

Triple antibiotic solution will contain 1 g of cefazolin, 50,000 U of bacitracin, and 80 mg of gentamicin in 500 mL of normal saline

Each participant will receive triple antibiotic solution on one breast and the chlorhexidine on the other breast

Outcomes

Surgical site infection

Starting date

17 March 2015

Contact information

Kent Higdon, MD 615‐936‐0160

[email protected]

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Notes

Recruiting

NCT02527512

Trial name or title

Bacterial contamination: iodine vs saline irrigation in pediatric spine surgery

Methods

Parallel (2‐arm) RCT

Participants

Children aged 3‐18 years undergoing surgery for diagnosis of spinal deformity

Interventions

Povidone‐iodine ‐ 0.35% povidone‐iodine (Betadine)

Normal saline ‐ sterile sodium chloride (NaCl) solution

Outcomes

Postoperative infection

Starting date

7 August 2015 (received), anticipated start date February 2017

Contact information

Principal investigator: Michael Glotzbecker, MD; Boston Children’s Hospital

Notes

Not yet open to recruitment

NCT02714023

Trial name or title

Water and saline head‐to‐head in the blinded evaluation study trial (WASHITBEST)

Methods

Parallel‐group (2‐arm) RCT

Participants

Participants diagnosed with acute appendicitis aged at least 6 years

Interventions

Irrigation of the abdomen during surgery with normal saline

Irrigation of the abdomen during surgery with sterile water

Outcomes

Postoperative deep space organ infection as defined by the Surgical Infection Society (time frame: 30 d)

Infection after surgery within the peritoneal space

Temperature > 38.5º C (time frame: 30 d)

> 2 d to return of bowel function as evident by either flatus or bowel movement (time frame: 30 d)

Length of hospital stay (time frame: 30 d)

Starting date

8 March 2016 (information received). Study start date April 2013

Contact information

Arthur Rawlings, MD

University of Missouri‐Columbia

Notes

Completed

RCT: randomised controlled trial

Data and analyses

Open in table viewer
Comparison 1. All irrigation versus no irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

14

6106

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.68, 1.11]

Analysis 1.1

Comparison 1 All irrigation versus no irrigation, Outcome 1 SSI.

Comparison 1 All irrigation versus no irrigation, Outcome 1 SSI.

1.1 clean or clean‐contaminated

7

4801

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.82, 1.21]

1.2 contaminated or dirty

7

1305

Risk Ratio (M‐H, Random, 95% CI)

0.74 [0.47, 1.16]

2 Adverse events Show forest plot

3

403

Risk Ratio (M‐H, Random, 95% CI)

1.05 [0.76, 1.44]

Analysis 1.2

Comparison 1 All irrigation versus no irrigation, Outcome 2 Adverse events.

Comparison 1 All irrigation versus no irrigation, Outcome 2 Adverse events.

3 Abscess Show forest plot

3

331

Risk Ratio (M‐H, Random, 95% CI)

0.91 [0.54, 1.54]

Analysis 1.3

Comparison 1 All irrigation versus no irrigation, Outcome 3 Abscess.

Comparison 1 All irrigation versus no irrigation, Outcome 3 Abscess.

4 Mortality Show forest plot

2

280

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.36, 2.04]

Analysis 1.4

Comparison 1 All irrigation versus no irrigation, Outcome 4 Mortality.

Comparison 1 All irrigation versus no irrigation, Outcome 4 Mortality.

5 Hospital stay Show forest plot

7

1597

Mean Difference (IV, Random, 95% CI)

‐0.13 [‐0.38, 0.12]

Analysis 1.5

Comparison 1 All irrigation versus no irrigation, Outcome 5 Hospital stay.

Comparison 1 All irrigation versus no irrigation, Outcome 5 Hospital stay.

6 Return to theatre (reoperation) Show forest plot

2

3247

Risk Ratio (M‐H, Random, 95% CI)

0.72 [0.28, 1.84]

Analysis 1.6

Comparison 1 All irrigation versus no irrigation, Outcome 6 Return to theatre (reoperation).

Comparison 1 All irrigation versus no irrigation, Outcome 6 Return to theatre (reoperation).

7 Readmission to hospital Show forest plot

2

3247

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.10, 4.90]

Analysis 1.7

Comparison 1 All irrigation versus no irrigation, Outcome 7 Readmission to hospital.

Comparison 1 All irrigation versus no irrigation, Outcome 7 Readmission to hospital.

Open in table viewer
Comparison 2. Antibacterial irrigation versus non‐antibacterial irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

30

5141

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.44, 0.75]

Analysis 2.1

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 1 SSI.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 1 SSI.

1.1 clean

4

680

Risk Ratio (M‐H, Random, 95% CI)

0.16 [0.03, 0.89]

1.2 clean‐contaminated

13

2210

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.40, 0.79]

1.3 contaminated or dirty

13

2251

Risk Ratio (M‐H, Random, 95% CI)

0.61 [0.40, 0.92]

2 Wound dehiscence Show forest plot

3

660

Risk Ratio (M‐H, Random, 95% CI)

1.26 [0.65, 2.45]

Analysis 2.2

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 2 Wound dehiscence.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 2 Wound dehiscence.

3 Adverse events Show forest plot

3

178

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.22, 1.34]

Analysis 2.3

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 3 Adverse events.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 3 Adverse events.

4 Abscess Show forest plot

9

1309

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.42, 1.62]

Analysis 2.4

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 4 Abscess.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 4 Abscess.

5 Mortality Show forest plot

11

1121

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.48, 1.36]

Analysis 2.5

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 5 Mortality.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 5 Mortality.

6 Hospital stay Show forest plot

7

635

Mean Difference (IV, Random, 95% CI)

‐0.85 [‐1.60, ‐0.09]

Analysis 2.6

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 6 Hospital stay.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 6 Hospital stay.

7 Return to theatre (reoperation) Show forest plot

2

403

Risk Ratio (M‐H, Random, 95% CI)

1.26 [0.12, 13.60]

Analysis 2.7

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 7 Return to theatre (reoperation).

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 7 Return to theatre (reoperation).

Open in table viewer
Comparison 3. Icodextrin versus lactated Ringer's solution

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mortality Show forest plot

2

875

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 3.1

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 1 Mortality.

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 1 Mortality.

2 Adverse events Show forest plot

2

875

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.96, 1.02]

Analysis 3.2

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 2 Adverse events.

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 2 Adverse events.

3 Treatment‐related adverse events Show forest plot

2

875

Risk Ratio (M‐H, Random, 95% CI)

1.35 [0.98, 1.86]

Analysis 3.3

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 3 Treatment‐related adverse events.

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 3 Treatment‐related adverse events.

Open in table viewer
Comparison 4. Standard irrigation versus pulsatile irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

2

484

Risk Ratio (M‐H, Random, 95% CI)

0.34 [0.19, 0.62]

Analysis 4.1

Comparison 4 Standard irrigation versus pulsatile irrigation, Outcome 1 SSI.

Comparison 4 Standard irrigation versus pulsatile irrigation, Outcome 1 SSI.

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias summary: review authors' judgements about each risk of bias item for each included study
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies

Funnel plot of comparison 1: all irrigation versus no irrigation, outcome: 1.1 surgical site infection
Figuras y tablas -
Figure 4

Funnel plot of comparison 1: all irrigation versus no irrigation, outcome: 1.1 surgical site infection

Funnel plot of comparison 2: antibacterial versus non‐antibacterial irrigation, outcome: 2.1 surgical site infection
Figuras y tablas -
Figure 5

Funnel plot of comparison 2: antibacterial versus non‐antibacterial irrigation, outcome: 2.1 surgical site infection

Comparison 1 All irrigation versus no irrigation, Outcome 1 SSI.
Figuras y tablas -
Analysis 1.1

Comparison 1 All irrigation versus no irrigation, Outcome 1 SSI.

Comparison 1 All irrigation versus no irrigation, Outcome 2 Adverse events.
Figuras y tablas -
Analysis 1.2

Comparison 1 All irrigation versus no irrigation, Outcome 2 Adverse events.

Comparison 1 All irrigation versus no irrigation, Outcome 3 Abscess.
Figuras y tablas -
Analysis 1.3

Comparison 1 All irrigation versus no irrigation, Outcome 3 Abscess.

Comparison 1 All irrigation versus no irrigation, Outcome 4 Mortality.
Figuras y tablas -
Analysis 1.4

Comparison 1 All irrigation versus no irrigation, Outcome 4 Mortality.

Comparison 1 All irrigation versus no irrigation, Outcome 5 Hospital stay.
Figuras y tablas -
Analysis 1.5

Comparison 1 All irrigation versus no irrigation, Outcome 5 Hospital stay.

Comparison 1 All irrigation versus no irrigation, Outcome 6 Return to theatre (reoperation).
Figuras y tablas -
Analysis 1.6

Comparison 1 All irrigation versus no irrigation, Outcome 6 Return to theatre (reoperation).

Comparison 1 All irrigation versus no irrigation, Outcome 7 Readmission to hospital.
Figuras y tablas -
Analysis 1.7

Comparison 1 All irrigation versus no irrigation, Outcome 7 Readmission to hospital.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 1 SSI.
Figuras y tablas -
Analysis 2.1

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 1 SSI.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 2 Wound dehiscence.
Figuras y tablas -
Analysis 2.2

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 2 Wound dehiscence.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 3 Adverse events.
Figuras y tablas -
Analysis 2.3

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 3 Adverse events.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 4 Abscess.
Figuras y tablas -
Analysis 2.4

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 4 Abscess.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 5 Mortality.
Figuras y tablas -
Analysis 2.5

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 5 Mortality.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 6 Hospital stay.
Figuras y tablas -
Analysis 2.6

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 6 Hospital stay.

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 7 Return to theatre (reoperation).
Figuras y tablas -
Analysis 2.7

Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 7 Return to theatre (reoperation).

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 1 Mortality.
Figuras y tablas -
Analysis 3.1

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 1 Mortality.

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 2 Adverse events.
Figuras y tablas -
Analysis 3.2

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 2 Adverse events.

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 3 Treatment‐related adverse events.
Figuras y tablas -
Analysis 3.3

Comparison 3 Icodextrin versus lactated Ringer's solution, Outcome 3 Treatment‐related adverse events.

Comparison 4 Standard irrigation versus pulsatile irrigation, Outcome 1 SSI.
Figuras y tablas -
Analysis 4.1

Comparison 4 Standard irrigation versus pulsatile irrigation, Outcome 1 SSI.

Summary of findings for the main comparison. All irrigation compared with no irrigation for prevention of surgical site infection

All irrigation compared with no irrigation for prevention of surgical site infection

Patient or population: participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures

Setting: hospitals
Intervention: irrigation of any type
Comparison: no irrigation

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with no irrigation

Risk with irrigation

SSI

Study population: participants undergoing clean‐contaminated, contaminated

or dirty surgical procedures

RR 0.87
(0.68 to 1.11)

6106
(14 RCTs)

⊕⊕⊝⊝
Low1

On the basis of the included studies there is no clear difference between the intervention and comparison groups in the incidence of SSI.

98 per 1000

85 per 1000
(67 to 108)

Risk difference: 13 fewer SSI occur per 1000 with irrigation than with no irrigation (31 fewer to 10 more)

Wound dehiscence

Study population: participants undergoing clean procedures (split‐body design)

RR 1.17
(0.44 to 3.06)

30
(1 RCT)

⊕⊕⊝⊝
Low2

There is no clear difference between surgical sites treated with irrigation and those in the control condition. This is based on a single split‐body design with small numbers of participants.

200 per 1000

234 per 1000
(88 to 612)

Risk difference: 34 more wound dehiscences occur per 1000 with irrigation than with no irrigation (112 fewer to 412 more)

Adverse events

Study population: participants undergoing clean‐contaminated or dirty surgical procedures

RR 1.05 (0.76 to 1.44)

403

(3 RCTs)

⊕⊕⊝⊝
Low3

There is no clear difference in the number of adverse events between participants treated with irrigation and those in the control condition.

247 per 1000

259 per 1000 (187 to 355)

Risk difference: 12 more per 1000 (from 59 fewer to 108 more)

Adverse events: abscess formation

Study population: participants undergoing dirty or contaminated surgical procedures

RR 0.91 (0.54 to 1.54)

331

(3 RCTs)

⊕⊕⊕⊝

Moderate4

There is no clear difference in the number of adverse events between participants treated with irrigation and those in the control condition.

149 per 1000

136 per 1000

Risk difference: 13 fewer per 1000 (from 69 fewer to 80 more)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; RR: risk ratio; SSI: surgical site infection

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

1Downgraded once for risk of bias in one or more domains other than performance bias in studies that account for more than 50% of the analysis weight; downgraded once for imprecision because confidence intervals include both benefit and harm. Publication bias could not be clearly ruled out but was not additionally downgraded for as the evidence was unclear.
2Downgraded twice for imprecision because confidence intervals are wide and fragile and include the possibility of both benefit and harm. There is also uncertainty as to whether the analysis was correctly adjusted for a split‐body design.
3Downgraded once for imprecision and once for high risk of detection bias in the study with 77% of the analysis weight.
4Downgraded once for imprecision.

Figuras y tablas -
Summary of findings for the main comparison. All irrigation compared with no irrigation for prevention of surgical site infection
Summary of findings 2. Irrigation with antibacterial solution compared with irrigation with non‐antibacterial solution for prevention of surgical site infection

Irrigation with antibacterial compared with non‐antibacterial solution for prevention of surgical site infection

Patient or population: participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures
Setting: hospitals
Intervention: irrigation with antibacterial solution (antiseptic or antibiotic)
Comparison: irrigation with solution without antibacterial properties

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with non‐antibacterial

Risk with antibacterial

SSI

Study population: participants undergoing clean‐contaminated, contaminated or dirty surgical procedures

RR 0.57
(0.44 to 0.75)

5141
(30 RCTs)

⊕⊕⊝⊝
Low1

The included studies found that there may be fewer SSIs in participants treated with antibacterial irrigation compared with those treated with non‐antibacterial irrigation.

140 per 1000

80 per 1000
(62 to 105)

Risk difference: 60 fewer SSI occur per 1000 with antibacterial irrigation than with non‐antibacterial (78 to 35 fewer)

Wound dehiscence

Study population: participants undergoing clean or clean‐contaminated surgical procedures

RR 1.26
(0.65 to 2.45)

660
(3 RCTs)

⊕⊝⊝⊝
Very low2

The effect of antibacterial compared with non‐antibacterial irrigation on wound dehiscence is very uncertain.

45 per 1000

56 per 1000
(29 to 109)

Risk difference: 11 more wound dehiscences occur per 1000 with antibacterial irrigation than with non‐antibacterial (16 fewer to 64 more)

Adverse events

Study population: participants undergoing clean, clean‐contaminated or dirty surgical procedures

RR 0.55 (0.22 to 1.34)

178

(3 RCTs)

⊕⊕⊝⊝
Low3

It is unclear whether there is a difference in the incidence of all adverse events between participants treated with antibacterial irrigation compared with those treated with non‐antibacterial irrigation.

67 per 1000

37 per 1000 (15 to 90)

Risk difference: 30 fewer adverse events occur per 1000 with antibacterial irrigation than with non‐antibacterial (53 fewer to 23 more)

Adverse events: abscess formation

Study population: participants undergoing clean‐contaminated, contaminated or dirty surgical procedures

RR 0.82 (0.42 to 1.62)

1309

(9 RCTs)

⊕⊝⊝⊝
Very low4

The effect of antibacterial compared with non‐antibacterial irrigation on abscess formation is very uncertain

31 per 1000

25 per 1000 (13 to 50)

Risk difference: 6 fewer abscesses form per 1000 with antibacterial irrigation than with non‐antibacterial (18 fewer to 19 more)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; RR: risk ratio; SSI: surgical site infection

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

1Downgraded once for risk of bias due to high risk of bias for at least one domain in studies contributing over 50% of the weight and once for probable publication bias. We did not further downgrade for inconsistency because the inconsistency present appeared due to the difference between larger and smaller studies and hence was accounted for by the downgrade for potential publication bias.
2Downgraded once for inconsistency due to study with highest weight showing effect in opposite direction to other included studies, once for high risk of bias and twice for imprecision, due to confidence intervals being wide and fragile, and including both benefit and harm.
3Downgraded twice for imprecision due to wide and fragile confidence intervals, which included both benefit and harm, as well as no difference between interventions.
4Downgraded once for risk of bias in studies with the majority of the weight and twice for imprecision due to wide and fragile confidence intervals, which included both benefit and harm, as well as no difference between interventions.

Figuras y tablas -
Summary of findings 2. Irrigation with antibacterial solution compared with irrigation with non‐antibacterial solution for prevention of surgical site infection
Summary of findings 3. Standard irrigation compared with pulsatile irrigation for prevention of surgical site infection

Standard irrigation compared with pulsatile irrigation for prevention of surgical site infection

Patient or population: participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures
Setting: hospital
Intervention: standard irrigation with saline
Comparison: pulsatile irrigation with saline

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with standard irrigation

Risk with pulsatile irrigation

SSI

Study population: participants undergoing clean or clean‐contaminated surgical procedures

RR 0.34
(0.19 to 0.62)

484
(2 RCTs)

⊕⊕⊝⊝
Low1

Included studies show that there may be fewer SSIs in participants treated with pulsatile saline irrigation compared with standard techniques; the evidence is low certainty due to high risk of biases in the study contributing the majority of participants and weight to the analysis.

165 per 1000

56 per 1000
(31 to 103)

Risk difference: 109 fewer SSI occur per 1000 with pulsatile irrigation than with standard (134 fewer to 62 fewer)

Wound dehiscence

Study population: participants undergoing

clean‐contaminated surgical procedures

RR 0.31
(0.01 to 7.55)

128
(1 RCT)

⊕⊕⊝⊝
Low2

There is no clear difference in the incidence of wound dehiscence between groups treated with standard or pulsatile techniques of saline irrigation. Confidence intervals include both benefit and harm and are wide and fragile.

16 per 1000

5 per 1000
(0 to 122)

Risk difference: 11 fewer wound dehiscences occur per 1000 with pulsatile irrigation than with standard (16 fewer to 106 more)

Adverse events

Study population: participants undergoing clean‐contaminated surgical procedures

RR 1.31 (0.87 to 1.97)

128 (1 RCT)

⊕⊕⊝⊝
Low2

There is no clear difference in the incidence of adverse events between groups treated with standard or pulsatile techniques of saline irrigation. Confidence intervals include both benefit and harm and are wide and fragile.

486 per 1000

371 per 1000

Risk difference: 115 fewer adverse events occur per 1000 with pulsatile irrigation (360 fewer to 48 more)

Adverse events: abscess formation

There were no reported data on abscess formation

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; RR: risk ratio; SSI: surgical site infection

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

1Downgraded twice for high risk of bias in multiple domains for study contributing most of the weight.
2Downgraded twice for imprecision due to wide and fragile confidence intervals, which include both benefit and harm.

Figuras y tablas -
Summary of findings 3. Standard irrigation compared with pulsatile irrigation for prevention of surgical site infection
Table 1. Summary of GRADE assessments for comparisons with limited data

Comparison

Surgery

Participants (studies)

SSI RR (95% CI)

GRADE judgement: certainty of the evidence

Reason for downgrading

Icodextrin vs Ringer's solution

Clean‐contaminated

(uterine)

426 (1 RCT)

Trew 2011

2.89 (0.30 to 27.56)

Low

Downgraded twice for very serious imprecision

Povidone iodine vs Dermacyn

Clean

(cardiac)

190 (1 RCT)

Mohd 2010

2.80 (1.05 to 7.47)

Low

Downgraded once for high risk of bias and once for imprecision

Povidone iodine vs chlorhexidine

Dirty

(peritonitis)

53 (1 RCT)1

Vallance 1985

1.13 (0.78 to 1.63)

Very low

Downgraded twice for high risk of bias in multiple domains and once for imprecision

Cepharin vs cefoxitin

Clean‐contaminated

(caesarean section)

132 (1 RCT)1

Levin 1983

Not estimable

(no events in either group)

No assessment possible

Epicillin vs lincomycin

Contaminated

(appendicitis)

162 (1 RCT)1

Marti 1979

Not estimable

(data not reported for groups)

No assessment possible

Gentamicin vs clindamycin

Clean

(breast)

51 (1 RCT)1

Oller 2015

Not estimable

(no events in either group)

No assessment possible

Cephapirin versus moxalactam

Clean‐contaminated

(caesarean section)

149 (total 360) (1 RCT)2

Dashow 1986

1.69 (0.29 to 9.84)

Low

Downgraded twice for very serious imprecision

Cephapirin versus cefamandole

Clean‐contaminated

(caesarean section)

134 (total 360) (1 RCT)2

Dashow 1986

1.37 (0.24 to 7.95)

Low

Downgraded twice for very serious imprecision

Cephapirin versus ampicillin

Clean‐contaminated

(caesarean section)

140 (total 360) (1 RCT)2

Dashow 1986

7.00 (0.37 to 133.06)

Low

Downgraded twice for very serious imprecision

Cefamandole versus moxalactam

Clean‐contaminated

(caesarean section)

143 (total 360) (1 RCT)2

Dashow 1986

1.23 (0.18 to 8.52)

Low

Downgraded twice for very serious imprecision

Cefamandole versus ampicillin

Clean‐contaminated

(caesarean section)

134 (total 360) (1 RCT)2

Dashow 1986

5.46 (0.27 to 111.65)

Low

Downgraded twice for very serious imprecision

Moxalactam versus ampicillin

Clean‐contaminated

(caesarean section)

149 (total 360) (1 RCT)2

Dashow 1986

4.44 (0.22 to 90.88)

Low

Downgraded twice for very serious imprecision

Cefazolin versus cefamandole

Clean‐contaminated

(caesarean section)

207 (1 RCT)

Peterson 1990

4.58 (0.22 to 93.38)

Low

Downgraded twice for very serious imprecision

1Three‐armed trial; not all participants relevant to this comparison.
2Five‐armed trial; not all participants relevant to this comparison.

CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio; SSI: surgical site infection

Figuras y tablas -
Table 1. Summary of GRADE assessments for comparisons with limited data
Table 2. Summary of primary outcome data: surgical site infection (SSI) and wound dehiscence

Study

Surgical category/type

Participants

Interventions

Definition of SSI

Follow‐up

SSI events

Risk ratio (95% CI)

Wound dehiscence risk ratio (95% CI)

Comparison of irrigation compared with no irrigation

Bourgeois 1985

Clean‐contaminated

Caeasarean section

223

Antibiotic irrigation/saline irrigation

No irrigation

NR

Buanes 1991

Dirty

Perforated appendicitis

35

Saline postoperative irrigation

No postoperative irrigation

Temperature > 38.5C for > 24 h plus localised, drainage‐confirmed accumulation of fluid

6 weeks

9/39

2/44

5.08 (1.17 to 22.09)

Not included in pooled analysis ‐ intervention too different

NR

Cervantes‐Sanchez 2000

Contaminated

Appendicitis

283

Saline irrigation

No irrigation

Collection of pus or positive bacteriologic culture from wound discharge

4 weeks

11/127

39/156

0.25 (0.19 to 0.65)

NR

Cho 2004

Clean‐contaminated

Gastrectomy

34

Saline irrigation

No irrigation

Centers for Disease Control and Prevention criteria

2 weeks

1/17

3/17

0.33 (0.04 to 2.89)

NR

De Jong 1982

Mixed

Abdominal/inguinal hernia

592

Antiseptic irrigation

No irrigation

Purulent discharge seen within 4 weeks or culturing of fluid from the wound was positive

4 weeks

36/279

39/279

0.92 (0.61 to 1.41)

NR

Elliott 19861

Clean‐contaminated

Caeasarean section

158

Antibiotic irrigation

No irrigation

NR

6 weeks

0/80

1/78

0.33 (0.01 to 7.86)

NR

Gungorduk 2010

Clean‐contaminated

Caeasarean section

520

Saline irrigation

No irrigation

Wound drained purulent material/serosanguineous fluid plus induration, warmth and tenderness

6 weeks

17/260

19/260

0.89 (0.48 to 1.68)

NR

Harrigill 2003

Clean‐contaminated

Caeasarean section

196

Saline irrigation

No irrigation

Undue tenderness, erythema, discharge, or separation of the incision accompanying fever

NR

1/97

2/99

0.51 (0.05 to 5.54)

NR

Mahomed 2016

Clean‐contaminated

Caeasarean section

3270

Antiseptic irrigation

No irrigation

Abscess or wound draining pus or sero‐sanguinous fluid, or redness, induration, warmth and tenderness or general practitioner prescribed antibiotics

4 weeks

144/1520

147/1507

0.97 (0.78 to 1.21)

NR

Oleson 1980

Dirty

Perforated appendicitis

33

Antibiotic irrigation/saline irrigation

No irrigation

NR

Mean 8 d (5‐16)

5/20

4/10

0.63 (0.21 to 1.83)

NR

Ozlem 2015

Dirty

Perforated appendicitis

14

Saline irrigation

No irrigation

NR

NR

2/7

0/7

5.00 (0.28 to 88.53)

NR

Platt 2003

Clean

Breast

30

Saline irrigation

No irrigation

Wound discharge, invasive infection

8 weeks

0/30

0/30

Not estimable

Not included in pooled analysis ‐ split‐body design

1.15 (0.44 to 3.06)

Schein 1990

Dirty

Abdominal infection

87

Saline irrigation/ Antibiotic irrigation

No irrigation

Discharge of pus

2 weeks

10/58

6/29

0.83 (0.34 to 2.07)

NR

Snow 2016

Mixed

Appendix

83

Saline irrigation

No irrigation

NR

6 weeks

0/40

0/41

Not estimable

NR

St Peter 2012

Dirty

Appendix

220

Saline irrigation

No irrigation

NR

NR

Tanaka 2015

Clean‐contaminated

Liver resection

193

Saline irrigation

No irrigation

Incisional or organ/space infection

Incisional infection: clinically apparent cellulitis, induration, or purulent discharge.

Organ/space infection: radiologic evidence of fluid collection necessitating drainage or antibiotic therapy

4 weeks

21/96

13/97

1.63 (0.87 to 3.07)

NR

Tanphiphat 1978

Contaminated

Appendix

374

Antiseptic irrigation

No irrigation

Collection of pus that emptied itself spontaneously or after incision

2 weeks

13/128

12/124

1.05 (0.50 to 2.21)

NR

Temizkan 2016

Clean‐contaminated

Caeasarean section

430

Saline irrigation

No irrigation

Partial or total separation of incision, plus purulent or serous wound discharge with induration, warmth, and tenderness

NR

1/215

2/215

0.50 (0.05 to 5.47)

NR

Tighe 1982

Contaminated

Appendix

131

Antiseptic irrigation

No irrigation

Non‐antibacterial irrigation

Prescence of pus either spontaneously or on probing. All infections confirmed bacteriologically

NR

17/131 Results are not given by intervention group; no effect estimate calculable

NR

Viney 2012

Clean‐contaminated

Caeasarean section

236

Saline irrigation

No irrigation

NR

NR

Comparison of antibacterial irrigationwith non‐antibacterial irrigation

Al‐Shehri 1994

Mixed

Appendicits

254

Antibiotic

Saline

Purulent discharge in wound, regardless of culture results, or occurrence of serous discharge with positive culture

1 month

1/120

7/134

0.16 (0.02 to 1.28)

NR

Baker 1994

Clean‐contaminated

Colorectal

330

Antiseptic

Saline

Spontaneous or incisional discharge from wound, pus or serous fluid, with infective organism identified on culture

6 weeks

17/150

17/150

1.00 (0.53 to 1.88)

NR

Bourgeois 1985

Clean‐contaminated

Caeasarean section

223

Antibiotic irrigation

Saline irrigation

(No irrigation)

NR

NR

Browne 1978

Dirty

Peritonitis

35

Antiseptic irrigation

Saline irrigation

NR

NR

Carl 2000

Clean‐contaminated

40

Antibiotic

Saline

NR

4‐6 weeks

1/20

1/20

1.00 (0.07 to 14.90)

NR

Case 1987

Clean

Breast

54

Antibiotic

Saline

NR

6 weeks

0/23

1/30

0.43 (0.02 to 10.11)

0.43 (0.02 to 10.11)

Chang 2006

Clean

Spinal

244

Antiseptic

Saline

Superficial (above lumbosacral fascia) or deep (below lumbosacral fascia), early onset (within 2 weeks) or late onset (otherwise). Deep infections confirmed by laboratory parameters: erythrocyte sedimentation rate, level of C‐reactive protein, and positive biopsy culture

2 weeks, long‐term follow‐up to 19 months

0/120

6/124

0.08 (0.00 to 1.40)

Only included in sensitivity analysis due to suspected data overlap with Cheng 2005

0.52 (0.05 to 5.62)

Cheng 2005

Clean

Spinal

417

Antiseptic

Saline

Unusual pain, tenderness, erythema, induration, fever, or wound drainage; investigated with erythrocyte sedimentation rate, C‐reactive protein, and bacteriological cultures from operative site or blood

2 weeks', long‐term follow‐up to mean 15.5 months

0/208

7/206

0.07 (0.00 to 1.015)

NR

Dashow 1986

Clean‐contaminated

Caesarean

360

4 antibiotics

Saline

Wound breakdown with positive culture or presence of cellulitis

NR

7/283

3/77

0.63 (0.17 to 2.40)

NR

Greig 1987

Mixed

Colorectal

129

Antibiotic

Saline

Discharge of pus from the wound "wound sepsis"

1 month

15/64

18/65

0.85 (0.47 to 1.53)

NR

Halsall 1981

Mixed

Appendicitis

192

Antiseptic

Saline

Wound discharging pus

4 weeks

18/99

29/93

0.58 (0.35 to 0.98)

NR

Kokavec 2008

Clean

Orthopaedic

162

Antiseptic

Saline

Positive bacteriological examination

6 weeks then mean 7.8 (2‐4) months

0/89

2/73

0.16 (0.01 to 3.37)

NR

Kubota 1999

Dirty

Perforated appendicitis

16

Antiseptic

Saline

NR

NR

1/8

4/8

0.25 (0.04 to 1.77)

NR

Kubota 2015

Dirty

Perforated appendicitis

44

Antiseptic

Saline

Infection at operation site, up to 30 d after surgery; confirmed causative pathogen(s) identical to those of appendicitis

30 d

0/24

4/20

0.09 (0.01 to 1.64)

NR

Levin 1983

Clean‐contaminated

Caeasarean section

128

2 Antibiotics

Saline

Purulent wound discharge with or without wound separation

8 weeks

0/85

3/43

0.07 (0.00 to 1.38)

NR

Lord 1983

Mixed

Gastrointestinal/colorectal

200

Antibiotic

Saline

NR

NR

3/100

9/100

0.33 (0.09 to 1.20)

NR

Magann 1993

Clean‐contaminated

Caeasarean section

100

Antibiotic

Saline

Hyperemic skin incision and fluctuant mass which when opened contained purulent material

NR

2/50

4/50

0.50 (0.10 to 0.50)

NR

Marti 1979

Contaminated

Appendicitis

162

2 Antibiotics

Saline

Septic complications with spontaneous or induced purulent discharge

4 d; longer follow‐up unclear

Results are not given by intervention group; no effect estimate calculable

NR

Mirsharifi 2008

Clean‐contaminated

Cholecystectomy

102

Antibiotic

Saline

Erythema, induration, tenderness, warmth, suppurative discharge

6 weeks

6/51

6/51

1.00 (0.35 to 2.89)

NR

Moylan 1968

Clean‐contaminated

Abdominal

260

Antibiotic

Saline

NR, wounds were monitored with daily photographs

Until discharge

12/124

23/116

0.49 (0.25 to 0.94)

NR

Neeff 2016

Clean‐contaminated

Colorectal

197

Antiseptic

Non‐antibacterial

NR

NR

19/101

22/96

0.82 (0.48 to 1.42)

NR

Oestreicher 1989

Mixed

General surgery

540

Antiseptic

Saline

NR

NR

16/267

15/273

1.09 (0.55 to 2.16)

NR

Oleson 1980

Dirty

Perforated appendicitis

33

Antibiotic irrigation

Saline irrigation

No irrigation

NR

mean 8 d (5‐16)

3/10

2/10

1.50 (0.32 to 3.09)

NR

Oller 2015

Clean

Breast

51

2 Antibiotics

Saline

NR

NR

0/34

0/17

Not estimable

NR

Rambo 1972

Dirty

Peritonitis

94

Antibiotic

Saline

NR

NR

11/44

13/50

0.96 (0.48 to 1.92)

NR

Ruiz‐Tovar 2011

Clean‐contaminated

Colorectal

128

Antibiotic

Saline

NR

NR

6/64

27/64

0.22 (0.10 to 0.50)

NR

Ruiz‐Tovar 2012

Clean‐contaminated

Colorectal

108

Antibiotic

Saline

Presence of purulent discharge, confirmed with microbiologic culture

30 d

2/52

7/51

0.29 (0.06 to 1.31)

NR

Ruiz‐Tovar 2013

Clean

Breast

40

Antibiotic

Saline

NR

2 weeks

0/20

0/20

Not estimable

NR

Ruiz‐Tovar 2016a

Clean‐contaminated

Colorectal

106

Antibiotic

Saline

NR

30 d

2/52

7/52

0.20 (0.05 to 1.87)

NR

Ruiz‐Tovar 2016b

Clean‐contaminated

Bariatric surgery

80

Antibiotic

Saline

NR

30 d after discharge

NR

NR

Schein 1990

Dirty

Abdominal infection

87

Antibiotic

Saline

(No irrigation)

Discharge of pus

2 weeks

5/29

5/29

(6/29)

1.00 (0.32 to 3.09)

NR

Silverman 1986

Mixed

Gastrointestinal/colorectal

159

Antibiotic

Saline

Discharge of pus

6 weeks

10/85

24/74

0.36 (0.19 to 0.71)

NR

Sindelar 1979

Mixed

General Surgery

500

Antiseptic

Saline

Pus discharged within 12 weeks or serous drainage from questionable wounds plus positive culture

12 weeks

7/242

39/258

0.19 (0.09 to 0.42)

NR

Takesue 2011

Clean‐contaminated

Colorectal

400

Antiseptic

Saline

National Nosocomial Infections Surveillance system

30 d (total 3 months)

19/180

29/183

0.67 (0.39 to 1.14)

1.44 (0.71 to 2.93)

Tighe 1982

Contaminated

Appendix

131

Antiseptic irrigation

Non‐antibacterial irrigation

(No irrigation)

Prescence of pus either spontaneously or on probing. All infections confirmed bacteriologically

NR

7/131 Results are not given by intervention group; No effect estimate calculable

NR

Vallance 1985

Dirty

Peritonitis

53

2 Antiseptics

Saline

Pus in wound, sero‐sanguinous discharge, Inflammation or induration

1 month

23/29

10/16

0.61 (0.40 to 0.92)

NR

Comparisons of two different agents in the same class

Brown 2007

Clean‐contaminated

Uterine

449

2 non‐antibacterials

Icodextrin

Ringer's solution

NR clearly; data on infection ambiguous

NR

Dashow 1986

Clean‐contaminated

Caesarean

360

4 antibiotics

(Saline)

Cephapirin

Cefamandole

Moxalactam

Ampicillin

Wound breakdown with positive culture or presence of cellulitis

NR

3/70

2/64

2/79

0/70

Cephapirin: cefamandole

1.37 (0.24 to 7.95)

Cephapirin: moxalactam

1.69 (0.29 to 9.84)

Cephapirin: ampicillin

7.00 (0.37 to 133.06)

Cefamandole: moxalactam

1.23 (0.18 to 8.52)

Cefamandole: ampicillin

5.46 (0.27 to 111.65)

Moxalactam: ampicillin

4.44 (0.22 to 90.88)

NR

Levin 1983;

Clean‐contaminated

Caesarean

128

2 antibiotics

(Saline)

Cephapirin

cefoxitin

Purulent wound discharge with or without wound separation

8 weeks

0/44

0/41

Not estimable; zero events

NR

Marti 1979

Contaminated

Appendicitis

162

2 antibiotics

(Saline)

Epicillin

Lincomycin

Septic complications with spontaneous or induced purulent discharge

4 d; longer follow‐up unclear

Not estimable; number of participants and events per group not reported

NR

Mohd 2010;

Clean

Cardiac

190

2 antiseptics

Povidone iodine

Dermacyn

Centers for Disease Control and Prevention criteria

6 weeks

14/90

5/88

2.80 (1.05 to 7.47)

NR

Oller 2015

Clean

Breast

51

2 antibiotics

Clindamycin

Gentamicin

NR

NR

0/17

0/17

Not estimable; zero events

NR

Peterson 1990

Clean‐contaminated

Caesarean

207

113 in relevant groups

2 antibiotics

Cefazolin

Cefamandole

Presence of cellulitis and/or purulent exudate

> 2 weeks

2/59

0/54

4.58 (0.22 to 93.38)

NR

Shimizu 2011

Clean

Brain

20

2 non‐antibacterials

Saline

Artificial CSF

NR

NR

Trew 2011

Clean‐contaminated

Uterine

498

2 non‐antibacterials

Icodextrin

Ringer's solution

NR

4‐16 weeks

3/217

1/209

2.89 (0.30 to 27.56)

NR

Vallance 1985

Dirty

Peritonitis

53

2 antiseptics

(Saline)

Povidone iodine

Chlorhexidine

Pus in wound, sero‐sanguinous discharge, Inflammation or induration

1 month

4/16

4/13

1.13 (95% CI 0.78 to 1.63)

NR

Comparison of pulsatile versus standard irrigation delivery

Hargrove 2006

Clean

Orthopaedic

356

Pulsatile saline

Standard saline

Nosocomial Infection National Surveillance Survey

30 days or discharge

9/164

30/192

0.35 (0.17 to 0.72)

NR

Nikfarjam 2014

Clean‐contaminated

Abdominal

137

Pulsatile saline

Standard saline

Purulent drainage, with or without laboratory confirmation; organisms isolated from aseptically obtained culture of fluid or tissue; at least 1 of the following: pain or tenderness, localised swelling, redness, or heat and incision is deliberately opened by surgeon, unless incision is culture‐negative; diagnosis of superficial incisional SSI by surgeon or attending physician

1 month

4/66

12/62

0.31 (0.11 to 0.92)

0.31 (0.01 to 7.55)

1Elliott is a 4‐armed trial with a factorial design, arms with and without intravenous antibiotics are combined

CI: confidence interval; CSF: cerebrospinal fluid; NR: not reported; RR: risk ratio

Figuras y tablas -
Table 2. Summary of primary outcome data: surgical site infection (SSI) and wound dehiscence
Table 3. Summary of subgroup analyses

Comparison

Subgroup basis

Pre‐specified or exploratory

Subgroups used

Subgroup results
RR (95% CI)

I2 & Chi2 subgroup differences

I2 & Chi2 overall

Irrigation vs no irrigation

Surgical classification

Pre‐specified

Clean‐contaminated

Contaminated/Dirty/Mixed

1.00 (0.82, 1.21)

0.74 (0.47 to 1.16)

I2 = 29.1%.

Chi2 = 1.41

I2 = 28%

Chi2 = 16.58

Irrigation vs no irrigation

Type of irrigation

Exploratory

Non‐antibacterial

Antiseptic

Antibiotic

0.80 (0.46 to 1.41)

0.97 (0.81 to 1.17)

0.92 (0.42 to 1.99)

I2 = 0%

Chi2 = 0.39

I2 = 28%

Chi2 = 16.58

Antibacterial vs non‐antibacterial

Surgical classification

Pre‐specified

Clean

Clean‐contaminated

Contaminated/Dirty/Mixed

0.17 (0.03 to 0.89)

0.57 (0.40 to 0.79)

0.61 (0.40 to 0.92)

I2= 9.7%

Chi2 = 2.21

I2 = 53%

Chi2 = 56.94

Antibacterial vs non‐antibacterial

Type of irrigation

Exploratory

Antiseptic

Antibiotic

0.63 (0.40 to 0.95)

0.57 (0.44 to 0.75)

I2= 0%

Chi2 = 0.38

I2 = 53%

Chi2 = 56.94

CI: confidence interval; RR: risk ratio

Figuras y tablas -
Table 3. Summary of subgroup analyses
Table 4. Summary of secondary outcomes

Study

Surgical category/type

Participants (N)

Follow‐up

Interventions

Mortality
RR (95% CI)

Systemic antibiotics
RR (95% CI)

Antibiotic resistance
RR (95% CI)

Adverse events
RR (95% CI)

Reoperation
RR (95% CI)

Readmission
RR (95% CI)

Length of stay (days (95% CI))

Irrigation compared with no irrigation

Bourgeois 1985

Clean‐contaminated

Caeasarean section

223

6 weeks

Antibiotic irrigation/Saline irrigation

No irrigation

Specific complication

only

Difference in means ‐0.46 (‐0.64 to ‐0.29)

Buanes 1991

Dirty

Perforated appendicitis

85

6 weeks

Saline postoperative irrigation

No postoperative irrigation

Medians

5 (3‐11) vs 5 (4‐12)

Cervantes‐Sanchez 2000

Contaminated

Appendicitis

283

4 weeks

Saline irrigation

No irrigation

No group data

Cho 2004

Clean‐contaminated

Gastrectomy

34

2 weeks (primary outcome)

Saline irrigation

No irrigation

No secondary outcomes were reported

De Jong 1982

Mixed

Abdominal/inguinal hernia

592

4 weeks (primary outcome)

Antiseptic irrigation

No irrigation

No secondary outcomes were reported

Elliott 19861

Clean‐contaminated

Caeasarean section

158

6 weeks

Antibiotic irrigation

No irrigation

Specific complication

only

Difference in means

‐0.20 (‐0.57 to 0.17)

Gungorduk 2010

Clean‐contaminated

Caeasarean section

520

6 weeks

Saline irrigation

No irrigation

Difference in means 0.01 (‐0.03 to 0.05)

Harrigill 2003

Clean‐contaminated

Caeasarean section

196

NR

Saline irrigation

No irrigation

Overall

RR 1.10 (0.55 to 2.22)

Difference in means 0.10 (‐0.17 to 0.37)

Mahomed 2016

Clean‐contaminated

Caeasarean section

3270

4 weeks

Antiseptic irrigation

No irrigation

RR 0.77 (0.29 to 2.07)

RR 1.29 (0.81 to 2.06)

Oleson 1980

Dirty

Perforated appendicitis

33

mean 8 days (5‐16)

Antibiotic irrigation/Saline irrigation

No irrigation

Abscess

RR 0.17 (0.01 to 3.94)

Medians

14 (8‐22) vs 13 (9‐22)

Ozlem 2015

Dirty

Perforated appendicitis

14

NR

Saline irrigation

No irrigation

Overall

RR 1.00 (0.08 to 13.02)

Abscess but no group data

Platt 2003

Clean

Breast

30

8 weeks

Saline irrigation

No irrigation

Schein 1990

Dirty

Abdominal infection

87

2 weeks

Saline irrigation

Antibiotic irrigation

No irrigation

RR 0.75 (0.30 to 1.90)

Difference in means not estimable

11.5 vs 13

Snow 2016

Mixed

Appendix

83

6 weeks

Saline irrigation

No irrigation

Abscess RR 1.02 (0.15 to 6.93)

Medians

2.0 (1‐3) vs 2.0 (1‐2.25)

St Peter 2012

Dirty

Appendix

220

2‐4 weeks

Saline irrigation

No irrigation

Abscess

RR 0.95 (0.55 to 1.65)

RR 0.33 (0.01 to 8.09)

RR 0.14 (0.01 to 2.73)

Difference in means ‐0.10 (‐0.85 to 0.65)

Tanaka 2015

Clean‐contaminated

Liver resection

193

4 weeks

Saline irrigation

No irrigation

RR 2.02 (0.36 to 2.04)

Overall

RR 1.04 (0.72 to 1.49)

Difference in means 0.00 (‐3.74 to 3.74)

Tanphiphat 1978

Contaminated

Appendix

374

2 weeks

Antiseptic irrigation

No irrigation

No secondary outcomes were reported

Temizkan 2016

Clean‐contaminated

Caeasarean section

430

NR

Saline irrigation

No irrigation

No secondary outcomes were reported

Tighe 1982

Contaminated

Appendix

131

NR

Antiseptic irrigation

No irrigation

Non‐antibacterial irrigation

53/131 participants "distributed evenly across the groups"

No group data

Viney 2012

Clean‐contaminated

Caeasarean section

236

NR

Saline irrigation

No irrigation

Median discharge

day: 3 in both groups

Antibacterial irrigation vs non‐antibacterial irrigation

Al‐Shehri 1994

Mixed

Appendicits

254

1 month

Antibiotic

Saline

Abscess

RR not estimable 0 events

No group data

Baker 1994

Clean‐contaminated

Colorectal

330

6 weeks

Antiseptic

Saline

RR 1.00 (0.25 to 3.92)

Abscess RR 2.0 (0.18 to 21.82)

No group data

Bourgeois 1985

Clean‐contaminated

Caeasarean section

223

6 weeks

Antibiotic irrigation

Saline irrigation

(No irrigation)

Specific complication

only

Difference in means ‐1.08 (‐1.25 to ‐0.92)

Browne 1978

Dirty

Peritonitis

35

NR

Antiseptic irrigation

Saline irrigation

RR 7.39 (0.41 to 133.24)

Carl 2000

Clean‐contaminated

Caeasarean section

40

4‐6 weeks

Antibiotic

Saline

Case 1987

Clean

Breast

54

6 weeks

Antibiotic

Saline

Chang 2006

Clean

Spinal

244

2 weeks, long‐term follow‐up to 19 months

Antiseptic

Saline

All 6 participants with SSI received these; all in saline group

5/6 infections positive for MRSA

Cheng 2005

Clean

Spinal

417

2 weeks long ‐term follow ‐up to mean 15.5 months

Antiseptic

Saline

Dashow 1986

Clean‐contaminated

Caeasarean section

360

NR

4 antibiotics

Saline

Abscess

RR not estimable 0 events

Greig 1987

Mixed

Colorectal

129

1 month

Antibiotic

Saline

No secondary outcomes were reported

Halsall 1981

Mixed

Appendicitis

192

4 weeks

Antiseptic

Saline

Difference in means not estimable (6.4 vs 6.6)

Kokavec 2008

Clean

Orthopaedic

162

mean 7‐8 months (range 2‐14 months) (primary outcome)

Antiseptic

Saline

No secondary outcomes were reported

Kubota 1999

Dirty

Perforated appendicitis

16

NR

Antiseptic

Saline

Abscess RR 0.33 (0.02 to 7.14)

Difference in means ‐10.60 (‐19.06 to ‐2.14)

Kubota 2015

Dirty

Perforated appendicitis

44

30 days

Antiseptic

Saline

Abscess

RR 0.83 (0.06 to 12.49)

Difference in means ‐0.70 (‐3.31 to 1.91)

Levin 1983

Clean‐contaminated

Caeasarean section

128

8 weeks

Antibiotic

Saline

Specific complication

only

Difference in means ‐0.35 (‐1.06 to 0.36)

Lord 1983

Mixed

Gastrointestinal/colorectal

200

NR

Antibiotic

Saline

RR 1.67 (0.41 to 6.79)

Specific organisms

Specific complication

only

Magann 1993

Clean‐contaminated

Caeasarean section

100

NR

Antibiotic

Saline

Specific complication

only

Marti 1979

Contaminated

Appendicitis

162

4 days; longer follow‐up unclear

Antibiotic

Saline

Specific complication

only

Mirsharifi 2008

Clean‐contaminated

Cholecystectomy

102

6 weeks

Antibiotic

Saline

No secondary outcomes were reported

Moylan 1968

Clean‐contaminated

Abdominal

260

Until discharge

Antibiotic

Saline

Kanamycin resistance

Kanamycin: 12/12

Saline: "over half" of 23

Specific complication

only

Neeff 2016

Clean‐contaminated

Colorectal

197

NR

Antiseptic

Saline

No secondary outcomes were reported

Oestreicher 1989

Mixed

General surgery

540

NR

Antiseptic

Saline

No secondary outcomes were reported

Oleson 1980

Dirty

Perforated appendicitis

33

Mean 8 days (5‐16

Antibiotic irrigation

Saline irrigation

No irrigation

Abscess

RR not estimable 0 events

Medians 13 (9‐20

13 (10‐22)

Oller 2015

Clean

Breast

51

NR

Antibiotic 1/ Antibiotic 2

Saline

RR not estimable, 0 events

Medians 3 (1‐3)

3 (1‐3)

Rambo 1972

Dirty

Peritonitis

94

NR

Antibiotic

Saline

RR 0.71 (0.25 to 2.01)

Specific organisms

Abscess grouped with another event ‐ not estimable

Ruiz‐Tovar 2011

Clean‐contaminated

Colorectal

128

NR

Antibiotic

Saline

No secondary outcomes were reported

Ruiz‐Tovar 2012

Clean‐contaminated

Colorectal

108

30 days

Antibiotic

Saline

RR 0.50 (0.05 to 5.35)

Abscess RR 0.14 (0.01 to 2.65)

Medians 6 (5‐32)

6.5 (5‐14)

Ruiz‐Tovar 2013

Clean

Breast

40

2 weeks

Antibiotic

Saline

RR not estimable, 0 events

Overall RR not estimable 0 events

Medians

3 (1‐3)

3 (1‐3)

Ruiz‐Tovar 2016a

Clean‐contaminated

Colorectal

106

30 days

Antibiotic

Saline

RR 1.00 (0.06 to 15.57)

Specific complication

only

Medians

6.5 (5‐14)

6 (5‐32)

Ruiz‐Tovar 2016b

Clean‐contaminated

Bariatric surgery

80

30 days

Antibiotic

Saline

RR 0.33 (0.01 to 7.95)

Overall RR 0.50 (0.05 to 5.30)

Schein 1990

Dirty

Abdominal infection

87

2 weeks

Antibiotic

Saline

RR 0.50 (0.14 to 1.81)

Overall RR 0.56 (0.21 to 1.46)

Abscess RR 0.33 (0.01 to 7.86)

Difference in means not estimable 10 vs 13

Silverman 1986

Mixed

Gastrointestinal/colorectal

159

6 weeks

Antibiotic

Saline

Abscess RR 0.96 (0.43 to 2.13)

Specific additional complication

RR 6.10 (0.32 to 116.28)

Sindelar 1979

Mixed

General Surgery

500

12 weeks

Antiseptic

Saline

No secondary outcomes were reported

Takesue 2011

Clean‐contaminated

Colorectal

400

30 days (total 3 months)

Antiseptic

Saline

MRSA

4/14 vs 8/24 MSSA

0/14 vs 3/24

Tighe 1982

Contaminated

Appendix

131

NR

Antiseptic

Non‐antibacterial

(No irrigation)

53/131 participants "distributed evenly across the groups"

No group data

Vallance 1985

Dirty

Peritonitis

53

1 month

Antiseptic

Saline

RR 0.61 (0.17 to 2.16)

Difference in means ‐0.70 (‐3.32 to 1.92)

Comparisons of two different agents in the same class

Brown 2007

Clean‐contaminated

Uterine

449

28‐56 days

2 non‐antibacterials

Icodextrin

Ringer's solution

RR not estimable ‐ 0 events

Total: RR 0.99 (0.96 to 1.02)

Treatment‐related RR 1.42 (0.98 to 2.05)

Serious RR 1.20 (0.80 to 1.78)

Serious treatment‐related RR 0.71 (0.29 to 1.73)

Dashow 1986

Clean‐contaminated

Caeasarean section

360

NR

4 antibiotics

(Saline)

Cephapirin

Cefamandole

Moxalactam

Ampicillin

Abscess: no effect estimate calculable ‐ 0 events

Other specific events

Levin 1983

Clean‐contaminated

Caeasarean section

128

8 weeks

2 antibiotics

(Saline)

Cephapirin

Cefoxitin

Specific event data only

Difference in means 0.10 (‐0.78 to 0.58)

Marti 1979

Contaminated

Appendicitis

162

4 days; longer follow‐up unclear

2 antibiotics

(Saline)

Epicillin

Lincomycin

1 abscess in antibiotic groups; no group data

Mohd 2010

Clean

Cardiac

190

6 weeks

2 antiseptics

Povidone iodine

Dermacyn

4 deaths but no group data; group data for composite outcome with reopening of chest

RR 8.80 (0.48 to 161.11)

Oller 2015

Clean

Breast

51

NR

2 antibiotics

Clindamycin

Gentamicin

RR not estimable, 0 events

Median 3 (1‐3) in each group

Peterson 1990

Clean‐contaminated

Caeasarean section

207

113 in relevant groups

2 weeks + (primary outcome)

2 antibiotics

Cefazolin

Cefamandole

No secondary outcomes were reported

Shimizu 2011

Clean

Brain

20

10 days

2 non‐antibacterials

Saline

Artificial CSF

2 participants in each group, included MRI data. RR not calculated

‐‐

Trew 2011

Clean‐contaminated

Uterine

498

4‐16 weeks

2 non‐antibacterials

Icodextrin

Ringer's solution

RR not estimable ‐ 0 events

Total: RR 0.95 (0.73 to 1.24)

Treatment‐related RR 1.16 (0.60 to 2.23)

Vallance 1985

Dirty

Peritonitis

53

1 month

2 antiseptics

(Saline)

Povidone iodine

Chlorhexidine

RR 0.45 (0.05 to 3.90) within 4 days, no group data for later events

Difference in means 3.30 (0.53 to 3.90)

Comparison of pulsatile versus standard irrigationdelivery

Hargrove 2006

Clean

Orthopaedic

356

30 days or discharge

Pulsatile saline

Standard saline

No group data

No group data "half" SSI positive for MRSA

Nikfarjam 2014

Clean‐contaminated

Abdominal

137

1 month

Pulsatile saline

Standard saline

No group data: 14/16 SSI treated

Qualitative data on organisms isolated

Complications, not wound infections RR 1.31 (0.87 to 1.97)

RR 0.56 (0.14 to 2.26)

RR 1.41 (0.53 to 3.73)

Median

9 (5 ‐45)

9 (4‐71)

More details of interventions can be found in Table 1 and Characteristics of included studies

1 Elliott is a four‐armed trial with a factorial design, arms with and without iv antibiotics are combined

CI: confidence interval; CSF: cerebrospinal fluid; MRI: magnetic resonance imaging; MRSA: methicillin‐resistant Staphylococcus aureus; RR: risk ratio; SSI: surgical site infection

Figuras y tablas -
Table 4. Summary of secondary outcomes
Comparison 1. All irrigation versus no irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

14

6106

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.68, 1.11]

1.1 clean or clean‐contaminated

7

4801

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.82, 1.21]

1.2 contaminated or dirty

7

1305

Risk Ratio (M‐H, Random, 95% CI)

0.74 [0.47, 1.16]

2 Adverse events Show forest plot

3

403

Risk Ratio (M‐H, Random, 95% CI)

1.05 [0.76, 1.44]

3 Abscess Show forest plot

3

331

Risk Ratio (M‐H, Random, 95% CI)

0.91 [0.54, 1.54]

4 Mortality Show forest plot

2

280

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.36, 2.04]

5 Hospital stay Show forest plot

7

1597

Mean Difference (IV, Random, 95% CI)

‐0.13 [‐0.38, 0.12]

6 Return to theatre (reoperation) Show forest plot

2

3247

Risk Ratio (M‐H, Random, 95% CI)

0.72 [0.28, 1.84]

7 Readmission to hospital Show forest plot

2

3247

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.10, 4.90]

Figuras y tablas -
Comparison 1. All irrigation versus no irrigation
Comparison 2. Antibacterial irrigation versus non‐antibacterial irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

30

5141

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.44, 0.75]

1.1 clean

4

680

Risk Ratio (M‐H, Random, 95% CI)

0.16 [0.03, 0.89]

1.2 clean‐contaminated

13

2210

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.40, 0.79]

1.3 contaminated or dirty

13

2251

Risk Ratio (M‐H, Random, 95% CI)

0.61 [0.40, 0.92]

2 Wound dehiscence Show forest plot

3

660

Risk Ratio (M‐H, Random, 95% CI)

1.26 [0.65, 2.45]

3 Adverse events Show forest plot

3

178

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.22, 1.34]

4 Abscess Show forest plot

9

1309

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.42, 1.62]

5 Mortality Show forest plot

11

1121

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.48, 1.36]

6 Hospital stay Show forest plot

7

635

Mean Difference (IV, Random, 95% CI)

‐0.85 [‐1.60, ‐0.09]

7 Return to theatre (reoperation) Show forest plot

2

403

Risk Ratio (M‐H, Random, 95% CI)

1.26 [0.12, 13.60]

Figuras y tablas -
Comparison 2. Antibacterial irrigation versus non‐antibacterial irrigation
Comparison 3. Icodextrin versus lactated Ringer's solution

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mortality Show forest plot

2

875

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Adverse events Show forest plot

2

875

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.96, 1.02]

3 Treatment‐related adverse events Show forest plot

2

875

Risk Ratio (M‐H, Random, 95% CI)

1.35 [0.98, 1.86]

Figuras y tablas -
Comparison 3. Icodextrin versus lactated Ringer's solution
Comparison 4. Standard irrigation versus pulsatile irrigation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 SSI Show forest plot

2

484

Risk Ratio (M‐H, Random, 95% CI)

0.34 [0.19, 0.62]

Figuras y tablas -
Comparison 4. Standard irrigation versus pulsatile irrigation